Screening for diabetes in optometric practice by HOWSE, JENNIFER,HELEN
Durham E-Theses
Screening for diabetes in optometric practice
HOWSE, JENNIFER,HELEN
How to cite:
HOWSE, JENNIFER,HELEN (2010) Screening for diabetes in optometric practice. Doctoral thesis,
Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/262/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-profit purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Office, Durham University, University Office, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
  
i 
 
 
 
 
 
 
 
Screening for diabetes in optometric practice 
 
Jennifer Helen Howse 
 
Submitted for the degree of Doctor of Philosophy 
May 2010 
 
Durham University 
  
ii 
Abstract 
Diabetes is an increasing problem worldwide and is placing increasing strain on 
the healthcare system. It often goes undiagnosed for many years until 
complications occur. Identifying undiagnosed disease presents a challenge to all 
healthcare professionals. In the UK, screening has traditionally been the role of 
general practitioners, although other professionals such as pharmacists have 
recently become involved. Optometrists may also be in a good position to carry 
out screening tests themselves. Their role in screening for diabetes has not 
been previously investigated. 
 
The first part of the thesis takes a qualitative approach to explore optometrists’ 
perceptions, attitudes and beliefs about diabetes and screening for the disease. 
It demonstrated that if certain barriers, such as cost and training, can be 
overcome, some optometrists are willing to carry out screening tests. It also 
raises issues regarding their professional roles and their relationship with other 
healthcare providers. 
 
The second part of the thesis describes the development and implementation of 
a screening scheme using random capillary blood glucose (rCBG) tests. Over 
three-quarters of eligible adults participated in the screening. We found that 
around one third (318) of those had a rCBG level requiring further investigation. 
Half of these people reported attending their GP and receiving further 
investigation. 16 (5%) were subsequently diagnosed with either diabetes or pre-
diabetes. Those who participated in the screening programme found the test 
procedure to be comfortable, convenient and would recommend it to others. 
 
Analyses of strategies to identify those most at risk who would benefit from 
screening suggest that offering rCBG tests to those who are aged over 40 years 
with either a BMI of 25kg/m2 or more, or a family history of diabetes or both, 
would be effective for detection purposes. 
 
This research confirmed the feasibility of testing for diabetes in optometry 
practices and opens the door for another, PCT-based, study. This novel 
approach has never been tried before. 
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Chapter 1 
Introduction 
Diabetes is an increasing issue in today’s society, with frequent news 
reports about the dangers of increasing prevalence of the disease. 
Despite frequent media coverage, many people are unaware of the risks 
and symptoms of the disease and the rate of undiagnosed disease is 
thought to be high. 
 
Identifying those people who are at risk of having undiagnosed diabetes 
is a challenge. Although in the UK health care is free at the point of 
delivery and cost or lack of insurance is not a factor in accessing 
services, there are still many people who do not use medical services 
such as GPs’ practices for preventative care or earlier diagnosis. 
Currently most testing for diabetes in the UK is carried out in GPs’ 
practices, though some pharmacies offer screening services using 
capillary blood glucose testing (1). The National Health check 
programme, which is currently being rolled out across the UK, includes 
fasting plasma glucose or HbA1c tests for those who are determined to be 
at risk of developing diabetes (2). Even with these services, there are still 
people who have undiagnosed disease and are not accessing healthcare 
professionals able to screen or diagnose the condition. 
 
Optometrists carry out around 17million sight tests a year (3) and may be 
seeing many people who may have undiagnosed diabetes. Currently, 
they are not involved in screening for any systemic diseases, though their 
training requires them to study various systemic conditions including 
hypertension and diabetes, both of which have ocular complications (4). It 
has been suggested that optometrists are in a position to measure blood 
pressure to identify those requiring treatment for hypertension (5). This 
was felt to be an approach to advance the profession. However, their role 
in detecting undiagnosed diabetes in routine practice has not been 
considered. 
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Optometrists, as a profession, are currently positioned between business 
and healthcare. The majority of UK optometrists are working in high street 
practices. They provide services on behalf of the National Health Service 
(NHS), but are not employed by them. Due to the way the NHS funds 
sight testing, the business side of selling spectacles is essential for 
practices to continue to provide services. This conflict between business 
and healthcare affects the way optometrists are viewed by other 
healthcare professionals and the public and how they perceive 
themselves and their role.  
 
Like pharmacists, optometry practices are often situated in high street 
locations, and often have longer opening hours, including weekends, than 
GPs practices may have, making access easier for some people. 
However, while pharmacists have been included in screening services, 
optometrists have not yet taken up these initiatives. This may be for a 
variety of reasons. Optometrists may not see it as their role to offer these 
services, or might feel that other professionals do not want them to do so. 
The attitudes of healthcare professionals and the public towards 
optometrists will impact on whether it is feasible for optometrists to offer 
services outside their traditional sight testing role, such as screening for 
diabetes. 
 
This thesis aims to explore some of these ideas, firstly using qualitative 
methods to evaluate the perceptions and attitudes of optometrists 
themselves to screening, diabetes itself and their possible role in such 
extended healthcare. Secondly, a screening service will be tested in high 
street practices to establish the feasibility of such a service in this new 
location. Finally, a study embedded in the screening project will consider 
the acceptability of the new service to the participants.  
 
Chapter 2 is a review of the literature. Diabetes and pre-diabetes are 
discussed in terms of prevalence, diagnosis and risk factors. Screening 
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for diabetes is considered, and the role that other healthcare 
professionals have in screening. Finally the current role of optometrists 
within the UK health care system is considered. 
 
Chapters 3 and 4 describe a qualitative evaluation of optometrists’ beliefs 
and attitudes towards diabetes and screening. The background and study 
design is described in chapter 3 and the results discussed in chapter 4.  
 
Chapter 5 describes the design of a feasibility study using random 
capillary blood glucose (rCBG) to screen for diabetes and pre-diabetes in 
optometry practices.  The results of the rCBG tests are described in 
chapter 6. The follow up with participants who had a rCBG measurement 
requiring further investigation is considered in chapter 7. 
 
The design and results of a study to evaluate acceptability of the 
screening service to participants is discussed in chapter 8. 
 
The economic implications of using optometrists and optometry practices 
as a location to screen for diabetes is discussed in chapter 9. The costs 
of screening and the use of different strategies for identifying those at risk 
of diabetes who would benefit from participating in screening is 
considered. 
 
Chapter 10 discusses the findings and implications of the studies 
described in the previous chapters. 
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Chapter 2  
Literature review 
2.1 Diabetes 
Diabetes mellitus was has long been recognised.  A description of a 
polyuric condition has been found in ancient Egyptian papyrus dating 
from 1550BC. Diabetes was used as a term in the 2nd century AD to 
describe conditions where there was an increase in urine and is derived 
from the Greek ‘to pass through’. Polyuria in association with sweet 
tasting urine was first recorded in India in the 5th and 6th century AD. The 
term mellitus, which is derived from the Greek and Latin terms for honey, 
was added in the 17th century. This was used to distinguish diabetes 
mellitus from different other polyuric conditions where there is no 
glycosuria and so do not feature sweet tasting urine (6). 
 
2.1.1 Classification  
Diabetes mellitus describes a metabolic disorder that causes chronic 
hyperglycaemia due to either defective insulin secretion or insulin action, 
or both. (7).   
 
The first World Health Organisation (WHO) classification of diabetes 
mellitus was published in 1980 (8) and revised in 1985 (9). The 1980 
report proposed two classifications, IDDM (insulin dependant diabetes 
mellitus) or Type 1 and NIDDM (non insulin dependant diabetes mellitus) 
or Type 2. The nomenclature Type 1 and 2 was not used in the 1985 
study group report, with the terms NIDDM and IDDM used only. 
 
In 1999 WHO recommended that the terms NIDDM and IDDM should no 
longer be used, as they can cause confusion. Type 1 and Type 2 were 
reintroduced to ensure that classification was based on disease aetiology 
rather than treatment method (7). Type 1 Diabetes covers those cases 
where disease is due to pancreatic islet beta-cell destruction. This can be 
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idiopathic or more commonly is due to autoimmune processes. It does 
not include cases where beta-cell destruction is due to a specific disease 
such as cystic fibrosis. Type 2 diabetes covers those cases that result 
from defects in insulin secretion and is often combined with a degree of 
insulin resistance. This category covers a range from defective insulin 
secretion with no insulin resistance to largely insulin resistance with a 
degree of defective secretion. The deficiency in insulin secretion is 
usually relative rather than absolute. 
 
The WHO classification names other specific type of diabetes that do not 
fit in to the Type 1 and 2 categories. These include drug or chemical 
induced disease, gestational diabetes, diseases of the exocrine pancreas 
and genetic defects of beta-cell function (7). 
 
Diabetes can be further subdivided into three groups corresponding to 
treatment requirements unrelated to the initial cause. ‘Insulin required for 
survival’ which corresponds with the class IDDM. The groups ‘Insulin 
required for control’ and “Not insulin requiring ‘ correspond to the classes 
of NIDDM. 
 
Type 2 is the commonest form of diabetes. Of the estimated 2,168,000 
people with all types of diabetes (both diagnosed and undiagnosed) in 
England in 2001, 92.3% were thought to have Type 2. 667,000 of these 
people are likely to not have been diagnosed. (10).  
 
The onset of Type 1 diabetes typically occurs earlier than Type 2, with 
onset peaking between 10 and 14 years. In the UK the incidence of Type 
1 diabetes in this age group is 26 per 100,000 per year (11).  In contrast, 
the incidence and prevalence of Type 2 diabetes increases with age. The 
prevalence of Type 2 diabetes in Middlesbrough is between 4.22 and 
5.51 cases per 1000 in the 20 to 39 year age groups. This rises to 
between 43.50 and 47.12 cases per 1000 of the population aged over 70 
years (12). 
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2.1.2 Prevalence and predictions 
Diabetes Mellitus is an increasing problem in Western society and 
worldwide.  The worldwide prevalence of diabetes in 2000 was estimated 
to be 171 million (2.8% of the population). The prevalence was set to 
increase to 366 million by 2030 (4.4% of the population) (13).  A higher 
prevalence of 4.0% in 1995 increasing to 5.4% in 2025 has also been 
reported (14). 
 
Predicted estimates of the prevalence of diabetes in the United States 
vary from 11.5% in 2011 increasing to 13.5% in 2021 (considering both 
diagnosed and undiagnosed disease)(15) and 4.72% in 2010 increasing 
to 5.89% in 2025 (considering those with diagnosed diabetes only)(16). 
The estimated number of people with diagnosed diabetes in 2050 has 
been revised from 7.21% of the population (16) to 12.0% (17). The 
increase in estimated prevalence is due to an increase in the incidence of 
diagnosed disease and a small reduction in the relative risk of mortality 
associated with diabetes between 2000 and 2004 (17). The models used 
to predict future prevalence assume that there will be no changes in 
treatment, average life expectancy, disease prevention or cure.  
 
The estimated prevalence of all types of diabetes (Type 1 and Type 2, 
both diagnosed and undiagnosed) in England in 2001 was 4.41%. The 
prevalence of diabetes in England varies between different ethnic groups, 
with highest prevalence in South Asian and Black African Caribbean 
populations (6.6% and 5.7% respectively)(10). In a population of older 
people (60-79 yrs) in the United Kingdom 7.6% of men and 5.1% of 
women were known to have diabetes, with a further 6.7% and 6.0% found 
to have diabetes when tested (18). 
 
The crude annual incidence of newly diagnosed Type 2 diabetes has 
been reported as 1.93 cases per 1000 people in the UK. It was 
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acknowledged that this rate may not represent the true incidence of new 
cases of diagnosis as it was recorded in a predominately white 
Caucasians and in a population where no screening procedures were in 
place (19). 
 
Incidence of Type 2 diabetes increases with age. The estimated 
prevalence ranges from 0.32% in those under 29 years to 13.47% in the 
over 60 years age group (10). 
 
There has been an increase in the incidence of childhood Type 2 
diabetes. In a twelve month period in 2004 and 2005, 67 cases of Type 2 
diabetes were confirmed in children less than 17 years in the UK, giving 
an incidence of 0.53 cases per 100,000 per year. Incidence was found to 
be higher then average in Black and South Asian populations, 3.9 and 
1.25 case per 100,000 per year respectively. 95% of the children 
diagnosed with Type 2 diabetes were found to be overweight and 84% 
had a family history of the disease (20). 5% of people under the age of 30 
years attending diabetic clinics in Leeds were diagnosed with Type 2 
diabetes(21). Children with Type 2 diabetes are often South Asian, 
overweight and have a strong family history of diabetes. Many of these 
children are diagnosed coincidentally (22). 
 
The average age at which Type 2 diabetes is diagnosed appears to be 
changing. In the US, the average age for diagnosis in 1988 to 1994 was 
52.04 years. In the period 1999 to 2000 the average age was 46.01 
years. Whether this is a real change in the onset of disease or a reflection 
of increased screening and earlier diagnosis is not clear (23). The 
increasing rates of obesity worldwide may also have an influential role in 
the earlier diagnosis of the disease.  
 
The prevalence of Type 2 diabetes increases with age in all populations 
studied, with the increases more pronounced in populations who have 
high prevalence of diabetes (24). 
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2.1.3 Risk factors 
Diabetes has a number of risk factors. These can be modifiable, such as 
obesity and lack of exercise, or non-modifiable such as age or ethnicity. 
 
Diabetes is a polygenic disease. Several genes have been identified as 
being candidate genes for Type 2 diabetes including USF1, CAPN10, 
HNF4α, PPARγ, ADRB3, KCNJ11, TCF7L2 and ENPP1 (25) (26) (27).  
These genetic factors cannot be used for clinical diagnosis as other 
modifiable factors such as environmental influences will also play a role in 
disease development (25).  
 
Family history has been shown to be a risk factor for the development of 
diabetes, with people with a sibling with Type 2 diabetes having a four 
times greater risk of developing diabetes in their lifetime than the general 
population (28). It has been suggested that a strong family history is 
associated with earlier onset of Type 2 diabetes, though family history 
does not appear to affect the clinical characteristics or complications (29) 
(30).  
 
Ethnicity has also been shown to a risk factor for Type 2 diabetes. 
Prevalence has been shown to be higher in South Asians than White 
Europeans living in the same area. In an area of Coventry it was found 
that the prevalence of diagnosed and undiagnosed Type 2 diabetes was 
11.2% in Asian men and 8.9% in Asian women compared with 2.8% in 
white men and 4.3% in white women(31). It was found that the 
prevalence of diabetes in Asians in an area of London was nearly four 
times higher than in Europeans, with seven times as many Asians 
diagnosed as having diabetes between the ages of 40 and 64 years than 
white Europeans (32). Higher prevalence in South Asian populations 
compared with European populations has also been demonstrated in 
urban populations in Norway (33). Higher prevalence has also been 
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shown in African Caribbean populations when compared with white 
Europeans populations (34, 35).  
 
The age of onset of diabetes is also associated with ethnicity. Seven 
times as many Asians as Europeans were diagnosed as having Type 2 
diabetes between the ages of 30 to 54 years in an area of London (32). In 
one study in the UK, all the cases of childhood onset Type 2 were 
reported in children of Indian, Pakistani and Arabic origin (22). A Danish 
study reported Type 2 diabetes in children with Turkish and Pakistani 
backgrounds (36). In the US, prevalence of Type 2 diabetes in 
adolescents is highest in American Indian and African American groups 
and lowest in non-Hispanic white children (37). 
 
The estimated prevalence of all types of diabetes, both diagnosed and 
undiagnosed, in the UK in 2001 was 0.33% in the 0-29 years age group 
rising to 13.92% in the population aged 60 years and more (10). 
 
Diet is considered to be a factor in the development of diabetes. It is 
difficult to determine exactly what effect individual nutrients have, as they 
are taken as part of a wider diet (38). It has been suggested that 
increased consumption of vegetables, fresh fruit and wholemeal bread 
reduce the risk of diabetes whereas daily consumption of meat increases 
the risk (39).  
 
Obesity as determined by body mass index (BMI) and abdominal obesity 
are modifiable risk factors. Abdominal obesity, measured by waist to hip 
ratio (WHR), has been shown to increase the risk of developing diabetes 
even when adjusted for BMI (40).  
 
Hypertension is a known risk factor for diabetes. In study of 99 patients 
attending a hypertension clinic in a UK hospital, 58 were found to have 
abnormal glucose tolerance (24 diabetes, 18 impaired glucose tolerance 
and 16 impaired fasting glucose) (41). Certain antihypertensive drugs, 
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including beta-blockers and thiazide diuretics, are associated with 
increased risk of diabetes (42). 
 
Prevalence of diabetes and impaired glucose tolerance is known to be 
higher in women with polycystic ovary syndrome (PCOS) (43) (44) (45). 
PCOS is relatively common with an estimated prevalence of around 5-
10% in premenopausal women (46). PCOS is associated with other risk 
factors for diabetes, such as obesity. However, obese women with PCOS 
have a higher prevalence of IGT and diabetes than age and weight 
matched population of women without PCOS (46).  Women with PCOS 
are at increased risk of developing the metabolic syndrome, a condition 
characterised by increased abdominal obesity, raised triglyceride levels, 
decreased HDL cholesterol, raised blood pressure and dysglycemia (47). 
It is considered to be a risk factor for the development of diabetes (42). 
Traits of metabolic syndrome have shown to be useful in determining 
whether a person should undergo OGTT to detect IGT and diabetes (48). 
 
Gestational diabetes is known to affect between 4 and 12% of 
pregnancies in the US (49). Blood glucose levels will usually return to 
normal levels after pregnancy. However there is an increased risk that 
they will develop Type 2 diabetes. A systematic review of studies 
considering Type 2 diabetes in women with a history of gestational 
diabetes found cumulative incidence of Type 2 diabetes ranged from 
2.6% to 70% with follow up lasting from 6 weeks to 28 years postpartum 
(50). The Diabetes Prevention Programme showed that women with IGT 
and a history of gestation diabetes where more likely to progress to 
diabetes compared with women who had IGT and no previous history of 
gestational diabetes (51).  
 
There is known to be a link between depression and diabetes. The risk of 
depression has been shown to be higher in people with diabetes than 
those without (52), with a prevalence of depression between 8.5% and 
32.5% among people with diabetes (53). There is evidence to show that, 
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as well as increased risk of depression in people with diabetes, there is 
an increased risk of developing diabetes among people with depression. 
In the Diabetes Prevention Programme (DPP), antidepressant medication 
was found to be associated with the risk of developing diabetes in those 
group given lifestyle intervention or placebo even when weight and initial 
fasting glucose was controlled for. Antidepressant use did not affect 
progression to diabetes in the group given metformin. However, 
participants who reported symptoms of depression while not taking 
medication did not show an increased risk of developing diabetes when 
adjusted for other factors such as weight (54). Depressive symptoms 
have been associated with factors that are known to increase the risk of 
diabetes, such as BMI and physical inactivity. However, some studies 
have found increased risk of developing diabetes in people with 
depressive symptoms after demographic and lifestyle factors have been 
taken into account (55).  
 
Diabetes has a higher prevalence among people with schizophrenia than 
those without with prevalence of 15% reported in some studies (53). As 
with depression, schizophrenia is associated with factors that influence 
the development of diabetes, such as physical inactivity, obesity and 
smoking. Some antipsychotic drugs have been linked with 
hyperglycaemia. Atypical anti-psychotics, which were used in around 
90% of people with schizophrenia in the US, have been shown to 
increase risk of developing diabetes when used long-term (56). Several 
mechanisms for this have been suggested for this, including insulin 
resistance, weight gain and toxic effects on the pancreatic islet cells (53).  
 
Physical inactivity increases the risk of developing diabetes. (57). 
Physical activity has been shown to reduce the risk of diabetes, whether it 
is leisure activity (58) (59), occupational activity (58) or commuting either 
by foot or bike  (58).  Though moderate to vigourous activity decreases 
risk of developing diabetes significantly (60), lower intensity activity, such 
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as walking or gardening has been shown to reduce the risk of developing 
diabetes by 17% when controlled for BMI (61). 
2.1.4 Diagnosis of diabetes  
The oral glucose tolerance test (OGTT) has been used as the standard 
diagnostic test for diabetes. However, the use of fasting plasma glucose 
(FPG) was recommended by WHO in 1997 and the lower threshold was 
lowered from 7.8mmol/l to 7.0mmol/l (62). OGTT is still a valid method for 
diagnosis, though it is recognised that it is more inconvenient than FPG 
measurements.  
 
The criteria for diagnosing diabetes has changed over time. The current 
WHO criteria are shown in figure 1 (7).   
 
Figure 1 - WHO criteria for diagnosis of diabetes  
 Venous whole 
blood 
Capillary whole 
blood 
Venous plasma 
Fasting ≥6.1 mmol/l ≥6.1 mmol/l ≥7.0mmol/l 
2 hours post 
glucose load 
≥10.0 mmol/l ≥11.1 mmol/l ≥11.1mmol/l 
 
2.1.5 Symptoms and complications 
Diabetes is often described as presenting with a classic triad of 
symptoms consisting of polyuria, thirst and weight loss (63). The 
American Diabetes Association (ADA) list seven symptoms associated 
with diabetes, frequent urination, excessive thirst, extreme hunger, 
unusual weight loss, increased fatigue, irritability and blurry vision. The 
International Diabetes Federation (IDF) includes the same symptoms, but 
excludes irritability and adds slow wound healing and recurrent infection 
(64). 
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A study of patients newly diagnosed with Type 2 diabetes investigated 
the presence and duration of typical symptoms prior to diagnosis. Over 
half the participants reported abnormal thirst (63.7%), fatigue (61.0%) or 
frequent urination (53.9%). Other commonly reported symptoms included 
cramp in calves (31.9%), genital itching (27.2%) and visual disturbances 
(24.9%). 89% of patients reported having at least one symptom in a two 
year period prior to diagnosis (65). 
 
Complications of diabetes can be macrovascular or microvascular (66). 
Macrovascular complications, such as stroke and cardiovascular disease 
are not specific to diabetes, but more prevalent in people with diabetes 
than those without. There has been a report in the reduction in mortality 
due to cardiovascular disease in the general population that has not been 
seen in the population with diabetes (67). 
 
In the United States, between the period 1971-1975 and 1982-1984, age 
adjusted heart disease mortality declined by 36.4% men with no diabetes 
compared with a decline of 13.1% in men with diabetes. During the same 
period women without diabetes experience a decline in mortality of 27%, 
however women with the disease showed an increase in heart disease 
related mortality of 23%(68). Following first myocardial infarction, people 
with Type 2 diabetes have been shown to have increased mortality by 
40% when compared with people without diabetes. The risk increases for 
younger people with diabetes (69). 
   
Microvascular complications include neuropathy, retinopathy and 
nephropathy (66).  
 
Diabetic retinopathy is thought to account for 4.8% of global cases of 
blindness (70). It is thought the be the leading cause of blindness in 
adults of working age, with age related macular degeneration causing 
more blindness in people aged over 65 years (71, 72).  
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In people with newly diagnosed Type 2 diabetes, retinopathy has been 
found to be present in between 4.0% (65) and 36.7% (73) of cases. There 
has found to be a considerable difference in prevalence in different 
studies. Drivsholm et al. (65) and Olivarius et al. (74) found the lowest 
prevalence of retinopathy among newly diagnosed patients (between 4 
and 5%). These Danish studies took place between 1989 and 1992 and 
relied on fundoscopy by an ophthalmologist to diagnose retinopathy, with 
the presence of microaneurysms only being classified as the least severe 
for of the disease. The UKPDS study, which found 36.7% of newly 
diagnosed patients to have some form of retinopathy used retinal 
photographs which were assessed by two independent readers to 
determine the presence of eye disease, with the presence of one 
microaneurysm in one eye being classified as having diabetic retinopathy 
present. Retinal photography began as part of the UKPDS study in 1983 
(75). Both the UKPDS (75) and Danish studies (65) (74) considered 
patients diagnosed with Type 2 diabetes by their GP in the course of their 
normal practice, rather than in a dedicated screening programme. 
Mitchell et al. (76) found a higher prevalence of retinopathy than the 
Danish studies, but lower than in the UKPDS. The 39 participants in this 
were newly diagnosed as a result of blood glucose testing as part of the 
Blue Mountains Eye Study rather than through their GP. Like the UKPDS 
study, retinal photographs were used to determine the presence of 
diabetic retinopathy, instead of fundoscopy. There is a wide range of 
reported prevalence of diabetic retinopathy in those newly diagnosed. 
This may relate to several factors; the method used to examine the 
fundus, criteria used to diagnose the disease and the method of the 
detection of newly diagnosed participants, whether through screening or 
after presenting to a GP. Figure 2 summarises the prevalence of diabetic 
retinopathy in newly diagnosed patients.  
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Figure 2 - Prevalence of diabetic retinopathy in people with newly 
diagnosed Type 2 diabetes 
Authors Year County Notes % Prevalence 
Drivsholm et. al. 
(65) 
2005 Denmark Female  
n=548 
4.0% 
Drivsholm et. al. 
(65) 
2005 Denmark Male 
n=589 
5.4% 
Olivarius et. al. 
(74) 
2001 Denmark n=1251 5.0% 
Litwin et. al. 
(77) 
2002 UK n=1953 18.4% 
Mitchell et. al. 
(76) 
1997 Australia n=39 15.8% 
Rema et. al. 
(78) 
2001 India n=438 7.3% 
Stratton et. al. 
(75) 
2001 UK n=1919 36.7% 
Ramachandran 
et. al. (79) 
1996 India n=69 6.7% 
 
 
Retinopathy is described as non-proliferative or proliferative according to 
whether abnormal new vessels are present. Early stages of retinopathy 
are asymptomatic. Non-proliferative diabetic retinopathy (NPDR) is 
graded as background or pre-proliferative by the UK National Screening 
Committee or as mild, moderate or severe background retinopathy by the 
Scottish Diabetic Retinopathy Grading Scheme (80).  Proliferative 
retinopathy is characterised by neovascularisation and can cause vision 
loss due to pre-retinal or vitreous haemorrhages or through tractional 
retinal detachment.  Neovascularisation can also occur in the iris and 
anterior chamber angle leading to rubeosis iridis and rubeotic glaucoma.  
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Vision loss can also occur through macular oedema that can occur at any 
stage of retinopathy (81). 
 
Ocular complications other than retinopathy can also occur. Refractive 
changes have been reported in poorly controlled diabetes (82). Although 
refraction changes in hyperglycaemia have traditionally been thought to 
be myopic, transient hyperopic shift have also been reported (83) (84). 
 
Age-related cataracts are common in patients with diabetes and tend to 
present at a younger age than in people without diabetes (85). Diabetes 
has been shown to be a risk factor in posterior subcapsular (PSC), 
cortical and mixed cataract (86) (87).  In some rare cases, cataracts can 
be reversible when glycaemic control is obtained (88).  
 
Ocular muscle palsies are known complications of diabetes and often 
present with sudden onset diplopia. In the cause of third nerve palsy 
associated with diabetes, the pupil is often spared (89). 
 
Duration of diabetes and glycaemic control are both known factors in the 
progression of some ocular complications, including retinopathy. 3 to 4 
years after diagnosis around 19% of patients with Type 1 diabetes and 
24% of those with Type 2 will have some form of retinopathy (90).  In the 
UKPDS study, 22% of those with no retinopathy at diagnosis had 
developed retinopathy within 6 years of diagnosis of Type 2 diabetes. 
They reported that development of diabetes was associated with both 
baseline glycaemia and glycaemic exposure over the follow-up period  
(75). This suggests that earlier diagnosis of diabetes and good glycaemic 
control may reduce the progression of diabetic retinopathy. Intensive 
glycaemic control is also thought to reduce the risk of other microvascular 
and macrovascular complications (73). 
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2.2 Pre-diabetes and non-diabetic hyperglycaemia 
The term pre-diabetes was used in the 1960s to describe a condition 
where there was an increased risk of diabetes either due to a strong 
family history of diabetes, for example an identical twin, or a condition 
occurring in pregnancy, such as large baby. The World Health 
Organisation rejected this term in 1980 as it was considered not to be a 
useful description and had the potential to carry negative connotations. 
By 2005 the term ‘pre-diabetes’ was being used again to describe the 
condition of non-diabetic hyperglycaemia (NDH), both impaired fasting 
glucose (IFG) and impaired glucose tolerance (IGT) (91). These 
hyperglycaemic states are known to be precursors of diabetes and can 
occur in isolation; isolated Impaired Fasting Glucose (i-IFG) or isolated 
Impaired Glucose Tolerance (i-IGT); or in combination (IFG/IGT). (92) 
2.2.1 Impaired Glucose Tolerance 
The diagnostic category IGT was recommended in 1979 by the US 
National Diabetes Data Group and accepted by WHO the following year 
(93). It was intended to indicate the range of values between normal 
glucose levels and those levels where there was known risk of developing 
diabetic complications, in particular retinopathy (94).  
 
Currently IGT is defined as fasting plasma glucose (FPG) of <7.0mmol/l 
and 2hr post challenge plasma glucose of >7.8 to <11.0 mmol/l (91).  
 
Prevalence of IGT in 40 to 74 year age group is 15.8% (95). The 
NHANES II study estimated that the prevalence of IGT in the adult US 
population was 11.2%, rising from 6.4% in 20-44 years age group to 
22.8% in the 65-74 years age group (96). 
2.2.2 Impaired Fasting Glucose 
In 1997 an International Expert Committee re-examined the classification 
of diabetes and recommended that fasting plasma glucose (FPG) could 
be used for the diagnosis of diabetes and that the cut off point for 
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diabetes should be lowered to 7.0mmol/l from 7.8mmol/l. Normal FPG 
was considered to be <6.1mmol/l. IFG was introduced to indicate the 
range between normal and diabetic FPG ranges (62). Currently IFG is 
defined by WHO as FPG of 6.1-6.9 mmol/l and by American Diabetes 
Association as FPG of 5.6-6.9 mmol/l (91). The lower cut-off point used 
by the ADA increases the prevalence of IFG to similar levels as IGT. In a 
population of 1040 adults without diabetes, aged between 40-69 years, 
25% were found to have IFG using the WHO criteria. If the ADA criteria 
was applied to the same population, the prevalence rose to 61% (97).  
 
Prevalence of IFG in the US population aged 20 years and over is 6.9%. 
In the 75 years and over age group, the prevalence was found to be 
14.1% (17.9% Male, 11.9% female) (95). 
2.2.3 Progression to and prevention of diabetes 
IGT and IFG have been shown to be an independent risk factor for the 
development of diabetes (98). The rates of progression to diabetes in 
people with IGT has been shown to be higher then in those with IFG. In 
turn, people with IFG have a higher rate of progression than then in 
people with normal glucose tolerance (93) (99). The highest rate of 
progression to diabetes is seen in those with both IGT and IFG, where is 
a 12-fold increase in annualised relative risk (93). 
 
Both lifestyle and drug interventions have shown that it is possible to 
reduce the progression to diabetes. In the Dream study, Rosiglitazone 
reduced incidence of diabetes in people with IGT, IFG or both by 60% 
compared with a placebo (25.0% progression to diabetes in placebo 
group compared with 10.6% in rosiglitazone group) (100). In the DPP 
study, Metformin reduced the incidence of diabetes by 31% when 
compared to the control groups (101).  
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Lifestyle (exercise, diet or both) intervention in people with IGT showed 
decreased incidence of diabetes in both Chinese (102), Finnish (103) and 
UK populations (104).  
 
These studies have shown that intervention is successful in reducing 
progression to diabetes in those individuals with IGT. However, there is 
less evidence to show to similar effects in people with IFG (105).   
 
2.2.4 Pre-diabetes and cardiovascular disease  
Diabetes is a recognised risk factor for cardiovascular disease and is 
known to increase mortality following myocardial infarction (68). It has 
also been recognised that non-diabetic hyperglycaemia is also a risk 
factor for cardiovascular disease (106) (107) (108). IGT is associated with 
increased incidence of cardiovascular disease and mortality associated 
with it (105) (109) (110). 
 
2.3 Screening for diabetes 
One of the earliest examples of mass community based screening for 
diabetes is from the United States where around 70% of the population of 
Oxford, Massachusetts were screened in 1946-47 using urine and blood 
tests (111).  
 
In the UK, the National Health check programme is currently being 
implemented. This screening programme for those aged between 40 and 
74 years includes a risk assessment of factors including smoking status, 
BMI measurement, physical activity and blood pressure measurement. 
For those at risk of developing diabetes, a fasting plasma glucose or 
HbA1c measurement is included.  
 
Screening for a disease is justified if seven conditions can be met (112). 
These are shown in figure 3. 
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Figure 3 - Appropriateness of screening - from Engelgau et. al. (112) 
Does diabetes represent an important health problem that imposes a 
significant health burden on the population? 
Is the natural history of Type 2 diabetes well understood? 
Does diabetes have a recognisable clinically silent stage during which the 
disease can be diagnosed? 
Does treatment after early detection of Type 2 diabetes yield benefits 
superior to those obtained when treatment is delayed? 
Are there tests that can detect preclinical (asymptomatic) diabetes that 
are reliable and acceptable? 
Are the costs of case finding and treatment reasonable and balanced in 
relationship to health expenditure as a whole? 
Will screening be an ongoing process? 
 
Does diabetes represent an important health problem that imposes a 
significant health burden on the population? 
Diabetes places a considerable burden on the population. The cost of 
treating complications not only occurs at the time when a complication 
occurs, but also in following years (113). It has been estimated that 
though the prevalence of diabetes in the US is around 5%, 15% of health 
care expenditure was on patients with the disease. The prevalence of 
diabetes is increasing (13) so increasing health care costs are likely.  The 
burden diabetes places on society is not simply due to health care costs, 
but also social care and loss of productivity due to early mortality and 
illness (114). 
 
Is the natural history of Type 2 diabetes well understood? 
The biochemical onset of diabetes is followed by a clinically silent period 
when the disease is undiagnosed. Initially it may be difficult to detect with 
a screening test, but as hyperglycaemia increases it will become easier to 
detect. This detectable preclinical stage is followed by the development of 
symptoms, then complications due to the disease (112). 
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Does diabetes have a recognisable preclinical stage during which the 
disease can be diagnosed? 
Diabetes can be diagnosed in asymptomatic individuals in the same way 
that it can be diagnosed in patients with further complications.  Based on 
the occurrence of complications on diagnosis it has been estimated that 
the clinically silent stage can last up to 12 years (115).  
 
Does treatment after early detection of Type 2 diabetes yield benefits 
superior to those obtained when treatment is delayed? 
It is known that improved glycaemic control can improve the outcomes for 
patients with diabetes (116) (73).  However it is not clear how much the 
outcomes are changed by the earlier detection of the disease in the 
clinically silent stages in people with screen-detected diabetes. If patients 
comply with the treatment and lifestyle advice they receive at diagnosis, 
early detection due to screening is likely to be beneficial. However, if 
advice is ignored and medication not used correctly the benefits of 
screening are not likely to be big (112).  There is currently no evidence 
from randomised controlled trials on the outcomes of screening for 
diabetes (117). 
 
Are there tests that can detect asymptomatic diabetes that are reliable 
and acceptable? 
Screening tests are available that can be used to detect asymptomatic 
diabetes. A number of different tests are available. Ideally such tests 
should be reproducible, reliable and give a reasonable balance between 
sensitivity and specificity (112). 
   
Are the costs of case finding and treatment reasonable and balanced in 
relationship to health expenditure as a whole? 
The cost of the screening process itself varies depending on the method 
used. Screening allows diabetes to be diagnosed earlier before 
symptoms may have developed. Earlier diagnosis will have the effect of 
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increasing the cost of treatment for the condition, as there will be a 
greater number of years that the treatment is needed for. However, if 
earlier intervention decreases the occurrence or severity of complications, 
the cost involved in treating complications would be decreased by 
screening. There is currently some uncertainty as to whether screening is 
cost effective (118). Screening the population as a whole is inefficient and 
would not be considered cost effective (117).  However the National 
Screening Committee does consider targeted screening to be cost 
effective (119). Screening hypertensive patients of all ages has been 
shown to be more cost effective than screening the whole population. 
When the age of the patient is taken into account it was found to be more 
cost effective to screen people aged 55-75 years rather than younger 
people (120). 
 
Will screening be an ongoing process?  
A one off screening test is unlikely to be 100% specific and so some 
people with diabetes will not be diagnosed. As new cases of diabetes will 
be developing with time screening need to be repeated at regular 
intervals. Currently with no national screening programme in the UK this 
is not necessarily happening. The American Diabetes Association 
recommends screening those at risk every 3 years (112). Screening 
every three years has been shown to be cost effective (121).  
 
There are various tools available for screening for diabetes including risk 
questionnaires, urinalysis and blood tests. Screening tests for diabetes 
tend to fall into two broad categories, questionnaires or biochemical tests.  
 
Biochemical tests tend to perform better than questionnaires, with venous 
and capillary glucose measurements performing better than urinary 
glucose or HbA1c(112). Breath tests have also been suggested as a 
screening method, though this is not used at present (122).  
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Urinalysis has been used in a number of studies to detect undiagnosed 
diabetes, with participants asked to self-test for glycosuria (123) (124) 
(125) (126). 
 
Screening tests recommended by the American Diabetes Association 
(ADA) include the ADA risk assessment questionnaire and capillary blood 
glucose using a cut off point 140mg/dl(7.8mmol/l) (127). A comparison of 
these screening tests showed a sensitivity of 72-78% and a specificity of 
50-51% for the ADA questionnaire and sensitivity and specificity of 56-
65% and 95-96% respectively for the capillary blood glucose test with a 
cut off point of 140mg/dl(7.8mmol/l). If the cut off point was lowered to 
120mg/dl(6.6mmol/dl) the sensitivity increased to 75-88% while specificity 
decreased to 86-88%. When the lower cut of level was combined with the 
ADA questionnaire the sensitivity and specificity is 58-63% and 92-94% 
(127).  
 
The ADA risk assessment questionnaire has been used to prompt 
clinicians to carry out further investigative tests. It has been shown that if 
the questionnaire is completed by the patient then handed to the clinician 
when attending a clinic for an unrelated matter, it results in a small 
increase in the rate of diagnosis of diabetes (128). 
  
Risk questionnaires have been used both as a stand-alone screening tool 
(129) and in conjunction with another tests such as capillary blood 
glucose tests (130).  
 
Questionnaires have used a number of factors to assess the risk of 
diabetes in an individual. Some use the presence of one or more risk 
factor to identify individuals at risk (131) (132) (130). Others give each 
risk factor a score and indicate a total score over which a person is 
considered to be at risk (129). Others use a formula to calculate risk 
(133). Figure 4 shows risk factors considered by different questionnaires. 
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Figure 4 - Risk factors included in diabetes risk questionnaire 
 
RPSGB 
/Diabetes 
UK (131) 
American 
Diabetes 
Association 
risk 
questionnaire 
Finrisk 
(129) 
Cambridge 
risk score 
(133) (134)  
Swiss 
pharmacy 
(132) 
Australian 
pharmacy(130) 
ARIC(135)  Diabetes 
risk 
calculator 
(136) 
Method of 
calculating ‘at risk’ 
1 risk factor Score over 9a Score 
over 9b 
Risk factors 
entered in 
formula 
2 risk 
factors 
1 risk factor Scoring 
system 
Classification 
tree used 
Age  Y Y Y Y Y Y Y 
Family history of 
disease 
Y 
 
Y  Y Y Y Y Y 
Waist Size Y  Y    Y Y 
BMI Y Y Y Y Y Y Y  
Ischemic heart 
disease/ 
cerebrovascular 
disease 
Y     Y   
Hypertension Y  Y Y Y Y Y Y 
Gestational 
diabetes 
Y  Y   Y  Y 
Polycystic ovary 
syndrome 
Y     Y   
Mental health 
problems 
Y        
Hypertriglyceridemia Y        
Women with baby 
over 9lb 
 Y   Y    
History of high 
blood glucose 
Y  Y   Y   
Lack of physical 
activity 
  Y  Y   Y 
Daily intake of 
fruit/veg 
  Y      
Steroid medication    Y     
Smoking    Y   Y  
Ethnicity Y     Y Y Y 
Cholesterol       Y   
Rapid pulse       Y  
Symptoms Y        
 
 
Many of the screening questionnaire and algorithms to determine risk 
have been validated on particular groups. Many questionnaires are tested 
on Caucasian population and are known to perform less well when tested 
on other populations (137) (138). 
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2.3.1 Screening using Capillary Blood Glucose (CBG) 
It has been suggested that capillary blood glucose tests are suitable for 
epidemiological studies and screening as a cost effective alternative to 
venous blood samples (139). Capillary blood tests, both random and 
fasting, have been used in screening for Type 2 diabetes in several 
studies. Different cut off points have been used in different situations (36, 
130, 140, 141). These have ranged from 4.5 mmol/l (140) to 11 mmol/l 
(130). Cut off levels used are shown in figure 5. The equipment used to 
measure capillary blood glucose uses whole blood, but some machines 
convert to the reading to give a plasma equivalent reading. In many of the 
studies below it is not clear whether the reading are whole blood or 
plasma equivalent. 
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Figure 5 - Cut off levels used in studies using capillary blood 
glucose as a screening test. 
Author Year  Country Random/ 
Fasting 
Referral levels 
Sandbaek et 
al.(140) 
2005 Denmark Random ≥4.5 mmol/l 
Krass et al. (130) 2007 Australia Fasting ≥5.5 mmol/l 
Random ≥11.0 mmol/l 
(5.5-11.0 mmol/l retest) 
Eborall et al. 
(142) 
2007 UK Random ≥11.0 mmol/l 
(5.5-11.0 mmol/l retest) 
Simmons et al. 
(31)  
1989 UK Random ≥6.0 mmol/l 
Fasting >4.0 mmol/l 
Moses et al. 
(143) 
1985 Australia Random ≥8.0 mmol/l 
Engelgau et al. 
(141) 
1995 Egypt Random 30 years+ ≥115mg/dl (6.3 mmol/l) 
75 years+ ≥140mg/dl (7.7 mmol/l) 
George et al. 
(144) 
2005 UK Random ≥7.0 mmol/l 
 
Andersson et al. 
(145) 
1993 Sweden Random ≥8.0 mmol/l 
Lidfeldt et al. 
(146) 
2001 Sweden Random ≥8.0 mmol/l 
 
Hersberger et al. 
(132) 
2006 Switzerland Random ≥11.0 mmol/l (5.3-11.0mmol/l retest 
fasting – refer if ≥5.3 mmol/l) 
Fasting ≥6.1 mmol/l (5.3-6.0mmol/l retest 
fasting – refer if ≥5.3 mmol/l 
RPSGB/ 
Diabetes UK 
Guidelines (131) 
2006 UK Random ≥11.1 mmol/l 
(5.6-11.0 mmol/l retest) 
Fasting ≥6.1 mmol/l 
(5.6-6.0mmol/l refer as risk of 
IGT/IFG) 
Leiter et al. (147) 2001 Canada Random >5.5mmol/l 
Mann et al. (148) 2009 UK Random ≥5.5mmo/l 
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A WHO study group report states that a random capillary blood glucose 
level of 11.1 mmol/l suggests that diabetes is likely. A measurement of 
4.4 mmol/l or less indicates that diabetes is unlikely. There is an range of 
measurements from 4.4 mmol/l to 11.1 mmol/l where there is uncertainty 
as to the presence of diabetes (9). The ADA recommendations for 
screening with capillary whole blood uses cut off levels of 6.1mmol/l for 
fasting and 7.8mmol/l for random measurements (112). 
 
The specificity and sensitivity of capillary blood glucose as a screening 
test depends on two factors, the cut off levels used and the conditions 
that are to be screened for. It has been calculated that the most efficient 
cut off point for screening for diabetes is 120mg/dl (6.67 mmol/l) and 100 
mg/dl (5.56 mmol/l) for diabetes and pre-diabetes. Sensitivity of these cut 
off points were calculated at 68% for 120 mg/dl (6.67mmol/l) (diabetes 
only) and 62% for 100 mg/dl (5.56mmol/l) (diabetes plus pre-diabetes). 
Specificity for these cut off points for diabetes and diabetes plus pre-
diabetes were calculated as 89% and 70% respectively (149). 
 
Puavilai et al. carried out random capillary blood glucose and oral glucose 
tolerance test (OGTT) In a group of 845 people with at least one risk 
factor of diabetes. All the participants who had random capillary blood 
glucose over 13.3 mmol/l were confirmed to have diabetes following oral 
glucose tolerance test. Just under 50% (402) had random capillary blood 
glucose between 6.1 and 13.3 mmol/l and about 20% of these were found 
to have diabetes when the oral glucose tolerance test was completed 
(150).  
 
2.3.2 Screening by other health care professionals 
Currently in the UK there is no national screening programme for 
diabetes. However, with the introduction of the National Health Checks, 
screening for those between 40 and 74 years is beginning to be 
implemented (2). Previously, screening programmes have been either 
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organised locally (151) (126) (152) or screening has been done 
opportunistically when a patient attends the GPs practice (153). 
 
Other health care professionals are in the position to see patients in 
different settings than in GPs surgeries.  As diabetes is a disease that 
can cause a wide range of complications, healthcare professionals other 
than medical doctors often receive some training in diabetes. They may 
be in a position to offer screening services. 
 
Dentists (154), chiropodists (123) and pharmacists (132) have all 
considered some form of diabetic screening.  There is no information 
about screening by other allied health professionals, such as orthoptists, 
dieticians or physiotherapists. Orthoptists have been involved in 
screening patients with known diabetes for eye disease, but not in 
screening for the disease itself (155). 
 
Screening by chiropodists  
People with diabetes are at risk of developing peripheral neuropathy and 
so are at high risk of diabetic foot ulceration. It has been estimated that 
one in seven patients with Type 2 diabetes have some form of foot ulcer 
or pre-ulcer (156). Chiropodists are experienced in seeing patients with 
diabetes. 
 
Screening was trialled in a Liverpool chiropody clinic by asking patients 
aged 40 – 75 years to test a urine sample at home and ring the clinic if a 
positive result was recorded.  In a three-month period 17.3% of the 
patients in this age group were known to have diabetes. 1158 took the 
screening test home. 11 of these reported a positive result.  Following a 
glucose tolerance test, 4 were confirmed as having diabetes (0.4% of 
those given screening tests). This is a low rate of diagnosis, possible due 
to the fact that the population being tested had a high rate of diagnosed 
diabetes (123). They concluded that, while the screening was relatively 
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cost effective, it only lead to relatively low rates of diagnosis of diabetes. 
The authors of this study did not feel that screening in clinic could be 
recommended.  
 
This screening method of issuing tests to be administered at home is 
easier to administer and less time consuming in a clinical situation, but it 
cannot be determined whether all those patients who received a test used 
them. It is possible that people either did not use the test or did not use 
them correctly. It is also not possible to tell if all positive results were 
reported. 
 
Screening by dentists 
Diabetes has been shown to be a risk factor for some dental conditions 
such as gingivitis and periodontitis, with higher prevalence and severity of 
disease in patients with poor glycaemic control (157). 
 
It has been estimated that patients with family history of diabetes, 
hypertension, high cholesterol and a clinical finding of periodontal disease 
have a 27-53% chance of having diabetes. Attendance at a dental 
practice may be a good opportunity to screen individuals with these risk 
factors (154). In the US and UK approximately 60% of all adults visit the 
dentist at least once a year for routine examinations (154) (158). Dentists 
are likely to encounter some patients with undiagnosed disease. 
 
There have been few reported screening programmes in place in dental 
practices. Testing gingival crevice blood has been considered as a 
possible method of screening. Blood oozing from the gingiva following 
periodontal probing has been tested using glucose self-monitoring 
devices such as would be used for a finger pinprick test. The gingival 
crevice blood glucose measurements and capillary fingerstick blood 
glucose measurements have been shown to be correlated, either 
moderately (r=0.75 (159)) or highly (r=0.98 (160)). When compared with 
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laboratory standard gingival crevice blood had a correlation coefficient of 
r=0.975 and capillary fingerstick blood, r=0.98 (161). Samples of capillary 
blood glucose levels from left and right hands have been reported to have 
a correlation coefficient of r=0.93 (159). 
 
Though it has been suggested that screening using gingival crevice blood 
is feasible (161) (160), it does not appear that is has currently been used 
as method of screening at present. Concern has been raised over using 
blood samples collected after periodontal probing as there is a risk of 
lower glucose measurements due to contamination with saliva and other 
material from the gingiva (159).  
 
Screening by pharmacists 
Pharmacists have been involved in screening for diabetes in several 
countries. Swiss and Australian pharmacists have offered a free 
‘sequential screening’ where a risk questionnaire is followed by a capillary 
blood glucose test and referral when necessary (130, 132). 
 
Referral to the GP following a risk questionnaire only has been trialled 
alongside the sequential screening in Australia (130) and in Belgium 
(162). 
 
In Belgium, community pharmacists distributed information on Type 2 
diabetes to people visiting the pharmacy. This included a list of questions 
based on risk factors such as obesity, hypertension, age and family 
history of diabetes. If at least one risk factor was present, people were 
advised to consult their own doctor. 782 people were referred in a 3 
month trial period, leading to 39 new diagnosis of diabetes (162).  
 
The Australian study compared the effectiveness of referral on risk 
factors only to sequential screening, where those patients with risk factors 
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are offered a capillary blood glucose test and referral is made on the 
basis of the glucose levels (130).  
 
Over a three month period, 1286 people were screened with pharmacies 
being randomly allocated risk factor assessment only (Tick tests TT), or 
risk factor assessment followed by capillary blood glucose test 
(Sequential screening SS).  
 
Following the administration of the risk factor assessment, the two groups 
found similar proportions of those with risk factors (77% in TT group and 
78% in SS group). Of those with risk factors, those offered sequential 
screening were more willing to go on to the next step of testing, with only 
36% of those with risk factors in the TT group taking up the offer of 
referral for further testing.  81% of those with risk factors in the SS group 
were willing to undergo capillary blood glucose testing. 
 
Of those patients known to have attended their GP for further testing only 
1.6% of the TT group were found to have diabetes compared with 16% of 
the SS group. The authors suggest that the sequential screening method 
is more effective with a lower rate of patients offered referral (72% in TT 
compared with  24% in SS), but higher uptake of the referral. They 
suggested that a system such as sequential screening can be effective in 
community pharmacies and is a cost effective method (130). 
 
A similar pilot has been carried out in Swiss community pharmacies using 
sequential screening, with risk factor assessment followed by capillary 
blood glucose testing if necessary. 6.4% of those tested were referred to 
their GP for further testing. A further 73.7% received targeted lifestyle 
advice. As there was little feed back from GPs about the outcomes of the 
referrals, it is not possible to say how many of the referrals resulted in a 
diagnosis of diabetes (132).   
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A lower referral rate to GP was found in the Swiss study compared with 
the Australian study (6.4% (132) compared with 24.4% in the sequential 
screening group (130). It is not known how many of those referred in the 
Swiss group were diagnosed with diabetes.  The Swiss study only 
initiated blood glucose testing if two or more risk factors were present, 
whereas the Australian study offered the finger-prick test if only one risk 
factor was present. Different criteria for referral from the capillary blood 
glucose  tests were also used. If referral levels are set high the specificity 
increases but the sensitivity decreases. While fewer patients without 
diabetes are referred for further testing the chances that cases of the 
disease are missed is increased. 
 
In the UK, a plan for the ‘early identification of diabetes for community 
pharmacists’ has been developed with Diabetes UK and the Royal 
Pharmaceutical Society of Great Britain (RPSGB) (131). They 
recommend screening of people with one or more risk factors (see figure 
6). 
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Figure 6 - 'At risk' groups (from Diabetes UK) 
• White people aged over 40 years, or people from black, Asian and 
minority ethnic groups aged over 25 years with one or more of the 
following risk factors: 
      - First degree family history of diabetes 
      - People who are overweight/obese/morbidly obese with body mass              
index (BMI) of 25 kg/m2 and above and who have a sedentary 
lifestyle 
       - A waist measurement of ≥94cm(37inches) for white and black men, 
≥80cm(31.5 inches) for white, black and Asian women and 
≥90cm(35 inches) for Asian men. 
• People who have ischemic heart disease, cerebrovascular 
disease, peripheral vascular disease or treated hypertension 
• Women who have had gestational diabetes 
• Women with polycystic ovary syndrome who have a BMI≥30 
• Those known to have impaired glucose tolerance or impaired 
fasting glycaemia. 
• People with severe mental health problems 
• People who have hypertriglyceridemia not due to alcohol excess or 
liver disease. 
 
Two methods of screening are suggested, urine testing and finger prick 
test.  The overnight fasting capillary blood glucose level is described as 
the most useful, but it is acknowledged that it is not popular with patients 
and compliance is low. It is not suitable for screening people who 
undergo opportunistic screening while in the pharmacy for other reasons. 
Random capillary blood glucose is more useful for opportunistic testing, 
but can be misleading depending on when the person last ate. The 
RPSGB guidelines suggest that urine testing can be carried out either 
randomly or two hours after a meal, though if a person has risk factors 
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and a negative random test, they should be advised to carry out another 
test two hours after a meal. Any glucose detected should be reported. 
Figure 7 shows the criteria for referral. 
 
Figure 7 - Summary of referral criteria. Taken from RPSGB care 
recommendation guidelines (131) 
Overnight fasting, finger prick test 
<5.6 mmol/l (Whole blood) 
<6.1 mmol/l (Plasma 
equivalent) 
Low probability of diabetes. 
Give advice about healthy living and reduction of risk 
factors 
5.6 to 6.0 mmol/l (Whole 
blood) 
6.1 to 6.9 mmo/l (Plasma 
equivalent) 
Probability of impaired fasting glycaemia(IFG)/impaired 
glucose tolerance(IGT). 
Refer to GP 
6.1 to 11.0 mmol/l (Whole 
blood) 
7.0 to12.1 mmol/l (Plasma 
equivalent) 
Probability of diabetes. 
Refer to GP more urgently. 
≥11.1 mmol/l (Whole blood) 
≥12.2 mmol/l (Plasma 
equivalent) 
High probability of diabetes. 
Refer to GP with fast track appointment 
Random finger prick test 
≥11.1 mmol/l (whole blood) 
≥12.2 mmol/l (Plasma 
equivalent) 
Refer to GP practice with fast track appointment 
5.6 to 11.0 mmol/l (Whole 
blood) 
6.1 to 12.1mmol//l (Plasma 
equivalent) 
Re-test on fasting sample. 
Discuss with GP practice 
Urine-stick test, two hours after meal 
Glucose present Refer to GP practice 
Random urine-stick test 
Glucose present Refer to GP practice 
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In a UK pharmacy, just over two fifths of those tested had a random blood 
glucose measurement of 6.1mmol/l or over, 5.5% of those had a blood 
glucose over 12.2 mmol/l. The incidence of capillary blood glucose 
measurement of 6.1mmol/I or more ranged from 18.3% in white 
participants to 63.2% among South Asian participants (1).  There is no 
report of follow up of these to patients to determine how many were 
subsequently diagnosed with diabetes. 
 
2.4 Optometrists role in health care provision 
In the UK, primary eye care and sight tests are provided by optometrists 
(previously known as ophthalmic opticians) and ophthalmic medical 
practitioners (OMPs). Optometrists provide the majority of services. In 
2002 there were 566 OMPs compared with 7,856 optometrists. Around 
half of the OMPs were also employed as hospital doctors (163). In 
2005/06, the number of registered optometrists had risen to 9,242. 6,079 
were full time and 3,163 part-time, equating to 7,695 whole-time 
equivalents (3).  
 
Optometrists are regulated by the General Optical Council (GOC), one of 
a group of thirteen health and social care regulatory bodies which 
includes the General Medical Council (GMC) and General Dental Council 
(GDC). 
 
The GOC was created by the Opticians Act 1958. The 1989 Opticians Act 
sets out the powers of the GOC to set out rule and regulation in certain 
areas, such as registration, fitness to practice and sight testing rules. The 
act was modified in 2005 to include compulsory continuing education and 
training (CET) for all full registrants.  
 
The Opticians Act states that one of the duties of an optometrist or OMP 
is ‘to perform such examinations of the eye for the purpose of detecting 
injury, disease or abnormality in the eye or elsewhere as the regulations 
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require’ (164). Optometrists use techniques such as direct or indirect 
ophthalmoscopy to detect disease. This allows the internal eye to be 
viewed, in particular the vascular system which is susceptible to change 
and damage in systemic conditions such as hypertension and diabetes.    
 
2.4.1 Provision of Sight Tests 
Sight tests may be reimbursed by the NHS (rNHS) or non-reimbursed 
(nrNHS) (sometimes referred to as private sight test). Reasons for a test 
to be reimbursed by the NHS are shown in figure 8.  
 
Figure 8 - Reasons for a sight test to be reimbursed by the NHS 
(165) 
• Under 16 
• Aged 16, 17 or 18 in full time education 
• Aged 60 or over 
• Diagnosed glaucoma patient 
• Advised by ophthalmologist that at risk of glaucoma 
• Aged 40 or over and is a parent, brother, sister, son or daughter of 
a diagnosed glaucoma patient 
• Diagnosed as diabetic 
• Registered as severely sight impaired/blind or sight-
impaired/partially sighted 
• Needs complex lenses 
• Are getting, or partner gets: 
                 - Income Support 
                 - Income-based Jobseekers allowance 
                 - Pension Credit Guarantee Credit 
• Are entitled to, or named on, a valid NHS tax credit exemption 
certificate 
• Are named on a valid HC2 certificate 
 
  
39
The majority of people claiming an rNHS test would be entitled to a sight 
test once every 2 years. Some groups are entitled to a reimbursed test at 
more frequent intervals. These groups are shown in figure 9. 
 
Figure 9 - Minimum interval between rNHS sight tests 
• Under 16 years and no binocular vision anomaly – 1 year 
• Under 7 years and binocular vision anomaly or corrected refractive 
error – 6 months 
• Between 7 years and 16 years with binocular vision anomaly or 
rapidly progressing myopia – 6 months 
• 70 years and over – 1 year 
• 40 years and over and family history of glaucoma or with ocular 
hypertension – 1 year 
• Diabetic – 1 year 
 
In 2005/06 17.5 million sight tests were performed in Great Britain. Of 
these, 5.5 million were nrNHS. The majority of the sight tests were carried 
out by optometrists, with OMPs carrying out 2.3% of all tests conducted 
(3). People aged over 60 years accounted for 54% of rNHS tests in 
2005/06.  
 
Though it is known that optometrists carried out 17.074 million sight tests 
during 2005/06, it is not known how many people this would equate to. 
Details of the number of sights tests are given in figure 10. There are 
some groups of people who are entitled to an rNHS sight test more 
frequently than annually (figure 9), however these groups are not large. 
The majority of people who would not receive an rNHS test are advised to 
have eye examinations every two years. 
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Figure 10 - Sight test volumes by patient age group and NHS 
reimbursement (3) 
 No of tests in thousands 
Age rNHS nrNHS Total 
Under 16 2,533 31 2,564 
16 to 59 3,017 5,369 8,386 
60 and over 6,437 87 6,524 
Total 11,411 5,786 17,473 
 
It is likely that around 16 million people received an eye examination in 
2005/06. 
 
Optometrists may be in an ideal position to screen the ‘at risk’ population 
who may not be seen by other health care professionals. 
 
2.4.2 Optometrists role in detecting, screening and referring 
diseases  
The role of the optometrist in detecting systemic disease has been 
considered with respect to hypertension and it has been suggested that 
blood pressure measurements should be included as part of the routine 
eye examination (166). Recent surveys show that though around one 
tenth of practices have equipment to measure blood pressure it is used 
infrequently with referrals for hypertension made on ocular findings alone 
(5).  
 
Optometrists have been shown to be able to effective in detecting and 
managing retinopathy associated with diabetes (167, 168). Current 
literature concentrates on the optometrists role in a specific complication 
of the disease, diabetic retinopathy, with the emphasis being on their role 
in diabetic retinopathy screening (169). In many parts of the UK, diabetic 
retinopathy screening services are being set up using digital cameras, 
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taking the traditional diabetic screening away from the high street 
optometrist practices (170).  Retinopathy screening services are only 
effective for patients with known diabetes.  People with diabetes, both 
known and undiagnosed, are still seen routinely in high street practices 
and the optometrist can still have a role in the management of these 
people. 
 
Currently, in most situations, optometrists refer patients who they feel 
need further assessment to the GP. The GP then either deals with the 
patient or refers on to the required speciality, usually the Hospital Eye 
Service (HES). 
 
Referral are often made on a general ophthalmic services form (GOS18), 
of which one copy is retained by the optometrist with two copies sent to 
the GP, so that one can be sent on to the HES. These forms can also be 
used to notify the GP that a condition has been noted, but does not 
require treatment at the present time, for example early cataracts have 
been noted but the patient does not wish to have surgery. 
 
It has been found that nearly 3% of patients seen by optometrist are 
referred and 1% have notification letters sent to the GP. Around two 
thirds of those referred are to an ophthalmologist via the GP. A quarter of 
referrals are to the GP only (171).  
 
The majority of referrals from optometrists are in relation to cataracts 
(over one third of referrals received by one hospital department (172)). 
Studies that look at referrals received by the HES (172) (173) may not 
reflect the full extent of referrals made by optometrists. Not all patients 
that are referred will need to be seen by hospital departments. One study 
reported that 44% of referrals received by one GP practice were for 
cataracts. Not all of these were passed on to the HES as some patients 
decided not to go ahead with surgery(174). For patients where mild 
retinal changes are noted that would not require treatment, a referral to 
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the GP only would be required to ensure that the underlying systemic 
condition could be diagnosed and treated. There are little data on the 
number of patients that are referred to GPs with suspected diabetes as 
these referrals do not usually involve the HES unless there is a 
complication that required treatment. Most people with newly diagnosed 
diabetes who have retinopathy present at diagnosis do not have 
retinopathy at a level that would require referral to the HES. 
 
In a few areas some optometrists have direct referral to HES clinics for 
specific conditions, such as the posterior capsular opacification direct 
referral scheme in Taunton and North Somerset NHS trust. This scheme 
was shown to be accurate and effective and reduced waiting time and 
administration when compared with referral via a GP (175). 
 
2.4.3 Challenges and development of the role of optometrists 
Optometrists receive a significant amount of technical training during the 
years before they qualify, both in knowledge about systemic diseases, 
such as hypertension and diabetes, and in clinical techniques. Their 
current role involves identifying ocular and systemic disease when signs 
are present. An extension of this role may be into screening for disease 
when they identify risk factors, but no signs are present. 
 
The current professional role of the high street optometrist has two, 
sometimes conflicting aspects, health care and retail. Optometrists are 
not employed by the NHS, but they do carry out sight tests on some 
groups of people which are then reimbursed by the NHS. It has been 
recognised that the fee received by optometrists for performing the sight 
test is inadequate. In 2005-06 optometrists received £18.32 for each 
rNHS test, though the cost of a sight test was estimated to be £37 (176). 
This difference leads to a conflict between business and health care 
provision as spectacle sales have to make up the shortfall caused by the 
under-funding. In the last 30 years, with the introduction of advertising 
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and the growth of the multiple practices (177), the optometrist has had to 
become a businessman as well as a clinician. 
 
Pharmacists, many of who also operate in high street shops have taken a 
lead role in providing services such as screening for diabetes, blood 
pressure measurements and cholesterol checks. Roles that would 
traditionally been carried out in GP practices. Like pharmacists, 
optometrists are in a position to use their clinical training to provide 
services outside their traditional roles of refracting and selling glasses. It 
is timely to explore the potential roles optometrists can have in extended 
clinical roles. 
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Chapter 3 
A qualitative evaluation of optometrists’ perceptions, attitudes and 
beliefs towards screening and diagnosing diabetes: Part 1- 
Background, aims and methods  
Abstract 
Background 
Diabetes is an increasing problem in the UK. Optometrists carry out 
around 17 million sight tests a year in the UK and see a wide range of 
people. They see many people who are at risk of diabetes. It is known 
that optometrists refer people whom they suspect of having diabetes to 
general practitioners. Currently, optometrists do not routinely carry out 
any clinical tests that are not directly related to the eye. In their training as 
health care practitioners they develop skills and knowledge in many 
areas, including systemic diseases such as diabetes, which is not 
currently routinely utilised in their daily practice. 
Aim 
To investigate optometrists’ perceptions, attitudes and beliefs towards 
diabetes and screening for and diagnosing the disease in their practice. 
Methods 
A qualitative approach was used. A series of focus groups and interviews 
with 21 optometrists were held in two locations in the north of England. 
The discussions were transcribed and analysed using principles of 
grounded theory. 
Results 
Results of the focus groups and interviews are discussed in chapter 4. 
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3.1 Introduction 
Diabetes is an increasing problem with more people with Type 2 diabetes 
being diagnosed (178). The estimated prevalence of all types of diabetes 
in England in 2001 was 4.41%. This included an estimated 2,002,000 
people with Type 2 diabetes, of which only two thirds were diagnosed 
(10).  The worldwide prevalence of diabetes in 2000 was estimated to be 
171 million (2.8% of the population). The prevalence was set to increase 
to 366 million by 2030 (4.4% of the population) (13). Due to the insidious 
nature of the disease, many people are unaware that they have diabetes 
until complications occur (75). 
 
The National Service Framework for diabetes has a number of standards 
for the prevention, diagnosis and management of the disease that are to 
be achieved by 2013. Standard 2 states that, 'The NHS will develop, 
implement and monitor strategies to identify people who do not know they 
have diabetes' (179). 
 
Diabetes is a chronic disease that is suitable for screening as it is 
common, has a screening test and effective management. The National 
Screening Committee suggested that universal screening is unjustified in 
the United Kingdom, but targeted screening of “at risk patient groups” 
may be of benefit (117). Cost effectiveness analysis of universal 
screening compared with targeted screening of people with hypertension 
has shown that screening is more cost effective when targeted.   
Screening hypertensive patients aged 55 to 70 years was more cost 
effective than screening younger age groups (120). Optometrists may be 
in a suitable position to assess those patients who are at risk and then 
further assess need for formal testing by measurement of capillary blood 
glucose levels. 
 
Optometrists are in an ideal position to be involved in the process of 
detecting elevated blood glucose and helping in diagnosis of Type 2 
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diabetes. They see many patients who, while having no formal diagnosis 
of diabetes, may show signs or have symptoms of diabetes, or may even 
appear completely “normal”. 
 
Diabetes UK estimates that around half of people with newly diagnosed 
Type 2 diabetes have some form of advanced complication such as 
retinopathy, nephropathy or neuropathy. Presence of retinopathy has 
been reported in between 4.0% (65) to 36.7% (75) of people with newly 
diagnosed Type 2 diabetes.  
 
Diabetes can produce other ocular complications such as variable 
refraction (82), recurrent infections, early onset cataract (180) and ocular 
nerve palsies (89). Visual disturbances are a common symptom of 
diabetes. A Danish study showed that 24.9% of people with newly 
diagnosed Type 2 diabetes had complained of visual disturbances prior to 
diagnosis (65). 
 
3.1.1 Optometrists in the UK: training and role in UK healthcare 
Currently, UK optometrists have to obtain a degree level qualification at 
one of 8 UK universities (five in England, one in each of Wales, Scotland 
and Northern Ireland). They must achieve at least a 2ii degree to go on 
and undertake the pre-registration year where they work supervised and 
sit professional qualifying examinations.  During the course of the four 
years of training (five years in Scotland), students follow a course of study 
to achieve core competencies set out by the General Optical Council (4).  
 
The majority of UK optometrists work in high street practices. A small 
proportion are employed by the NHS in hospitals or work in an academic 
setting. High street practices are often categorised as independent or 
multiple practices. The multiple practices, such as Specsavers, Vision 
Express, Boots and Optical Express, have varying degrees of autonomy. 
Some operate as franchises, with each individual practice having some 
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limited independence while others are run from a main head office. The 
independent practices are often owned by the optometrist, and are often 
family run businesses. They have a high degree of autonomy when 
compared with the multiple practices.  
 
Individual optometrists working in high street practices may work in both 
independent and multiple practices. Employed optometrists will tend to 
work for one practice, or group of practices. However, self-employed 
locum optometrists often work in a number of practices.  
 
At present, optometrists do not have a role in diagnosing or screening for 
diabetes. Optometrists do not have the facilities to carry out diagnostic 
tests. They are thought to be in a position to carry out a capillary blood 
test (finger-prick test) such as is used by people with diabetes to monitor 
their condition. 
 
Optometrists are in a position to ask every patient about some diabetic 
risk factors during the course of a sight test. The College of Optometrists 
guidelines state that history should include ‘relevant personal or family 
history of an ocular or general health nature.’ 79% of Australian 
optometrists reported that they always or often asked patients over the 
age of 40 about diabetes (168).  
 
Optometrists may be in a good position to reach a section of the 
population who may not routinely access other healthcare professionals. 
In a Dutch community, 83% of inhabitants aged over 40 years of age 
attended an eye examination over a 5-year period (181). Anxiety is a 
common reason for people not to seek health care. This has been well 
documented in dental practice (182, 183), but has not been studied to 
any great extent in optometric practice (184). It is not known whether 
people are more or less likely to attend an optometrist than other health 
care providers. 
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Optometry, as a profession, is relatively new when compared with others 
such as medicine. When the NHS was formed in 1948 and free sight 
tests were introduced, it was envisaged that sight care would be provided 
within hospitals. However, it was realised that this would not be possible 
(185). The General Optical Council was formed to maintain the registers 
of optometrists, oversee training and provide disciplinary powers. The 
Opticians Act of 1958, which introduced the General Optical Council, 
occurred a century after the Medical Act of 1858 gave the General 
Medical Council similar powers to keep registers of qualified doctors and 
monitor their training and disciplinary procedures.  
 
In the 60 years since the Opticians Act regulated the profession and 
prevented unqualified people practising as optometrists there have been 
several significant changes in the way optometrists work, including 
business changes such as the introduction of advertising and competition 
from unregistered sellers, and professional changes such as 
supplementary prescribing, mandatory continuing education and training 
and involvement in extended care roles (177, 186). Even with these 
professional changes, there is a sense that the training and knowledge 
that the optometrist has is not used to the full in the narrow field that is 
allowed in routine sight testing in the high street. 
 
It is envisaged that this research will explore some of the ways 
optometrists view their professional role and development, and how they 
perceive the way others view the profession. 
3.2 Choice of method 
3.2.1 Research method 
A qualitative approach to investigating the beliefs and attitudes of 
optometrists to screening and diagnosing diabetes has been used as the 
method of choice. Qualitative methods are effective in discovering the 
views of a group of people. They can be used when the aim is to uncover 
views on a subject rather than quantify the size or number of the 
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responses (187). Qualitative methods include questionnaires, 
observation, interviews and focus groups.  
 
Written questionnaires are useful if the information required is clearly 
defined. They can provide a cheap and simple way to reach a large 
population. Administration of written questionnaires is simpler than seeing 
people for face to face interviews as they can be completed in the 
participant’s own time. There are not the scheduling problems of 
arranging for the participant and interviewer to be available at the same 
time. It can allow a greater degree of anonymity, as they do not have to 
speak to the interviewer. Questionnaires allow for information to be 
collected more quickly than is possible in interviews. 
 
Problems with this method include poor response rate and lack of control 
of who completes the questionnaire (188). Written questionnaires need 
careful preparation to ensure that they are understandable to the 
respondent.  Questionnaires can be more suitable for quantitative 
research than qualitative. Questionnaires with ‘tick box’ responses where 
the number of each response can be calculated can be a useful 
quantitative method, but cannot be used for qualitative research. For 
qualitative information, open questions must be used where the 
respondent is free to answer how they wish. This can lead to more 
complex coding required when analysing the results. 
 
Interviews can overcome some of the problems of questionnaires. 
Response rates can be higher as the interviewer is present. However 
they are more time consuming. They can be structured, semi-structured 
or unstructured. 
 
Structured interviews consist of the interviewer asking questions in a 
standardised way, similar to a questionnaire (189). They will often have 
fixed answers and there is no difference in the way the interview is 
conducted between subjects. 
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Semi-structured interviews, on a one to one basis, follow a loose 
structure from which the interviewer or respondent can deviate to follow 
ideas and thoughts in detail (189). This has the advantage over 
structured interviews in that the language in the questioning can be 
adapted to the individual.  They are useful for covering one topic in depth. 
 
The flexibility of questioning allows for the interviewer to follow topics and 
adapt questioning depending on the respondent. However, this means 
that the interviews are not the same for all subjects. 
 
Unstructured or open-ended interviews are often similar to a 
conversation. Subjects can respond in any way that they want and the 
conversation will flow from the responses that the interviewees gives. The 
interviewer’s role is to give direction to the interview so that respondents 
can ‘tell their story’ (190).   
 
Advantages of unstructured interviews are that they allow the interviewee 
to express their views and opinions in a way that is natural to them. The 
researcher is able to direct the conversation to more fully explore the 
topic and so get more detailed and, hopefully, more accurate information 
on a person’s attitudes to a subject. Disadvantages are that the process 
is time consuming; a single interview can take a few hours and so 
collecting information in this way is limited to a few respondents. This 
may mean that information cannot be generalised to a larger population. 
As a wide variation of information can be collected from each participant, 
analysis can be more complicated that it would be for a structured 
interview. 
 
Observational studies involve watching people to determine behaviours 
and interactions. It differs from other forms of qualitative research as it 
takes place in the normal setting for the behaviour that is being observed. 
Observation can be covert or overt. Covert observation is rarely used as it 
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can be difficult to justify ethically. In overt observation the role of the 
observer can take different forms, from complete observer, where their 
only role is to observe and they are not involved in any of the processes 
that they are there to observe, or complete participant, where the 
observer is also fully involved in the events in which they are interested 
(191). The main advantage of the observational study is that the 
behaviours are observed in a setting that is relevant. The disadvantage of 
the presence of a known observer is that behaviours and interactions 
may be altered. This is known as the ‘Hawthorne effect’ (192).  
 
Focus groups are group interviews typically involving between six and 
ten people (193). Groups are usually made up from people with some 
common feature, such as profession or experience. A certain degree of 
homogeneity is usually needed in the background of the participants, but 
not in their attitudes.  
 
Focus groups use the communication between individuals in the group to 
generate responses. They make use of communication methods used on 
a day-to-day basis such as jokes, anecdotes (194) and humour (195).  
They can allow group norms to be investigated and can encourage open 
conversation, bringing people in who would not feel comfortable 
contributing on a one to one interview (196). 
 
Focus groups can also use the participants to generate further 
questioning which can be useful in identifying group norms and values.  
 
It has been suggested that interviews are more useful when the aim is to 
establish the behaviour of an individual, whereas focus groups are useful 
in looking at group behaviours (197).  
 
Certain groups have been found to give different opinions in focus groups 
and interviews. Teenage boys in Glasgow were asked about their 
relationships with the opposite sex. The first group initially discussed the 
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subject in focus groups, where they expressed macho views. They were 
then interviewed individually, where the macho views continued to be 
expressed. By contrast the second group of boys were initially 
interviewed individually where they expressed a much more sensitive 
attitude towards girls. However, when they then joined together to discuss 
the topic as a group, they, too, expressed macho views similar to the first 
group (198).   
 
People will normally give consistent views throughout an individual 
interview, whereas they may change opinions during the course of a 
focus group discussion. This is not necessarily a weakness of the 
technique as people’s views can often change over time when presented 
with different facts or opinions (199). 
 
One advantage of the focus group is that information can be collected 
from different participants at one session and so information can be 
gathered from a greater number of participants than would be possible 
with individual interviews. A disadvantage of the method is that it is 
possible for a dominant individual to take over the discussion. To 
overcome this, the group moderator should aim to ensure that all 
participants are heard from in the course of the discussion.  
 
Both focus groups and individual interviews were used in this study. 
Focus groups were used initially as they provided a good method of 
bringing optometrists together as a group of professionals to discuss the 
subject. Screening for diabetes is not a procedure that optometrists are 
currently involved in and the interaction involved in focus groups may 
help them consider aspects of the subject that they would not have 
considered in an individual interview. Further individual interviews 
enabled themes to be explored in more depth and to see if there were 
any different opinions expressed in the one to one situation compared 
with the group environment. 
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3.2.2 Sampling  
Normally the samples used for qualitative research are much smaller than 
for quantitative methods. Quantitative methods will often use a large 
randomly selected sample relying on probability to give a representative 
sample that can be generalised to the whole population. Qualitative 
methods will use non-random selection. Random selection is not 
necessarily appropriate for qualitative methods. Random selection is 
effective in selecting a representative population if a large sample is 
taken from a normally distributed population. However, it is not known 
whether people’s values, beliefs and attitudes are normally distributed 
through a population and a small random sample is unlikely to produce a 
representative sample (200). Purposeful selection or judgement selection 
(200) is used to select a group that will allow the central issues to be 
brought out. There are different strategies for sampling, including extreme 
case, typical case, criterion based, homogenous and stratified purposeful 
sampling (201).  
  
Theoretical sampling uses the researchers’ knowledge to identify features 
that may affect the focus group. Stratification identifies the different 
characteristics of the different subgroups within the sample (202).  
 
Convenience groups may be used. Pre-existing groups, such as work 
colleagues, have advantages in that the group is established and already 
has relationships established which can be useful. This method provides 
an easily accessible group (200). However, there can be problems if 
there is an established hierarchy within the group, which may discourage 
contributions from some members of the group. A group of strangers will 
overcome this. However there will not be any pre-existing relationships. 
 
The focus groups used in this study were homogenous in that only 
optometrists have been involved. Stratified sampling was used to select a 
group that includes different subgroups (gender, part-time or full-time, 
practice type). They were selected from optometrists listing practice 
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addresses on the publicly accessible General Optical Council (GOC) 
register. 
 
3.2.3 Sample size 
While quantitative research requires certain sample sizes for the research 
to be valid, qualitative research relies on reaching “saturation” instead of 
reaching a particular number of participants. The number of participants 
can depend on the population and the research question being asked. 
“Theoretical Saturation” is the point at which no new concepts are being 
brought out in the analysis of the transcripts (203). At this point there is a 
likelihood of reduced or no new ideas and concepts and further groups or 
interviews are unlikely to useful. 
 
For research using focus groups, it is often suggested that three or four 
groups are needed (204), though more groups may be required if the 
research question is particularly complex.  
3.3 Methods 
3.3.1 Subjects, setting and sampling 
Focus groups and interviews with optometrists were used. The initial 
groups were set in North East England. As the groups progressed, it 
appeared that there were local issues with regards to relations between 
hospitals, GPs and optometrists following the local implementation of a 
diabetic retinopathy screening service, as some optometrists felt that they 
had been excluded from the retinopathy service by the hospital. A further 
group was held in the North West of England to overcome any potential 
bias due to the local issues. 
 
The optometrists in the North East were selected from the General 
Optical Council register. All optometrists are listed on the publicly 
accessible list, though a practice address is not always listed. Letters 
were sent to optometrists giving a practice address on the register. The 
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invitation letter and consent form is included in appendix A. As many of 
the optometrists listing practice names would be either employed or 
practice owners, simply using these addresses can exclude those 
optometrists working as locums who may not work in the same practices 
consistently. Local knowledge was used to invite locums who were known 
to work in the area, but did not include a practice address on the GOC 
register. Stratification was used to ensure that there was proportional 
representation of gender, practice type (multiple, independent or 
domiciliary), employment type (employed, locum, own practice) and 
employment status (full or part time).  
 
The groups and interviews were held locally to maximise participation. An 
early evening time was used so that it did not interfere with the normal 
working day. Letters were sent to 50 optometrists. This was followed up 
by telephone contact. Three groups were arranged, one of six people and 
two of five people. In the first two groups, two people cancelled on the 
day resulting in groups of four and three people respectively. In the third 
group one participant cancelled on the day and one did not arrive. 
Interviews were carried out with participants who were unable to attend 
the initial groups. If several optometrists from the same practice agreed to 
take part, they were put into different groups so there were no current 
work relationships within a group. Many participants knew each other and 
some had previously worked or studied together as there is a relatively 
small number of optometrists in the area. The group held in the North 
West of England consisted of a group who had studied together, but who 
did not work in the same practice. Reasons given for not taking part 
included work and family commitments. The demographics of those not 
taking part did not appear to be significantly different to those who took 
part. 
 
21 participants (12 male, 9 female, qualified between 3 to 37 years) 
included optometrists who worked in multiples, independents and 
domiciliary practices. 15 were full time, 6 worked part time. Nationally, 
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around one third of optometrists are part time. The same is true of the 
participants. 11 were employed, six owned a practice and three were 
locums. 16 worked in one or two practices only. 5 regularly worked in 
three or more practices. Demographic details are listed in figure 11.  
 
Figure 11 - Demographics of participants 
Participant Gender Years 
qualified 
Employment 
type 
F/T P/T No of 
practices 
Type of main practice 
A1 M 32 Employed F/T 1 Multiple – large 
A2 F 33 Employed P/T 1 Independent – small 
A3 F 22 Employed F/T 1 Multiple – small 
A4 M 12 Own practice F/T 2 Independent – small 
B1 M 23 Own practice F/T 1 Multiple – large 
B2 F 26 Own practice F/T 1 Independent – small 
B3 F 12 Employed P/T 1 Multiple – large 
C1 F 37 Locum P/T 2 Multiple – small 
C2 M 35 Own practice F/T 2 Independent – small 
C3 M 27 Own practice F/T 3 Independent – small 
D1 F 7 Locum P/T 2 Independent – small 
D2 M 7 Own practice F/T 2 Independent – small 
D3 F 7 Employed F/T 2 Independent – small 
D4 F 7 Employed F/T 2 Independent – small 
D5 M 3 Employed F/T 3 Independent – small 
D6 M 7 Employed F/T 3 Independent – small 
D7 M 7 Employed F/T 2 Independent – small 
E1 M 6 Employed F/T 3 Independent – small 
F1 M 20 Employed F/T 1 Multiple – small 
G1 M 21 Locum P/T 4+ Independent – small 
H1 F 7 Employed P/T 1 Domiciliary 
  
 
3.3.2 Analysis 
“Pragmatic variant” grounded theory and content analysis approach was 
used. The data collected was used to develop themes and categories that 
could then be built on in further interviews. (205) (203). Grounded theory, 
as developed by Glaser and Strauss, produces theories from the data 
that are collected and analysed instead using the data to prove or 
  
58
disprove the researchers’ own ideas (206) (203). Theories are developed 
from the data that are collected only and previous work and knowledge is 
not considered (203). In “pragmatic variant” grounded theory, prior 
knowledge and understanding is considered and used to develop the 
theory (205). “Constant comparative” methods were used to compare the 
perceptions, beliefs and attitudes of the participants (207) (208). An 
iterative process is used, analysing each transcript after the interview or 
focus group and before the next is carried out. Themes that are identified 
can then be developed in further interviews. The themes are also 
compared with those in previous groups to refine the developing theories. 
 
Each interview and focus group was recorded and transcribed by an 
experienced transcriptionist. The transcripts were then checked and 
corrected by listening to the original recordings. Each transcript was 
coded and themes identified before the next focus group or interview took 
place so that ideas could be developed in the next interview.  
 
Each of the transcripts were coded by two researchers, working 
independently, and the themes identified. The themes were then 
discussed to see if agreement was reached before the next interview. In 
all cases, the two coders agreed on the general themes. Multiple coding 
has been described as the qualitative equivalent of “inter-rater reliability” 
in quantitative research (209). By using multiple coders working 
independently, the risk of personal influence on the codes identified is 
reduced.  
 
After three groups, saturation appeared to have been reached and no 
new themes were identified (203). A further group was held in a different 
locality (North West England) to investigate whether the issues identified 
in the North East area were specific to the North East. No different 
themes were identified in the different location.  
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The focus groups were then followed by a series of one to one interviews. 
After 4 interviews, saturation was judged to have been reached. 
 
The focus groups and interviews are reported together. 
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Chapter 4 
A qualitative evaluation of optometrists’ 
perceptions, attitudes and beliefs towards 
screening and diagnosing diabetes: Part 2 – 
Results, analysis and discussion 
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Chapter 4 
A qualitative evaluation of optometrists’ perceptions, attitudes and 
beliefs towards screening and diagnosing diabetes: Part 2 – 
Results, analysis and discussion 
Abstract 
Results 
Results were spilt into four main themes: awareness of undiagnosed 
diabetes, acceptance of a screening service, barriers towards 
implementation of a service and the developing role of optometrists. 
 
Though it was felt that the public had an awareness of the risks of 
diabetes, this was often not fully understood or was underestimated. 
Optometrists’ understanding of diabetes was mixed, though all had seen 
people that they suspected had undiagnosed disease. 
 
The participants felt that the attitudes of optometrists, the public and other 
medical practitioners towards optometrists being involved in a scheme to 
detect undiagnosed diabetes would be mixed. It was felt that some 
doctors would not want optometrists to be involved. Optometrists were 
concerned that the patients most at risk would be the ones most likely to 
refuse screening, though it was suggested that successful communication 
would be the key to public acceptance. However, they felt that they did 
see some people who would be at risk of developing diabetes, who would 
not access other healthcare providers. Some participants questioned the 
need to identify people with asymptomatic diabetes, while others 
considered early detection to be beneficial in the long term for both the 
patient and society. Barriers to successful implementation included cost, 
appropriate remuneration, time and fear of litigation.  
 
It was believed that optometrists’ knowledge and training is underutilised 
and underestimated, and that optometrists are ideally situated, both in 
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skills and locations, to take on more extended roles. Conflicts between 
the healthcare and retail aspects of the profession have lead to 
uncertainty among optometrists about their position in the UK health 
service. 
Conclusions 
Some optometrists would be willing to carry out capillary blood glucose 
tests, provided that the scheme was simple for them to carry out, they 
had the support of other healthcare professionals and it could be financed 
in a way that did not cause practices to run the scheme at a loss. It might 
be possible to identify people with undiagnosed diabetes who attend an 
optometric practice who may not attend other healthcare providers. 
Involvement in screening for diabetes may be a step in development of 
the profession for some optometrists. 
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4.1 Results 
Four main themes were identified: 
a. Awareness of undiagnosed diabetes 
b.  Acceptability of a screening service 
c.  Barriers to and the implementation of a screening service 
d.  Current and developing role of optometrists 
 
These broad themes were split into several categories: 
a. Awareness of undiagnosed diabetes 
 i) Patients’ awareness  
 ii) Optometrists’ awareness 
b.  Acceptability of a screening service 
 i) Acceptability to patients 
 ii) Acceptability to optometrists 
 iii) Acceptability to general practitioners 
c.  Barriers to and implementation of a screening service 
 i) Cost 
 ii) Infection control/sharps handling 
 iii) Training and protocol 
 iv) Liability 
d.  Current and developing role of optometrists 
 
4.1.1 Respondent validation 
There are two main techniques to assess validity of qualitative research, 
triangulation and respondent validation. Triangulation uses different 
methods of collecting information to see if both methods arrive at the 
same conclusions (210) (211), such as combining interviews and focus 
groups with participant observation (209). Respondent validation is used 
to show a correspondence between the researcher’s understanding of the 
findings and the participants’ understanding (210) (211). In this case, 
respondent validation was chosen to assess the validity of the 
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interpretation, as all the information was collected through similar 
methods. 
 
Respondent validation can be done in a number of ways. Participants can 
check through the original transcripts prior to analysis to ensure that there 
are no errors and then read drafts as the research progresses. However, 
this is time consuming for the participant and may not be appropriate if 
the research topic is likely to be distressing for the participants (209). 
 
Each participant was sent a summary of the group or interview they 
participated in along with a summary of the results of all the groups. A 
simple response form was sent with a Likert scale, from 1 (Strongly 
agree) to 5 (strongly disagree), for them to rate their agreement with the 
findings. A section of the form invited any comments they may have. 
 
The results of this were that eleven participants (52.3%) responded to the 
summary. All indicated that they agreed or strongly agreed with the 
summary. Ten did not reply. Responses were received from at least one 
participant in each group. 
 
4.2 Results of focus groups and interviews 
The quotations have been annotated with a code to indicate the 
participant (from table 11), Gender (M – male, F – Female), practice type 
in which they work (M- Multiple, I – Independent) and line number from 
the transcripts. 
4.2.1 Awareness of undiagnosed diabetes 
Patients’ awareness of undiagnosed diabetes 
There was a belief expressed that many people were aware of the risks 
of diabetes, whether they picked them up on information from magazines, 
TV or friends and relatives with the disease. 
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“people know, I don’t know, from women’s magazines or 
whatever they get little snippets like ‘I’m thirsty all the time 
so does that mean I’m diabetic?’ so they do have little bits 
of  knowledge” A2FI, 454-456 
 
“Well quite often they do because it has a tendency to be 
hereditary so many diabetics have diabetic relatives and 
diabetes is extremely common as you know. Most older 
people will know somebody who’s diabetic anyway …….a 
lot of them would be aware of the possibility” C2MI, 28-32 
 
It was the perception of several participants that the demographics of the 
practices influenced patients’ understanding awareness of diabetes. It 
was believed that in some more deprived areas, awareness of general 
health issues was lower than in more affluent areas. They believed that in 
the areas where awareness was lowest, the prevalence of risk factors 
was likely to be higher. 
 
“I think most of them are but I think again it depends on 
what area you’re from. I think a lot of patients from East 
Cleveland and probably a lack of information up there, or 
not wanting to know is, you know, sizeable” F1MM, 24-27 
 
“Depends very much on the demographics of the practice 
and some of the practices where you might say, the lower 
end demographics, I don’t think health awareness is as 
prominent in, when you talk to patients, and they are the 
people that are more at risk really. If you go to a higher end 
I think, because I’ve had a chance to work in both types, 
the more affluent, the more educated, they may be more 
aware because they’ve read or they’ve watched 
programmes. Yeah. And they know that they have to look 
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after themselves because of the risk of developing 
problems.” G1MI, 22-29 
 
 
There was also a perception that, while some people were aware of 
diabetes and the risk factors, the understanding of the disease and what 
that meant was limited. There was also a perception that there was an 
unwillingness to act on some lifestyle advice, even if people were aware 
of what they should be doing. This was felt to be particularly true of 
younger people who were felt to be more likely to deny that they were at 
risk. 
 
“Well particularly with younger people, they connect poor 
health style with diabetes so if a younger person gets 
diabetes, type 2 diabetes, then it’s almost telling them that 
they’re not looking after themselves properly” C2MI, 46-48 
 
“I mean most people are aware of sort of general health 
and just having a good diet and things is important but they 
probably choose to ignore that.” E1MI, 29-31  
 
Optometrists’ awareness of undiagnosed diabetes 
There was limited knowledge of the extent of undiagnosed diabetes. 
There was a belief expressed that GPs were diagnosing more people 
with diabetes. 
 
“I thought it was 50% that was undiagnosed” B2FI, 21 
 
“I was very surprised to find that, you know, that the 
percentages that you were saying, you know, there were 
ever so many people undiagnosed, I was just, I thought the 
GP’s were on the case” A3FM, 74-76 
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There was some awareness that they must see patients who were likely 
to have undiagnosed diabetes as they felt diabetes to be prevalent in the 
population they were seeing. However, one participant expressed the 
view that they felt they saw less undiagnosed diabetes in their current 
practice, compared with previous practices due to the difference in the 
patients access to their GPs. 
 
“Well I don’t know, I think you can’t really say that because 
you know that diabetes is incredibly prevalent so you must 
see patients who have it, particularly if you think about all 
your horrendously obese patients who come in and you 
think ‘you must be ….’” D7MI, 28-31 
 
“I would have said less now than when we started 
practising. Whether that’s the area I’m in now or where I’m 
working compared to, but I used to find more in mid Wales 
because of people not having GPs” D2MI, 8-10 
 
Optometrists were aware that they saw some people who had 
undiagnosed diabetes and that they were able to identify signs of 
diabetes. There was a perception that, currently, the profession was 
picking up some cases of undiagnosed diabetes, usually due to the 
presence of ocular signs rather than symptoms. Prescription changes, 
such as a myopic shift, were a common reason for optometrist to suspect 
a patient had diabetes. Proliferative diabetic retinopathy was rarely seen, 
but participants reported seeing mild retinal changes and were being 
more aware that they should look for such signs in patients who reported 
risk factors.   
 
“sometimes you get really unusual prescription change and 
you think ‘I’m not going to risk prescribing this until this 
person’s at least gone and had some tests’” A2FI, 59-61 
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“Well I’ve certainly picked up undiagnosed patients with 
proliferative retinopathy so for those ones, yes but they are 
few and far between” B2FI, 530-531 
 
“It’s rare to find somebody who’s showing retinopathy and 
is an undiagnosed diabetic. I think that knowing that there 
is a lot of undiagnosed out there and knowing of the risk 
factors involved, I have it always at the back of my mind 
that I should be questioning myself – ‘am I going to expect 
to see anything?’ and certainly my techniques that I use for 
routine ophthalmoscopy have changed over the years and I 
feel I’m in a better position with the new techniques I’m 
using to be able to give a better examination and should be 
hopefully picking up things if they are there to be picked 
up.”  G1MI, 4-12 
 
There was a feeling that, currently, there is a lack of communication 
between GPs and optometrists. All had referred patients with suspected 
diabetes to a GP, but few received feedback from the GP. They felt that 
the GP did not report the outcome of referrals back to the referring 
optometrist, with information on the diagnosis tending to come from the 
patient on their next visit to the optometrist. It was also reported that, in 
some cases, the GPs’ diagnosis of diabetes may come several years 
after signs were noted by the optometrist. 
 
“From GPs? Very rarely any. Usually the next time the 
patient comes in, I find out” B2FI, 27 
 
“I think that’s the consensus really, you don’t get an awful 
lot back from GPs” B1MM, 29 
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“Yes, the feedback is usually verbal and through the 
patient. I mean classically you’ll find somebody who’s 
prescription has changed unexpectedly and equally and 
you send them off and they come back, they pop in a 
couple of weeks later and say ‘well look you know, I was 
diabetic, it’s sorted out now, can I get my eyes done now?” 
C3MI, 71-75 
 
“GPs can write letters?” D2MI, 21 
 
The question was raised by a few participants as to whether cases of 
undiagnosed diabetes needed to be diagnosed if the patient were 
currently free of symptoms. 
 
“…do they really want to be, have all those people 
diagnosed? At the minute, what they don’t know doesn’t 
hurt them” B3FM, 215-217 
 
“…the people that do present who are early diabetics and 
they may well be for years, their visual problems certainly 
are minor, and I would think also the rest of their general 
health is relatively minor because they have come in 
asymptomatic, usually. Very few occasionally do present 
with something more severe but I would argue that they’re 
probably bordering between Type 2 and Type 1 anyway. 
You know?” B1MM, 598-603 
 
4.2.2  Acceptability of screening service 
Acceptability to patients 
It was believed that the public would express a range of attitudes toward 
being screening as part of a routine sight test. There was a concern 
expressed that the patients who were most at risk of diabetes would be 
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the ones most likely to reject the offer and those who would be more 
health conscious and more likely to access other service who would 
accept it. 
 
“I wonder whether the ones that end up taking it are the 
ones that would have gone to their GP and said ‘look, I 
want my MOT’ or whatever anyway and would have 
routinely had it…. you’d have to think of a serious way of 
how you were going to market it to ensure that you were 
actually getting the people who wouldn’t be taking proper 
responsibility for their health anyway because that’s really 
the ones that you’re wanting to get through the system.” 
H1FD, 210-217 
 
“My patients I feel would [accept] because they’ve come for 
donkey’s years, know us very well and sort of, sometimes I 
think we know more about their health problems than what 
the GPs do!”  B2FI, 221-223 
 
It was felt that while some would be willing to accept diabetes testing by 
the optometrist, others may be put off from having a sight test because of 
it, which may then impact on the chance to pick up on other diseases.  
 
“It might put people off as well, more, because some 
people won’t go for an eye test and if they think they’re 
going to be, have their finger stabbed as well, it might stop 
people coming for eye tests where we pick up other things 
as well as possible diabetes” D3FI. 174-178  
 
There was a belief expressed that people would only be willing to attend 
optometry practices for things related to eyes and may not be ready to 
accept services which they did not relate directly to eyes. However, the 
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example of hearing services in some practices was given to illustrate a 
non-ocular service provided in practices that was accepted. 
 
“I think they’d rather go to an optometrist if it’s eyes, 
otherwise no” C3MI, 199 
 
“Some practices are doing hearing aids and things and 
people seem quite happy with that? And that’s nothing to 
do with the eyes really. It’s only close!“ C3MI, 374-375 
 
They believed that different people expected different things from a sight 
test, some simply wanting new glasses whereas other expected a full 
health check. Some believed that older patients may be more willing to 
accept the service that younger patients who, they believed, would be 
less health conscious. 
 
“they’re [younger patients] just there for a refraction and 
some specs but as they get older as I say they’re more 
health conscious, a lot more people are aware, certainly 
about diabetes and macula problems” B1MM, 98-100 
 
 “I think there are always going to be patients that see the 
sight test as a barrier to ‘I want some new glasses’ and 
there will always be the people who want an eye 
examination to know that everything’s healthy and don’t 
necessarily care [about glasses]” D2MI, 113-116 
 
There was a belief that some patients who access optometrists do not 
necessarily access other healthcare services such as GPs. Some 
participants felt that those who would accept the offer of screening would 
be those who may not access their own GP due to time constraints.  
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“I suppose on the other hand it might pick up, it might pick 
up the ones where you say ‘I’ve seen this and I think you 
should probably see your doctor about it to have some sort 
of regular test done’ it might pick up the ones that wouldn’t 
actually bother to go to their GP but would be happy for you 
to do it while you’re sat there because it means they don’t 
have to take another day off work to go and sit in a queue 
in a doctor’s surgery, so you might pick up those people. 
Because you know there’s those people, where you say ‘oh 
I told you last year to get your blood pressure checked. 
Have you done that?’ ‘Well, no I’ve been quite busy over 
the last two years’ …. Right!” D7MI, 227-235 
 
“I think people will respond to a need that’s urgent to them 
and if they can’t see ………, they can’t drive or whatever, 
they will be forced to come in and see, whereas otherwise 
they might grumble on with little aches and pains and just 
ignore those and never go to the GP’ G1MI, 61-66 
 
It was felt that, though the public are not always aware of what 
optometrists are able to do, they are increasingly aware of, and accepting 
of, optometrists offering services that are not part of their traditional sight 
testing roles. It was believed that some patients were aware that 
optometrists had the ability to detect some health issues by 
ophthalmoscopy. It was felt that patients accepted changes as long as 
they were explained to them. Communication was felt, by some, to be the 
key as to whether a service would be accepted. 
 
“I don’t think they realise what we can do anyway with 
anything else, some of them will come in and when you’ve 
done the ophthalmoscopy they’ll suddenly say ‘you can tell 
all sorts of things can’t you?’ as though we can, you know, 
it’s a crystal ball.” C1FM, 99-102 
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“Yeah I mean I think that having seen the way that our roles 
have changed over the years, I think people wouldn’t be 
that surprised if we offered, if we were offering that sort of 
service because if suddenly if you say ‘right you know we’re 
going to, this is, we’re going to just do the screening for 
diabetes, which is part of the general screening, are you 
happy to have it  done?’ most would say ‘yes’. “ C2MI, 368-
373 
 
 It’s changing, it’s changing as well, they’ll [the public], to be 
honest they will probably do whatever we do and they’ll get 
used to whatever we do so if we carry on doing exactly as 
we’re doing now, then they’ll expect that when they come to 
an eye test whereas if we start changing things and telling 
them why we changing, they will expect that when they 
come to an eye test. I mean it won’t change quickly but it 
will change” D7MI, 97-102 
 
There was a belief that some would be reluctant to accept a screening 
test as they would be unwilling to make the lifestyle changes if they were 
found to have the condition. There was a belief that some people would 
not be willing to accept lifestyle advice from optometrists, whereas they 
would from a GP or nurse. 
 
“Big difference between different people I think. Somebody 
like, somebody in Northallerton that goes to every 
screening possible and eats all the right food would be 
there regularly, wanting their finger pricked, but somebody 
from a different area that no way are they going to give up 
smoking or change their diet or anything they’ll just say ‘oh 
it’s a load of rubbish’ and not turn up. It might even become 
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a reason for not getting your eyes done if they thought you 
were going to take blood as well” C1FM, 357-363 
 
“I think there are patients who will access a service only if 
they feel they absolutely need it and consequently if 
somebody, you suspect of having other health problems, 
not necessarily diabetes, that you want to refer on, there’s 
sometimes a great deal of reluctance to take that on board 
and it’s whether it’s their pride or whether it’s burying their 
head in the sand and ‘I’m alright type of thing’ but you can 
usually tell as soon as they walk through the door if that’s 
an issue, don’t even need to look at their, look in their eyes” 
C2MI, 200-206 
 
“The question is are the people who are most likely to have 
diabetes going to refuse it because they think they might 
have diabetes but don’t want to know about it because they 
know that as soon as you’re diagnosed with it you’ve got to 
stop eating tasty food and change your life style and ..” 
D7MI, 191-194 
 
“I think the only problem we would have would be if we told 
patients they should exercise more or lose weight, they 
might sort of take it the wrong way. Because they didn’t 
come for that, if you see what I mean; whereas they would 
more expect that from a GP or you know a practice nurse” 
F1MM, 43-46 
 
It was felt that the people most likely to accept the service would be those 
attending independent practices. It was felt that they would be more 
health conscious, attending the test for a health check rather than for 
cheap glasses. However, it was believed that this group may be most 
likely to have tests done elsewhere. It was suggested that the patients 
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attending multiples may be less health conscious and would be least 
likely to take up the offer, but would be the group that would be less likely 
to be tested elsewhere. 
 
The type of practice and location was also felt to have an effect on 
whether the public would be willing to be involved in screening. This was 
due to the way different practices were perceived, and the reasons why 
the patient attends the practice. 
 
“I think it depends where we are, if the city centre or a high 
street practice, it is different. Because they see that 
practice as, as a high street shop. As opposed to a small, 
independent, well even in the multiple independent type 
practice which is on, in the suburbs somewhere, which they 
see as a health centre.” B1MM, 226-230 
 
“I think the independent sector of the market or the patients 
that would come to an independent practice are those who 
would be more conc, less price sensitive and more 
concerned about the service they receive therefore want 
the additional services that you can offer is what 
differentiates you from the crowd as it were” D2MI, 444-448 
 
 
It was felt that convenience would be a factor in whether a service would 
be accepted by the public. If the optometrist was more convenient than 
other health care providers and provided the service at no extra cost to 
the patient it was believed that people would accept it. 
 
“But most of them they just want some glasses, they only 
really want us to do screening like that if we were more 
convenient to get to than the doctors“ C1FM, 102-104 
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“Yeah the majority of patients particularly the elderly would 
hate the inconvenience and hate the atmosphere in 
hospitals and they would very much like to get everything 
done either by the GP or the community optometrist or the 
community pharmacist. The whole health care package. 
They would rather not go into hospital at all if that were 
possible, so, but they also would expect the health service 
to pay for all these secondary care packages. But yes the 
patients would very much like to have it done locally, 
particularly in somewhere like myself where there isn’t a 
hospital nearby” C3MI, 105-113 
Acceptability to optometrists 
It was thought that the attitudes of the profession of the whole towards 
offering screening services would cover the whole range of responses. 
Some believed that the majority of optometrists would be willing to be 
involved as long as it was not made too difficult for them to do so. 
Financial consideration, time constraints and the screening protocol 
would influence the willingness of optometrists to offer a blood glucose 
test in their practice. On the other hand, a few felt that there would be 
some people who would not want to be involved. 
 
“I think probably the majority of optometrists would be 
interested in doing it and I think they’ll be, I don’t know, 
maybe two thirds or so would be interested in doing it” 
A1MM, 514-517 
 
“I think if it was a case of carrying out a pinprick test and 
the optometrists themselves not having to even carry it out, 
maybe all they’ve got to do is look at the results and go 
‘yes’ and put them on a ‘refer to GP / not refer to GP pile’ 
…. reckon you’d get about a 70% uptake. If there was more 
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responsibility than that on the optometrist…. I think you’d 
get about 25, maybe.” H1FD. 253-260 
 
 “I’d be happy to do it, … if it would be useful I’d be more 
than happy to do it but it would need to be remunerated” 
D7MI, 273-275 
 
It was perceived that the attitude towards offering the screening would 
depend on the practice as well as the individual optometrist. Some felt 
that independent practices would be more willing to be involved than the 
larger multiples. However, it was also suggested that there would be 
some multiples and independents who would be willing to be involved 
and others, both multiples and independents, who would not. 
 
 
 “If you speak to independents, people who are working in 
their own practice, or working in small groups….., I think 
they’ll look at it and it will be the majority [willing to take it 
up]. If you’re looking at employed optometrists for corporate 
bodies, then it’s possible that corporate bodies at head 
office level may look at a local protocol and say ‘well, you 
know, if it doesn’t fit in with our business plan, we’re not 
interested’. … so you’ll find I think that depends on who you 
talk to.” G1MI, 179-189 
 
“ [multiple practices] is more business orientated whether 
we like it or not” B3FM, 180-182 
 
The type of practice was felt to be a factor in the willingness of people to 
be involved. It was felt that individual optometrists tended to work in 
practices in which they were comfortable and that provided the clinical 
environment they wanted.  
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“I think if you, that some sectors where people just want to 
do the job, straight forward and then go home, I think they’d 
probably be resistant to it. But in other sectors where 
people are actually interested to do things a bit differently, 
are a bit different and explore different avenues, I think 
they’d welcome it with open arms, so it depends on a) the 
particular practitioner and b) the working environment” 
C1FM, 385-390 
 
“I think you that you’d tend to find to a large extent, 
practitioners’ work environments that they’re comfortable 
and if they’re clinically motivated then they’ll often, you’ll 
find that they’re working in an environment that’s 
sympathetic to that anyway so I think you’d probably find 
that the two go hand in hand, the individual practitioners 
are, would be open to it because they know that the 
establishment that they work in would be open to it” C2MI, 
407-413 
 
It was also believed that offering a blood glucose testing service would 
result in the practice standing out from the others. Some believed that this 
would encourage independents to take it up. However, others felt that it 
would help any type of practice. 
 
“I think it would certainly make your practice stand out a 
little bit better if you, looked to be more than just selling 
spectacles to people, because obviously we’re still, we’re 
still looked on like that I think, you know if you start offering 
sort of other things” F1MM, 241-244 
 
I think a lot of the independents would offer it and this isn’t 
coming down, reflecting as like a negative on the multiples 
but the independents increasingly need to look at ways of 
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being unique and offering something different to keep their 
patients because they can’t do the low budget specs and 
things so I think a lot of the independents would go for it.” 
H1FD, 192-196 
 
The financial implications were felt to be of importance to some of the 
larger companies, whereas clinical implications would be more important 
to other practitioners. An interest in being involved was felt to be an 
important factor in whether screening was accepted. 
 
“I think it, increasingly the large multi national companies, 
not so much in this area but certainly in the south east, they 
would only be interested in it if there was a financial reason 
to do it, …. Whereas I think an independent can do it if they 
feel they want to do it.” C3MI, 414-418 
 
“There’d be some people that just, if they don’t think there’s 
any monetary gain, just won’t be interested but I think there 
just would be some people that just want to increase their 
clinical skills and find that that motivates them more than 
the money really.” C1FM, 421-424 
 
“Yeah, the driving force within a practice is the key issue, if 
you’ve got someone in a multiple who’s quite keen, they might 
be able to swing it and that practice may adopt, it depends how 
autonomous the practice is from head office. As from an 
independent’s point of view, you can talk round any independent 
if you can say something like ‘well this is going to enhance the 
perspectives the patient has for you, it’s going to give you variety 
during your day and your, you’re going to be, you safeguard the 
income by covering the cost’” G1MI, 196-203 
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The length of time that the optometrist had been in practice was also 
considered a factor in their willingness to take part in such a scheme. It 
was suggested that younger optometrists are more willing to take on new 
techniques and, as more people take it on, the technique becomes 
commonplace and more accepted. 
 
“I think that’s perhaps, I find that some of the newer ideas 
aren’t, or newer techniques I find really hard to get to grips 
with whereas my younger colleagues have taken to it and 
just expect to do it as a matter of course “C2MI, 184-187 
 
“But if it started back in the training at uni, then it would just 
be accepted then and then they would just do it, they 
wouldn’t even think about it “C1FM, 399-400 
  
Acceptability to general practitioners 
Many of the optometrists were concerned that general practitioners would 
feel that the optometrists were trying to do the GPs jobs. 
 
“I think that the relation we have, well we all have, with the GPs is 
very good but they’ll feel as if we’re doing their job.” A4MI, 296-297 
 
“I wonder whether they’d think they’re having their toes treaded on a 
bit? I think it would depend on the GP, some would say ’great, this is 
fantastic’ others will think that we’re treading on their toes.” H1FD, 
151-153 
 
It was felt that the GPs may feel that optometrists would be simply 
replicating work that they were doing. Some believed that GPs would not 
trust the results.  
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“I don’t think they’ll trust our results, I think they’ll recheck it” A4MI, 
98 
 
“I mean something like that is really duplicating what happens in the 
GP’s surgery and the GP’s surgery is usually no harder to get to 
than the optometrist, so I don’t really see the point if they think they 
might be diabetic then surely they should be sent to the practice 
nurse “C1FM, 188-191  
 
However, it was also suggested that GPs would not object to optometrists 
carrying out the service. It was suggested that it would be the kind of 
service that GPs would carry out, but that they would not object if they did 
not have to do it. 
 
“I don’t know if they’d [GPs] necessarily see the point of it, would be 
my opinion. I don’t think they’d be bothered about us doing it, 
because it’s not really taking any work off them particularly, nothing 
that they enjoy doing” D7MI, 242-245 
 
There was some concern that GPs may feel that optometrist led 
screening would conflict with initiatives they were trying to put in place. 
However, it was felt that, if the GPs were consulted in developing 
protocols for the service, they would be more willing to accept the results. 
The example was given of the cataract referral system where 
optometrists can refer directly to cataract clinics. 
 
“If you had them actually involved in designing the protocol, then 
you would probably get a better response than if you designed it all 
and said ‘right we’re going to do this, lump it or leave it!” B2FI, 198-
200 
 
“Unless they were signed, you know on board and happy with it, 
they might not be too comfortable, they might feel that they’d have 
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to check it out themselves, they might think it conflicts with things 
that they’re doing, they might have initiatives where they’re trying to 
pull into their practices, people that they’re not seeing. I mean the 
point we’re making here is we are seeing a lot of the people that 
may not normally be pulled in so it is an opportunity to grab ‘em and 
we’ve got to get everybody clear on that” G1MI, 132-138 
 
 
There was a perception among a minority of participants that GPs were 
not happy with the way the blood glucose measurements were being 
handled in the pharmacies. 
 
“They [GP] get very upset when the, they’ve [their patients] had a 
blood stick test at the pharmacist and the pharmacist has told them 
that they’re diabetic” B2FI, 110-112 
 
There was a feeling that some GPs in the area do not want optometrists 
to be involved in screening and joint care schemes.  It was perceived that 
there was a poor relationship between some medical professionals and 
optometrists. 
 
“I don’t get the impression … certainly that the GPs want us to be 
really that involved, you know, diagnosing and sort of screening” 
B3FM, 108-109 
 
‘Very rarely since the system changed here and the DRSS [Diabetic 
Retinopathy Screening Service] system came in, so I really think 
they’re not terrible interested in what we think, so, to be honest” 
F1MM, 64-65 
 
On the other hand, it was felt that the relationships with some GPs were 
good. Though feedback from referrals was felt to be an issue, it was 
believed that if a scheme was put in place, GPs would use it. It was also 
  
83
felt that some schemes to manage patients in an optometry practice 
instead of a GP’s surgery, such as ‘red eye referrals’, were accepted by 
both optometrists and GPs. 
 
 “We’ve got a couple of GPs, we’ve got a good relationship with and 
they quite often let us know but that’s more because we’re more 
friends rather than any sort of professional thing really” E1MI, 66-68 
 
“I think they’re aware of the problems that, with, about lack of 
feedback, …… ‘you’re going to screen this many diabetics AND 
you’re going to feedback to the optometrist who’ve sent them there’ 
and they got money for that then they would do it. I think that’s the 
bottom line.” E1MI, 224-230 
 
“As long as we each understand what our drives are, what we’re 
trying to do and we’re not conflicting, I think GPs generally do see 
optometrists as being the eye specialists, doing things that they 
can’t do and we’ve got more opportunity to work with them, keeping 
people away from the GPs; often, their only referral path will be into 
secondary care and they’re always looking for alternatives, keeping 
people in primary care and they’ve certainly looked at initiatives like 
‘red eye’ referral schemes very favourable and got on board” G1MI, 
141-148 
 
It was also believed that doctors would not want the extra work that a 
blood glucose testing service may involve. 
 
“But I guess even if you’ve done a pinprick test you’ve still got to do 
a still full blood test to confirm results. I expect some of the GPs 
would look on it and think we’re creating extra work for them even 
because we’re going to send all these new patients who didn’t know 
they were diabetic into them, so …” H1FD, 153-157 
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4.2.3  Barriers to, and implementation of, a screening service 
Cost 
The concerns raised over the cost of the service were based around two 
broad themes, costs of the service itself and the cost of the new cases 
discovered by the screening. 
 
It was generally agreed that a service could not be offered under the 
current GOS (General Optical Service) fee for carrying out a NHS sight 
test. It was felt that this fee was inadequate to cover the cost of a 
standard test. 
 
“optometry does rely on cross subsidy because of the 
woefully inadequate funding …… it’s [screening] going to 
be adequately funded to cover the true cost or it’s going to 
be an extra, almost like an interest; but we still have to 
carry on with the core business and that is producing 
prescriptions to dispense and cross subsidise.” G1MI, 232-
238 
 
“Already the test that we do for the NHS is filled to the brim with 
tests that we’re doing and obviously underpaid for so I think many 
opticians may be a little bit concerned about adding an additional 
test and not getting any remuneration” D6MI, 142-145 
 
It was felt that a screening service fell outside the normal sight test 
requirements and that the service could not be met with the standard 
NHS sight test fee. The general attitude was that it would only be feasible 
if it was funded by the Primary Care Trust (PCT). 
 
“If there’s no funding then I wouldn’t want to take responsibility for it” 
B1MM, 163-164 
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 “you would probably expect the PCT to pay for it,  how much I don’t 
know.” A1MM, 345-346 
 
It was felt that, if the PCT was willing to fund a service, there would be no 
reason not to offer it. However, there was also a belief that the PCT 
wouldn’t necessarily fund it. 
 
“if the PCTs put that to us, that’s that what they wanted done and 
funded it appropriately, then I, then yeah there would be no reason 
not to” C3MI, 264-266  
 
“For me it would be sorting out the finance I think. I’d probably be 
very happy to do it if the payment was right” D5MI, 272-273 
 
“Well it’s wide open for a formalised scheme isn’t it? I mean there’s 
an obvious need there and that should drive the PCT but whether it 
would or not, because PCTs tend to be driven from the Department 
of Health and not from the patients unfortunately” C3MI, 503-506 
 
It was felt that it would not be possible to offer screening services unless 
they were funded, even if the practitioner wanted to, as the profitability of 
the practice needed to be considered. 
 
“otherwise there is a danger that you start diluting the, effectively the 
profitability of a practice by doing clinical skills which, or developing 
clinical skills which will certainly enhance your kudos and enhance 
your feel good but not your bottom line.” C2MI, 435-438 
 
“you don’t mind offering the service but,……, you don’t want to do it 
for nothing, not that we’re being greedy because I don’t think we are 
particularly. But you know, it’s just so long as it’s fair, it’s got to be 
fair .”F1MM, 252-254 
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There was a feeling expressed that the NHS expected optometrists to 
carry out extra services for little or no financial reward. 
 
“That’s the big issue though isn’t it? The NHS are going to give us 
50p and say ‘oh now we want you to do all of this’ and before you 
know it you’ll be prostate exams and everything else!” D2MI, 62-64 
 
“they [local GPs] said ‘we’d really love you to do this glaucoma 
referral refinement for us; can you do that because we think you’re 
quite good locally at doing this’ and we thought ‘well that will be ….. 
we turned to the GPs surgery and said ‘well how much would you 
like to pay us?’ and they went very, very quiet and that was the end 
of that! … I think they assumed that we were just going to do it as 
some sort of ‘oh this would be nice for us to do’ and so it was, you 
know whether that will get the same sort of response with the 
diabetic thing” D2MI, 254-264 
 
General cost effectiveness was considered. Two main concerns were 
raised. One was that the NHS would not consider it cost effective if they 
were to reimburse optometrists, and so they would find cheaper 
alternatives. The other concern was that only the independent practices 
would take up the service, leaving a large number of people attending 
multiples without access to a screening service. 
 
“I mean my concern would be that it wouldn’t be cost effective for 
the NHS to do it through optoms” D5MI, 408-409 
 
“Yeah, but then that adds on to the question is, is it cost effective 
again because even, just because the independent needs all these 
extra bits to help him out if you’re only seeing the patients who 
come to independents which out of the population of patients who 
go to see opticians is actually still very, very small compared to the 
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big four [multiples], it’s, is that a cost effective way of screening for 
diabetes” D7MI, 454-459 
 
The time involved in carrying out the tests and the extra tasks related to 
the screening was of concern to the participants in the focus group as 
well as the related costs of the time. 
 
“it’s not actually the actual taking the test, doing the readings, that is 
not going to take any time or anything at all, it is the amount of 
questions you’re going to have to be able to answer.” B2FI, 187-189  
 
“I think anything that takes time and I know it’s not a great lot of time 
but it would take, if you mounted it up during the day, it would take a 
bit of time, I think you need to be, whether it’s the optom or the staff, 
the person that’s doing it, you know, trained up for it. You know, it’s, 
they’re taking a bit of responsibility on” F1MM, 233-237 
 
The attitude was expressed that members of staff other than the 
optometrist would be capable of carrying out the test, thereby reducing 
the cost of the optometrist’s time.  It was felt that some optical assistants 
would be willing to be trained to carry out such tests, though it was 
believed that some would be more willing to take on these roles than 
others.  
 
“I think in a large practice where they have, you know an optical 
assistant who does all your ancillary testing …. you probably would 
get one of them trained up to do it because your, you know, your 
time is more valuable than their time. In a small practice where you 
didn’t have an optical assistant you’d probably just have to do it 
yourself.” A2FI, 691-697 
 
“the kinds of people who are training up to do all those extra bits, 
rather than just be you know receptionists, they must have 
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something about then that makes them wasn’t to do more and more 
stuff” A3FM, 700-713 
 
“some member of staff would be far more willing to stick needles in 
people than others; their very nature; they’re the ones that like doing 
the NCT [non contact tonometry] as well.” A3FM, 708-710 
 
The cost of the new cases and the burden on GPs and other related 
diabetic services was also considered. The perception of some 
participants was that some of these services were overstretched already 
and that it would not be positive to find more cases of diabetes. 
 
“if they [GP] check it and find out that somebody is indeed diabetic 
then it’s still going to be a greater load on their resources isn’t it?” 
A3FM, 100-101 
 
“if they did find the 50% of diabetics that are undiagnosed, it would 
be a catastrophe for the NHS and their role in diabetes” B3FM, 55-
57 
 
“not only the GPs, it’s in the screening, it’s in the , you know the 
dieticians and everyone else, it’s it’s that’s what I mean it’s if you; do 
they really want to be, have all those people diagnosed?”  B3FM, 
187-189 
 
Other participants felt that, though diagnosing more patients with diabetes 
would cost more initially, it was beneficial in the long term. 
 
“And the more that are diagnosed the more they’ve got to spend 
them on them haven’t they” C1FM, 507-508 
“Yes it’s counter intuitive isn’t it? The better they get at health care 
the more it’s going to cost them” C3MI, 511-512 
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“Ah but the better the health of the nation in the long term” C2MI, 
513 
 
“The PCT could fund it…..and whether a case could be put 
forward to persuade them that in the long run it was going 
to save money because I think it would; if you pick up 
undiagnosed diabetes early you’re less likely to be 
spending money on those people because of the 
complications later on.” H1FD, 176-180 
 
Infection control and sharps handling 
Infection control and handling of sharps was considered one of the major 
obstacles. Taking blood samples would be more invasive than any other 
procedures normally offered in optometric practices, and would result in 
clinical waste and the associated costs, both of which practices are not 
used to handling at the present. 
 
“The immediate thought I have is that you, you’re entering a 
whole new sphere in terms of using, getting bloods from 
people, using sharps, clinical waste disposal which is 
something that we’re not involved in at the moment and it’s 
just the administrative side of that and the regulatory side of 
it that I see as the, probably the biggest stumbling block” 
C2MI, 170-174 
 
“I thought one of the problems would be the infection control 
because we’re not to the same guidelines as GP surgeries or 
hospitals” A4MI, 172-173 
 
There was concern about the extra risk assessments and audits that it 
was believed, would have to be undertaken to satisfy the PCT. 
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“the other thing I would worry about there would be the 
PCT and all the clinical governance with sort of the safety 
aspect of having blood and I can just see what the, how 
that would go! You’d have to have a whole different level of 
audit governance and stuff” E1MI, 140-143 
 
However, it was acknowledged that some body fluids are already 
handled, but that blood samples would be higher risk than tears. 
 
“I mean, what do we do about handling contact lenses and 
tears because in effect that’s clinical waste as well? A2FI, 
737-738 
 
 “the risk of kind of contracting hepatitis from tears is much 
less than from blood” A4MI, 764-765 
 
Although handling and disposal of sharps was considered by many to be 
a problem, some believed that this could be easily overcome. 
 
“Exactly so a lot of areas have actually got these collection 
schemes now in place where they pay the PCT or they pay 
a company to come and collect a box and they keep the 
box for six months and they pay something a year or 
something so you can easily organise that if that’s 
something that you would consider doing in the practice.” 
D7MI, 163-167 
 
Some participants believed that there would be patient groups on whom it 
would be unsafe to carry out blood tests.  
 
“what about warfarin patients and like this, you could, you 
know a patient on warfarin, if you needles stick then you 
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could create a significant problem, that or reduced immune 
system” B2FI, 168-170 
 
The reaction of both patients and optometrists to sharps and blood were 
also a concern. It was acknowledged that not everybody would be happy 
handling blood and sharps. 
 
“You’re more likely to have somebody fainting as well and 
having had two people faint in the consulting room anyway, 
it’s a fairly, especially when they come round and start 
being sick as well you know” D2MI, 170-172 
 
“I think there’ll also be opticians that won’t want to get 
involved in drawing blood. I mean not everybody likes the 
sight of blood” D3FI, 296-298 
Training and protocol 
The development of protocols and related training was considered. It was 
considered that there would need to be strict protocols on who to offer 
screening to. Some felt that it would be difficult to set up protocols, but if 
developed correctly they could be used to develop other services 
 
“my only fear is that there will be an awful lot of protocol compliance. 
Say we’re doing the finger prick test, there’s going to be issues 
about hygiene, protocols about where you store, how you dispose, 
who you’re going give it to, how you get consent, all these sort of 
things that for a new thing in today’s environment, you’ve got to set 
up, for such a small thing” G1MI, 113-117 
 
“Great idea, my only concern is that it would take such a lot of effort 
to set something up ….. I think if we got the right ear, of the right 
people, they would be so enthusiastic they would start to look at 
how we could do that with other things. You could do a full 
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screening check on all sorts of things and it would still seem 
relevant and it’s a great opportunity to expand on the current role 
that optometrists have in the NHS” G1MI, 122-128 
 
A few participants expressed concern as to whether a random blood 
glucose test would be worthwhile. There was a belief that random 
measurements would cause patients unnecessary worry.  
 
“But really if they’re not going to be fasting, what is the point? You 
know if it’s not going to be an accurate test? You know you’re going 
to be worrying a patient ‘ah well your sugar level’s a bit high’” B3FM, 
495-497 
 
The levels of blood glucose at which patients would be referred was also 
of concern for some of the participants, particularly with patients who 
would be seen by the optometrist on a Saturday and so would not be able 
to contact their GP for several days. 
 
“you know there would have to be additional training as to what is 
safe, can you tell the patient they’re ok, what is minimal ‘go and see 
a GP within a couple weeks’, ‘you’re going to go and see a GP 
today!’ or you know, ‘hang on, here’s a taxi, get yourself off to 
hospital now!” B1MM, 164-168 
 
“Especially if you do it on a, if you do do it on a Saturday morning 
and there’s no GPs open until next Monday” B2FI, 520-521 
  
There was a perception that further training would be required as the 
service would take optometrists outside their general knowledge areas, 
unless they had a specialist interest in diabetes. It was felt that 
optometrists did not have the knowledge to give patients information 
when referring for suspected diabetes following a pin prick test. However, 
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it was also reported that optometrists will currently refer patients who they 
suspect to have undiagnosed diabetes if ocular signs are present. 
 
“on our general training levels at the moment we wouldn’t have that 
information unless you had a specialist interest in it.” B2FI, 194-196 
 
“no it’s really the extra level of training and knowledge we would 
have to have about diabetes to be able, because you can, you just, 
you couldn’t sort of say ‘oh right, this reading’s high’ there is a sort 
of, you’ve got to go and see that, you’ll get away with that with some 
patients, fair enough, a lot of others will want to know the ins and 
outs of everything and you can’t give advice and, without the 
knowledge base so I do feel there would be training, not just the 
actual mechanics training implications I think that would..” B2FI, 
432-439 
 
It was felt that finger-prick tests are not a procedure that optometrists are 
currently used to carrying out and that they would need training before 
being confident enough to carry these out. 
 
“It’s a sphere of health care that I don’t have any experience and 
training in basically” C3MI, 227-228 
 
“it would be something that I would be doing so infrequently that I 
would not be confident in my abilities to do that  compared say with 
somebody like a practice nurse who can do that sort of thing with 
ease and had years of experience, I mean a lot of cases of doing it“ 
C2MI, 229-232 
 
However, it was also felt that it would not be difficult to achieve the extra 
level of training needed to carry out the role, either for an optometrist or 
an optical assistant, but there was a concern that the PCT may make 
training more difficult than it need be. 
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“I think if it was as straight forward as like the one at the blood 
donors, just some training and it would be alright” C1FM, 445-446 
 
“I would say, not much [training] really, maybe an 
afternoon, but having recent dealings with the PCTs I can 
imagine they would spin that out to six or seven months of 
lectures and all sorts here, there and everywhere and 
signing things off, so, but personally I’d only say maybe… if 
it was just a simple protocol and how to do something, 
that’s clearly written down, then just an afternoon 
possibly?” E1MI, 356-361 
Liability 
Liability and insurance was a concern for a small number of the 
participants. There was a perception that, if optometrists undertook the 
blood test service, they would be liable for any cases of diabetes that 
were missed in their practice. It was felt that, if a GP missed a case of 
undiagnosed diabetes the GP would not be liable, whereas the 
optometrist would be.  There was concern expressed that any advice 
given would result in the optometrist becoming responsible for any 
outcomes for the patient. 
 
“I think my concern about it would be what additional legal 
….. for example if you’ve forgotten to offer them the test 
and then five years later it turns out they’re diabetic …. are 
you going to be legally responsible for the fact that you 
didn’t, so I think from that point of view I’d be nervous about 
where the optometrist’s legal responsibility for findings and 
if test results went adrift and things, what that would be 
because it’s entering a completely new realm really” H1FD, 
129-138 
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“[GP] seeing them maybes two three times about an ulcer 
and really they’re not liable then if, you know whereas we, if 
we’d seen a patient who’s gone minus one fifty after being 
plano and we hadn’t referred them, you know, then we 
would be responsible.” B3FM, 300-305 
 
There was concern raised over whether current insurance would cover 
the service. It was felt that people would be unwilling to carry out any test 
that would not be covered by public indemnity insurance. 
 
“the receptionist that’s doing the pressures and the visual 
fields could do a quick click as well but you’d need to take 
legal advice wouldn’t you because there’s rules about, the 
receptionist can teach them to put contact lenses in and out 
then if they get one stuck it has to be an optometrist that 
actually goes fishing to find it doesn’t it” C1FM, 290-294 
 
“Well you see presently our professional indemnity 
insurance wouldn’t cover that because it’s not an accepted 
procedure for an optometrist and it would have to be an 
accepted procedure for an optometrist before the insurance 
people would cover it and I’m not doing anything I’m not 
insured for” C3MI, 295-298 
4.2.4 Current and developing role of optometrists 
It was felt that optometrists had some role to play in raising awareness of 
general health, in particular when it related to the eye. Many of the 
optometrists felt that their current role included a responsibility for general 
health issues, particularly with systemic diseases that may have ocular 
complications.  Some believed that the eye examination was a good 
opportunity to introduce patients to healthy living or smoking cessation 
information.  
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“Well I think as health care professionals we’ve got a responsibility 
to tell people about things that might affect their eyes. …..same as 
you know you get a patient in who smokes, family history of macula 
…. you going to inform them that smoking is not the best of things to 
be, you know, doing for that as it were or giving up smoking is. “  
D2MM, 79-85 
 
“I would agree that it’s an opportunity to do a full health check 
because we’re not just refracting for vision, we are checking for eye 
disease and we’re also looking for systemic problems and a 
thorough examination should try to highlight all of these things and 
it’s an opportunity to sort of talk about things like healthy living, 
nutrition, smoking cessation could be ….we could we be working 
with pharmacists and the doctors to try and lower blood pressure, 
try and reduce on smoking related diseases and all these kind of 
things, yeah” G1MI, 36-44 
 
The belief that optometry, as a profession, must develop was a recurring 
theme. The perception was that optometrists must get involved in 
extended care roles and disease monitoring. 
 
“I mean some places already measure blood pressure, this would 
just be an extension of that, I mean we do fundus photography 
already” A1MM, 147-149 
 
“There are a lot of schemes starting up throughout the country 
where monitoring and screening is occurring outside the GOS and 
that is the way forward, it’s happening very much in Wales and in 
Scotland. There’s various schemes being kicked off all round the 
country… Now there’s going to be GOS and other schemes, a lot of 
other schemes” C3MI, 316-322 
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“That actually involve eyes; certainly diabetic retinopathy screening I 
think we could get and should get more involved with, particularly as 
the health service system they’re using at the moment is full of 
holes, glaucoma monitoring I think is our bag, things like punctal 
plugs is something that have already been fitted and we’re actually 
insured for” C2MI, 469-473 
 
The measurement of blood pressure was given as one area where some 
optometrists had tried to develop their roles and provide services to 
people who may not access other services. 
 
“There was a time when I know some of my colleagues were buying 
these automatic spignometers and that, I thought, might have been 
a way … I think that would be a great way forward, there’s no 
reason at all why we can’t grab people, it’s a great way of grabbing 
people to do screening for other things because they are coming in 
on a rolling basis every two or three years and they might never 
ever go anywhere else” G1MI, 49-58 
 
Some participants, though they believed they were capable of taking on 
extended roles, felt that other healthcare professionals did not want them 
involved and did not appreciate the role of the optometrist. 
 
“I think just our profession seems to get kicked from being in it long 
enough, 20 years, you just seem to get kicked all the time. The 
diabetes one was the last big kick we got….There’s no doubt we 
can do it, I mean it’s just a case of how they react, you know. They, 
being GPs and the hospitals, you know, so, I mean they’ve been 
pretty much anti optoms for years, so, we’re just a means to an end 
for them really, you know, we write nice little referral letters for them 
to do their job….…. You know, so I’ve no doubts we can do it but it’s 
a case of how they see it, stepping on their toes or you know; some 
of them will be against it” F1MM, 377-388 
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Some participants were not happy with the way the retinal photography 
schemes for diabetic retinopathy monitoring had been implemented. 
Some would have liked to have been involved and had invested in 
equipment, but were not involved by hospitals. This generated the feeling 
that other healthcare professionals did not appreciate the role of the 
optometrist. 
 
“we were actually doing our own retinal photography before the 
health service actually; in my naivety I thought we were going to be 
involved with it but we actually got cut dead on this one.” C3MI, 126-
129 
 
“We were doing retinal photographs before the NHS framework was 
up and running so there were retinal cameras, there was one at 
[Hospital] which was, was broken down more than it was working or 
had no funding for staffing for years and so we provided the service 
to all our patients” C2MI, 130-134  
 
Although some participants reported negative experiences of the diabetic 
retinopathy monitoring schemes, most reported a positive attitude 
towards taking on extended roles, such as the ‘emergency eye care 
scheme’ as it was making use of the knowledge that they had and would 
not use in routine refractions.  
 
“I remember thinking at university, how many anterior uveitis am I 
going to see in a week? ..... then the reality’s not like that at all but I 
mean locally we’re doing this emergency eye care scheme now, so 
we’re seeing maybe one patient a day on that with all sorts wrong 
with them and that’s great, again it probably just covers costs, it 
doesn’t you know make any money out of it, we don’t lose on it but it 
makes the day a lot more interesting which, it’s just something 
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different really and it’s quite enjoyable, it’s quite sort of satisfying 
you know from that point of view.” E1MI, 267-276 
 
It was felt that optometrists were over-trained if they were only expected 
to refract. It was felt that refraction alone was not rewarding and did not 
utilise the full extent of optometrists’ skills and knowledge. 
 
“what happens is you learn about a huge spectrum of stuff and then 
you go away and practice one tiny bit of it” A3FM, 1070-1072 
 
“refracting is pretty boring, so if it was something different then that’s 
great” E1MI, 249-250 
 
“We’d have to be more pro-active, I mean just standing still is not 
good enough. We’re all trained to be, for what we do, if we just sort 
of sit in a room and just examine eyes all day, we’re probably well 
overtrained. I mean you can get anyone who can do refraction if 
you’re, probably teach them in two hours to do a refraction but yeah, 
I mean the skills are there, you’ve just got to use them you know 
and up until now they’ve probably been very under-used” F1MM, 
193-199 
 
It was noted that the profession is changing from simply providing glasses 
to diagnosing pathology. 
 
“If you go back 30 years, our main job was to provide an optic 
correction and if we found something pathological on the way then 
we picked it up and referred it and that was it but it’s much more 
complex than that” C3MI, 343-345 
 
 “We’re expected to diagnose now aren’t we. 30 years isn’t that long 
for a big change like that really” C1FM, 348-349 
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It was believed that the role would become more clinical, as long as there 
was no opposition form the medical profession. The attitude towards 
increased clinical roles was generally positive. 
 
“it would have been nice to have had more clinical stuff to do. You 
think, when you start off training you think you’re going to be doing 
more than you do but then you help patients in other ways” C1FM, 
340-342 
 
“I think it will need to and hopefully it will change so there’s more 
clinical stuff to be done” C1FM, 310-311 
 
“yeah it’s moving in that direction inexorably and there’s as long as 
there isn’t any resistance to this from the medical establishments 
then I see that the roles clinically, clinical roles expanding all the 
time. I think it will be unrecognisable in say 30 years time” C2MI, 
312-315 
 
One of the major changes to the profession that was felt to be coming in 
the future was the introduction of independent prescribing. It was felt that, 
while initial take up of that would be slow, it would be commonplace in the 
future. Several participants were unsure of how positive this would be in 
the current framework as the opportunities to use it would be limited. It 
was suggested that, for such roles to work, there would need to be 
changes in the way optometrists work with other professions. 
 
“Independent prescribing is going to happen this year and that’s the 
first time we’ve ever had that so there will be a trickle to begin with, 
of independent prescribers but I can see another 10, 15 years we’ll 
all be independently prescribing; with extra training. Certainly the 
younger ones will, I’m not sure I will! C2MI, 333-337 
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“I keep looking at this, all the independent prescribing and things 
that’s going on and even that I’m questioning how in reality, how 
useful that is….., I think you’d need to be working a lot closer with 
GPs, with other primary care practitioners of other professions and 
with the secondary health care;” H1FD, 224-230 
 
Changes in equipment was also given as a way in which optometry had 
changed within the time that participants had been in practice.  
 
“But on the other hand, when I started off, practices didn’t have a 
tonometer so you didn’t, you didn’t do pressures, but now” C1FM, 
300-301 
 
“Then, you know and now it’s the sort of thing that you get the extra 
kit so you aren’t doing you know different things; if you’d said to me 
seven years ago, ‘well you’ll be charging £49 for a check up’ I’d 
have looked at you and said ‘you can’t charge £49 that’s not 
sustainable’ and people are coming in, paying the money, to have 
their fundus photos, to sit and talk about the state or their retina with 
you and you know it’s the face to face time, you’re selling your own, 
you know, personal company if you like, your personal skills to talk 
to the patient about their eyes” D2MI, 520-527 
 
One of the main barriers to taking on extended and more clinical roles 
was the attitudes of other professionals and the PCTs towards 
optometrists. Some felt that the PCTs were already becoming more 
interested in involving optometrists. 
 
“I think that PCTs are more interested in taking optometrists on 
board. I mean we’ve had much more communication with PCTs in 
the last few years than ever before”  A1MM, 797-799 
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It was felt that there was a problem with the interaction between the retail 
side of optometry and the health care aspect, which may affect some 
people’s view of the profession. A few participants felt that there was a 
need to split the two aspects so healthcare and retail were entirely 
separate. 
 
 “I think our big problem is that we’re neither healthcare or retail” 
A4MI, 138 
 
“I think that the NHS is disintegrating and we’ll be able to pick up the 
pieces in lots of different area and I think we’ll be very good at 
picking those pieces up but the thing that always hold us back is the 
fact that, is the retail side, it’s we’re not health care, we’re more 
retail. You know until we split the two up, that’s always going to hold 
us back I think.” A4MI, 792-796 
 
“I would love to get rid of them [glasses], and not that hassle and 
just be a healthcare professional.” A4MI, 858-859 
 
However, other optometrists felt that the public would rather have the two 
aspects side by side. 
 
“you know if the people are happy to mix the two why should we not 
mind” A2FI, 815-816 
 
“the vast majority of the general public want to come through the 
door, have their eyes tested and go leave with a pair of your specs 
on the end of their nose, they just want it, one stop shop!” A3FM, 
887-890 
 
Many of the participants felt that there would be a partial split in the 
profession, with the majority providing a sight testing and dispensing 
service as is currently done, with a small number of optometrists, who 
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would receive further training, providing more extended and clinical 
services. It was felt that there was not a need for every optometrist to 
take on all clinical roles, and there was a place for people who wanted to 
concentrate on refraction and dispensing.  
 
“I think they’ll still be as it is at the moment, a big mix where, 
because the thing is people won’t want to get to the point where 
they have to decide if they’re going to be a refractionist or a clinical 
optom. …. I think, I suspect it will go that way but you can’t afford to 
have every optom as master clinician doing blood tests, glaucoma 
management and so on because there aren’t enough patients for 
that and most patients just need a straight forward eye examination 
and some glasses.” D7MI, 478-496 
 
“we’re going to get two tiers of optometrists, we’re going to get the 
optometrist who is in the normal practice, just refracting for 
dispensing and we’re going to get the other optometrists who have 
an interest in extending the role, do some extra training, develop 
new skills, and get involved in local protocols. I think generally 
optometry is going to stay pretty static otherwise because of the 
nature of the retail aspects of optometry.” G1MI, 223-228 
 
“I think there’ll be a split but I think some of the multiples are trying 
to take that on board and Specsavers in particular are starting to 
realise that there’s a big clinical market out there that they can take 
hold of as well so I think there will be a shift but I think there’ll still be 
refractionists as well” D7MI, 470-473 
 
For the role of the optometrist to develop, it was felt that work needed to 
be done to explain what optometrists are capable of doing. It was also 
believed that the public’s perception of what optometrists do needs to be 
changed. 
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“I think optometry has the great potential and I think that the, we 
need to sort of carry on advising the people who are in the, in the 
position to actually change things and that’s the fund-holding 
bodies, that we can do things, reassure them that it’s going to be 
correct and adequate for needs and I think slowly, bit by bit, the role 
of an optometrist will change” G1MI, 218-223 
 
“I think you still get people that are very surprised at what we 
actually do you know. …, but people are just, still see us just as like 
reading letters off a chart and in and out in five minutes but you 
know. So changing their perceptions to what we do is probably quite 
difficult, you know it will probably take a little bit of time” F1MM, 184-
188 
4.3 Discussion 
4.3.1 Awareness of diabetes 
The participants believed that the general public has some awareness of 
diabetes, but that the knowledge was often limited or inaccurate. Some 
participants felt that those people who were at risk would often not 
recognise the risk or not be willing to make necessary lifestyle changes. It 
has been shown that people do perceive diabetes to be a serious disease 
(212). However, those with risk factors often perceive their risk of 
developing diabetes to be low (213) (212). 
 
There was limited knowledge among the participants of the extent of 
undiagnosed diabetes, though most participants were aware that they 
have seen people whom they suspected of having undiagnosed diabetes. 
Refractive changes, such as myopic shifts, were the most commonly 
reported signs of diabetes. Most could name factors that would raise 
suspicion of diabetes, and reported having referred people to their GP 
with suspected diabetes. Even though they had previously identified and 
referred patients with suspected diabetes, a minority of the participants 
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felt their knowledge was insufficient to refer someone on the basis of a 
screening test. 
 
The knowledge of diabetes as a disease was also mixed. While some 
were confident in their knowledge, others were less sure. There was 
some confusion between different types of diabetes and the disease 
progression in a minority of the participants. A few questioned the need to 
identify people with diabetes if they were not experiencing any symptoms 
or showing complications. 
 
4.3.2 Acceptability of screening 
It was felt that some people would be willing to accept screening by 
optometrists, while others would not. Concern was expressed that, if 
some people believed they would be tested for diabetes as part of the 
sight test, they would be unwilling to attend. Some participants felt that 
different groups of people would be more likely to accept screening than 
others, with younger people and those attending multiple practices being 
less health conscious than older people and those attending independent 
practices. Others though, felt that, with effective communication of the 
reasons for offering screening, there would be no differences in the type 
of people taking up the offer of screening. It has been shown that the 
socioeconomic factors affecting uptake of cervical screening are age, 
educational level and marital status. Attitudes such as “not needing to be 
screened if you have no symptoms” also lead to reduced uptake of 
screening (214). However it may be that communication will not increase 
uptake in certain groups as it has been suggested the informed choice 
may reduce uptake in those people who are ‘present orientated’ while 
increasing uptake in those who are ‘future orientated’. ‘Present 
orientation’ has been associated with deprivation, so it has been 
suggested that informed choice may lower the uptake of breast cancer 
screening in those groups who may be at higher risk (215). 
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Some concern was expressed as to the levels of anxiety caused by 
screening and positive results. In some studies, small increases in 
anxiety have been shown in those patients who are determined to be at 
risk after screening compared with those with normal results soon after 
the initial test (216), but one year or more after screening there is no 
significant increase in anxiety (217) (218). Anxiety during screening tests, 
prior to being given the results, was shown to be low or moderate, with 
men showing less anxiety than women. However, nearly half this group 
reported that they thought that diabetes was a minor condition and less 
than a third knew that diabetes could cause complications, which may be 
a factor in the low level of anxiety reported (219). 
 
There was a perception among the optometrists that they did see some 
people who did not access other healthcare services. It was suggested 
that, while some would access all services available to them for routine 
services, whether they were experiencing symptoms or not, others will 
not access healthcare until they are experiencing symptoms. If people 
experience difficulty with daily routine tasks such as driving or reading 
they may visit an optometrist before they visit any other healthcare 
provider. 
 
4.3.3 Barriers 
The attitudes expressed to carrying out screening in practices were 
mixed, with convenience being a key factor in the extent of the take up by 
optometrists. The practice type was considered to be a factor by some, 
suggesting that independent practices may be more likely to take up 
screening initiatives than multiple practices. Others felt that the practice 
type was not important, but that the factors influencing acceptance of 
screening would be the interest of the optometrist and management. 
 
A recurring theme was the lack of communication between optometrists 
and other health care professionals. It was felt that, if a referral was made 
to the GP, the only feedback was often via that patient. A survey of 
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ophthalmology notes showed that only 16% of optometrist referral letters 
resulted in information being reported back to the optometrist (220). It has 
been suggested that feedback is poor as referral letters are sometime 
illegible and do not include all necessary details (173) (172). However, it 
has been shown by one practice, that even if the letters are typed, all 
contact details are included and a reply is requested, feedback is still only 
received in around 13% of cases (221). It has been noted that response 
to referrals would be useful in several respects. Firstly, the patient is likely 
to return to the optometrist at some point following the referral and 
information would be helpful for continuity of care (220). Secondly, it 
provides the optometrist with the opportunity to learn and refine or 
improve further referrals (222).  
 
It was believed that GPs would have mixed attitudes towards optometrists 
taking on screening roles. Some felt that GPs would not want optometrist 
involvement, while others would be happy. Success of any screening 
service would require GPs to be willing to undertake the further testing 
required. For both optometrists and GPs to be willing to participate in 
such a screening service and for the screening to run effectively with both 
groups of professional delivering the same information to the public, both 
optometrists and GPs must be involved in developing and agreeing on 
the protocols.  
 
The main perceived barriers to undertaking a role in diabetes 
identification included cost, appropriate reimbursement, infection control 
and legal responsibilities. These factors have been reported as barriers to 
optometrists undertaking other extended roles such as prescribing 
therapeutics (186) (223).  Infection control was felt to be a barrier that 
could be easily overcome with training. 
 
Cost was felt to be one of the biggest barriers. There was strong feeling 
that the current funding for the sight test was inadequate and extended 
roles could not be carried out as part of the current GOS sight test.  In 
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2005-2006 the reimbursement for a sight test was £18.32. However, the 
actual cost of a sight test at that time was calculated to be around £37 
(176). This under-funding of the sight test and need to cross-subsidise 
from spectacle sales results in funding of extended schemes being an 
important factor in the uptake of extended roles. In a survey in which 
around 14% of UK optometrists participated, 70% listed remuneration as 
a factor that would prevent them being involved in extended therapeutic 
roles (223). Schemes that had been successfully implemented at a local 
level which use optometrists to screen people with known diabetes for 
diabetic eye disease have been funded separately to the standard GOS 
sight test fee (169) (224). With the current method of funding sight tests, 
any scheme for testing blood glucose levels would have to be funded 
separately to the routine sight test for it to be financially viable for 
optometry practices. There was a concern that the PCTs would not 
consider optometrists providing services as cost effective.   
 
It was suggested that using optometrists to undertake the blood tests may 
not be the most cost effective way of providing the service. It was 
suggested that, in practices where auxiliary staff were trained to carry out 
tests such as intra-ocular pressures and visual field tests, these staff 
members also could carry out the diabetes screening.  It has been shown 
that a trained assistant can carry out tonometry as effectively as an 
optometrist (225).  The training that would be required for someone to 
carry out the screening tests would fall into two broad categories: firstly, 
the simple mechanics of carrying out the test and, secondly, the 
knowledge and extra understanding required to explain the results to the 
participants. Knowledge of systemic diseases and the ability to discuss 
‘the importance of systemic diseases and its ocular impact and its 
treatment’ is a core competency assessed during the pre-registration year 
(4).  Though optometrists’ training does include systemic diseases as well 
as ocular diseases, these focus groups and interviews show that some 
training would be required to ensure the knowledge of diabetes is 
sufficient to provide the public with the correct information.  
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Some were concerned that the increasing screening for diabetes would 
place an unacceptable burden on health services such as GPs and 
dieticians, and questioned the need to diagnose people who showed no 
diabetic complications. However, more felt that the initial increased 
spending on screening and treating the disease before significant 
complications occurred would be cost effective in the long term as better 
management would result in fewer complications. 
 
Some optometrists were concerned that people would not accept advice 
or services that are not directly related to the eye. However, it has been 
suggested that optometrists are in an ideal position to provide information 
or refer for non-ocular issues such as smoking cessation services (226) 
or depression (227). It was suggested that the optometrists do have a 
role to play in general health education. 
 
Many of the factors that were discussed in the course of the focus groups 
and interviews: cost implications, GPs attitudes towards optometrists, 
public perception of the role of optometrists and the expectations of what 
optometrists can do and should do; relate to the development of the 
professional role of the optometrist and the conflicts between the 
professional aspect and business aspect of the profession. Concerns 
over conflicts between professional motives and business motives have 
been acknowledged in optometry in the United States (228), The same 
factors apply to UK optometrists, where business motives for the need to 
make profit can conflict with the professional motive of providing a health 
care service. The introduction of advertising and competition from 
unregistered spectacle sellers in 1984 (177), and the growth of the 
multiple practices changed the business model of optometry. The relative 
under-funding of the GOS sight test and the resulting need for cross-
subsidisation of the sight test by spectacle sales (176) creates further 
conflict between the professional and business motives. 
 
  
110
4.3.4 Role of optometrists 
This research raises some questions as to how optometrists view their 
profession, how others perceive optometry and what a profession is. 
Thistlethwaite and Spencer define several characteristics of a profession. 
They see it as driven by a sense of vocation and a distinctive knowledge 
base. They see it as setting its own standards and controls with access to 
the profession by examinations. They also see it as having a special 
relationship with those it serves, being guided by particular ethical issues 
and being self regulating and accountable (229). Hafferty defined three 
factors that distinguish a profession; core knowledge and skills, ethical 
principles and service orientation (230). 
 
It can be argued that optometry does reflect many of the features that 
distinguish a profession. It is regulated by the General Optical Council, 
which is the equivalent of the General Medical Council. The College of 
Optometrists lays down a code of ethics and professional behaviour and 
defines the core competencies that must be achieved for registration (4). 
However, professionalism can also be defined as relating to the public’s 
expectations. The participants in this study felt that the profession was 
viewed in different ways, with the high street multiple viewed in a different 
way to the independent practices. 
 
The results suggest that the participants consider optometry to be a 
changing profession moving from refraction only to checking eye health 
and diagnosing some eye diseases in the lifetime of some of 
optometrists. Even participants who had been qualified for less than 10 
years felt that the profession had changed in the time they had been 
practicing, citing changes in equipment and shared care. The introduction 
of independent prescribing was given, by many, as an example of the 
changes, though there was no agreement as to whether this scheme 
would prove to be useful. Retinal screening programmes were given as 
an example of a scheme where optometrists wanted to be involved, but 
felt they were excluded by other healthcare professionals in their area.  
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Development of a profession involves developing and defending the 
boundaries of their roles. In the US, where there is different legislature 
concerning the role of optometry in different states, those states with the 
greatest professional roles for optometrists were the ones where the 
optometry professional groups were more effective in mobilising to effect 
change in the state legislation. For example, in changing legislation to 
allow optometrists to use drugs for diagnostic purposes. In others, where 
ophthalmologists were more effective in working as a group to defend 
their own professional boundaries, optometrists failed in their bid to allow 
diagnostic drug use by optometrists, a move that was strongly opposed 
by ophthalmologists (231).   
 
In the UK, regional variation in legislation is not as extensive as in the 
United States. Scotland has recently introduced a new way of funding the 
eye test, but the legal requirements for sight tests in England and Wales 
are the same. Though there are no legal differences in the way 
optometrists practice across England, there are differences in local 
extended care schemes. These extensions to the professional 
boundaries of optometry are not universal across the country, but vary 
regionally, such as glaucoma shared care in Bristol (232) and direct 
referral of posterior capsular opacification following cataract surgery in 
Taunton and Somerset (175). These schemes have been set up where 
local groups felt that there was a service that is required and could be 
provided. Optometrists are pushing their professional boundaries and are 
successful because there is cooperation with other professional groups.  
 
It was clear from the discussions that carrying out refraction alone was 
not felt to fully utilise the full range of optometrists training and 
knowledge. It was felt that there were two aspects to optometry, 
healthcare and retail. Some felt that the profession had to separate in to 
two aspects in the future, predicting a total split between clinical practices 
and retail, while others felt that there would be a two-tier system with 
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some predominately carrying out refractions and others taking on more 
extended roles. It is maybe not surprising that some optometrists do not 
seem to be happy with the role that they currently have in some high 
street practices where they are predominately carrying out tests that can 
be done by assistants, such as field tests and tonometry, or performed by 
new technologies, such as refraction and ocular photography. There is no 
aspect of optometry that cannot be performed by another group. Doctors 
can treat eye diseases and can train to carry out refractions, dispensing 
opticians can train to fit contact lenses, orthoptists are able to manage 
binocular vision problems and, since the 1980s, with the Opticians Act 
(1989) and the Health and Social security act (1984), unqualified people 
are allowed to supply spectacles, with a small number of exemptions. The 
clinical training that optometrists receive during the course of their 
university and pre-registration training covers a much wider range of 
topics than is routinely used in day-to-day practice. Optometrists are 
currently struggling with the dilemma that, in their current role, they are 
unable to utilise fully the skills and knowledge that they have, but often 
feel limited by their relationship with the UK health service. Though the 
NHS funds some sight tests, it is inadequate, and this results in cross-
subsidisation from spectacle sales (176) and some optometrists believe 
that other professions view optometry as a business rather than a health 
care profession. It was expressed that, as optometrists demonstrated 
what they were capable of doing, gradually public and other professionals 
opinion of what they could do would change, though it requires optometry 
to be proactive as a profession and define what it could do. 
4.3.5 Limitations and strengths 
No substantial differences were noted in the themes identified in the 
interviews and the focus groups and so these have been reported 
together. It has been suggested that, in some situations, views and 
attitudes expressed in focus groups can differ from those in one to one 
interviews (198). In this situation, this was not found to be the case. 
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Chapter 5 
Detection of diabetes in optometric practice – a feasibility study: 
part 1 – background, aims and methods 
Abstract 
Introduction 
It is estimated that around one third of all Type 2 diabetes is currently 
undiagnosed. At present, there is no national screening programme, but 
the National Service Framework for diabetes states that “The NHS will 
develop, implement and monitor strategies to identify people who do not 
know they have diabetes.” This makes it important to identify and develop 
strategies for diabetes detection in non-conventional settings. This 
research explores the potential role of optometrists in diabetes detection 
  
Objectives  
 a) To ascertain the feasibility and practicality of using random 
capillary blood glucose tests (rCBG) in optometry practices as a method 
for the early detection of diabetes in the “at risk” population. 
 b) To determine the acceptability of a diabetes detection service 
using rCBG in optometry practice to the “at risk population” attending 
optometry practice. 
c) To ascertain blood glucose levels in the “at risk population” 
attending optometry practices, with a view to identifying diabetes and pre-
diabetes. 
 
Design 
A community-based prospective survey 
 
Setting and participants 
People attending high street optometry practices in the North East of 
England 
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5.1 Introduction 
Universal screening for diabetes is currently not recommended. However, 
targeted screening has been found to be justified for detecting diabetes 
(117). As there is no national screening programme in place, screening 
often takes place opportunistically when patients attend their GP for other 
reasons or when complications present.  
 
Healthcare professionals other than GPs do have the ability to carry out 
screening tests and may be able to see individuals who would not present 
at their GPs’ practice. Both pharmacists and chiropodists have 
investigated the feasibility of screening within their routine practice. 
Currently, in the UK, pharmacists are the group most involved in 
screening for diabetes and have developed a protocol with Diabetes UK 
and the Royal Pharmaceutical Society of Great Britain (RPSGB) (131). 
 
Optometrists carry out over 17 million sight tests a year in the UK with 
over a third of these on patients aged 60 years or over. 68.6% of tests are 
reimbursed by the NHS (3). This older age group has a high risk of 
having diabetes (10). In one group of people aged 60 to 79 years, 6.7% 
of men and 6% of women were found to have undiagnosed diabetes (18). 
 
In the Middlesbrough Primary Care Trust (PCT) in the North East of 
England, 41,761 rNHS (reimbursed NHS test) sight tests were 
undertaken in the 12-month period from February 2006 to February 2007. 
In February 2007, 3114 rNHS sight tests were undertaken. 35% (1086) 
were aged 60 or over and 6.6% (205) of the tests were carried out on 
people diagnosed with either diabetes or glaucoma. In January 2007, 220 
people received an rNHS tests in North Tees PCT as they had previously 
been diagnosed with either diabetes or glaucoma (personal 
correspondence). 
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Though all people with diabetes are eligible for an rNHS sight test, there 
are no figures available for the number of patients with diabetes who 
received a test. The voucher that is used to claim reimbursement for the 
sight test carries several statements only one of which needs to be ticked 
for the sight test fee to be claimed. The voucher includes diabetes and 
glaucoma in one statement so does not allow for differentiation between 
the two conditions.   
 
If the proportion of reimbursed tests to non-reimbursed tests is similar in 
Middlesbrough to the rest of the country in 2005/06, the total number of 
sight tests, both reimbursed and non-reimbursed, carried out in 
Middlesbrough PCT in 2006/07 is estimated to be around 61,000. 
 
Current predictions by the Yorkshire and Humber Public Health 
Observatory (YHPHO) suggest that the current prevalence of all diabetes 
(Type 1, Type 2 both diagnosed and undiagnosed) in the North East is 
likely to be 4.73%. Assuming the population attending for sight tests is 
representative of the population as a whole, it would suggest that nearly 
3,000 people attending optometrists in the PCT would have diabetes. 
Around one third of these may be undiagnosed. By extrapolation, almost 
1000 people with undiagnosed diabetes may be attending optometrist’s 
practices in Middlesbrough PCT each year. The Middlesbrough PCT area 
is served by 12 practices and has a population of 138,000 (233) 
 
Optometrists are in a position to ask patients about diabetes risk factors 
during the course of a sight test. The College of Optometrists guidelines 
state that the history should include ‘relevant personal or family history of 
an ocular or general health nature.’ The College of Optometrists sets 
down ‘core competencies’ for pre-registration optometrists to achieve 
before they are allowed to register. These include the ability ‘to elicit 
significant symptoms’, to ‘elicit relevant family history’ and the ‘ability to 
discuss with a patient the importance of systemic disease and its ocular 
impact, its treatment and the possible ocular side effects of medication' 
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(4). 79% of Australian optometrists reported that they always, or often, 
asked patients over the age of 40 about diabetes (168).  
 
Optometrists may be in a good position to reach a section of the 
population who may not routinely access other healthcare professionals. 
Though it is not known to what extent the population at risk of diabetes 
may attend an optometrist’s practice, it has been shown that, in a Dutch 
community, 83% of the population aged over 40 years attended an eye 
examination over a 5-year period (181). A common reason for people not 
to access health care services is anxiety. This has been well documented 
in dental practice (182, 183), but has not been studied to any great extent 
in optometric practice (184). It is not known whether people are more or 
less likely to attend an optometrist than other health care providers. 
 
5.2 Methods 
5.2.1 Methodology 
A prospective survey of capillary blood glucose levels in people attending 
optometry practices in North East England and determined to be at 
increased risk of diabetes. 
5.2.2 Objectives 
 a) To ascertain the feasibility and practicality of using random 
capillary blood glucose tests (rCBG) in optometry practices as a method 
for the early detection of diabetes in the “at risk” population. 
 b) To determine the acceptability of a diabetes detection service 
using rCBG in optometry practice to patients. 
c) To ascertain blood glucose levels in the “at risk population” 
attending optometry practices, with a view to identifying diabetes and pre-
diabetes. 
5.2.3 Outcomes 
Primary Outcomes 
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i) An ascertainment of the proportion of the population attending 
optometry practices who are at risk of developing diabetes. 
ii) An ascertainment of the proportion of the “at risk population” attending 
optometry practices who are willing to undergo tests for diabetes. 
iii) An ascertainment of the capillary blood glucose levels of this group 
and ascertainment of the proportion of those tested who have blood 
glucose levels that require further investigation, either because they have 
diabetes or because they are in the pre-diabetic range. 
 
Secondary Outcomes 
iv) An ascertainment of the proportion of those referred for further 
investigation who subsequently visit their GP. 
v) An ascertainment of the proportion of the ”at risk” population attending 
optometry practices which is diagnosed with diabetes or pre-diabetes as 
a result of investigations following the rCBG test. 
vi) An ascertainment of the acceptability of the service to patients. 
 
The aim of the research was to investigate whether early detection of 
diabetes in optometric practice was feasible. This can be considered in 
two parts. Firstly, whether it is worthwhile carrying out the tests. This can 
be determined by the yield of new cases of diabetes and pre-diabetes 
and those needing further medical follow up found by this particular 
method. The second factor to consider is the practicality and feasibility of 
carrying out the testing and whether it is practical to run it alongside the 
normal day-to-day activities of the practice 
 
The survey is based on the use of random capillary blood glucose (finger-
prick) tests using the equipment routinely used by people with diabetes to 
self test their blood glucose levels. 
 
We identified three groups of people who could potentially carry out the 
capillary blood glucose tests.  
i) Optometrists 
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ii) Optical assistants 
iii) External researchers 
 
The first two groups are made up of people who are normally in the 
practice and the third approach uses a person external to the practice, 
whose only role would be to carry out the blood tests. There are 
advantages and disadvantages to each group carrying out the tests.  
 
Optometrists would be in a position to carry out the tests as they will see 
every patient attending for a sight test. However, in many practices they 
do not carry out basic screening tests that can be done by other trained 
assistants such as fields and intra-ocular pressures (IOP) using non-
contact tonometry.  
 
Trained optical assistants often carry out pre-test screening tests such as 
IOP measurements on those at risk of glaucoma. It has been shown that 
assistants can accurately measure IOP with a non-contact tonometer 
after 10 minutes training, as accurately as an optometrist (225). These 
tests are often done prior to the patient seeing the optometrist, as part of 
the registration process. Details such as history of diabetes, family history 
of glaucoma and age are recorded at this stage as this information is 
needed to determine whether a patient is eligible for a rNHS test. If a 
detection scheme is to be run on a long-term basis, it is likely that the 
optical assistants would be the ones to carry out the tests, or would be 
involved to some extent. 
 
External researchers have the advantage in that they are not required to 
carry out any tasks other than the capillary blood glucose tests and 
recording results. Thus, patients who present with risk factors of diabetes 
may be less likely to be missed if the practice is busy, if the trained optical 
assistant is performing other tasks or if the practice is under stress. 
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To determine whether it is worthwhile to run a scheme to detect 
undiagnosed diabetes in practices, the range of rCBG measurements and 
the number of new cases of disease that can be detected using this 
method must be determined. To determine this as accurately as possible, 
all patients presenting with risk factors need to be offered the tests. If 
practices use their own staff to do this there is a risk that cases may be 
missed if the practice is busy or if staff are required to carry out other 
tasks at the time. If an external researcher is used to carry out the 
capillary blood glucose tests it should minimise the possibility that 
potential subjects may be missed.  
 
Using an external researcher maximises the potential to find new cases 
of diabetes and the determination of the extent of undiagnosed diabetes 
in the “at risk” population attending optometrists’ practices. However, this 
only allows the determination of whether or not it is worthwhile offering a 
service to detect early diagnosis in optometric practices. If such a service 
is to be practical in the long-term, the tests would probably need to be 
carried out by a person within the practice, instead of an external 
researcher.  
 
In this study, an external researcher was used to administer the blood 
glucose tests. This allowed us to determine whether it is worthwhile to 
screen in optometry practices. However, it would not allow us to 
determine how feasible it is with the core optometry team itself. 
 
The researcher assistants received training in using and calibrating the 
monitor, carrying out the tests, explaining the test results to participants, 
completing the required forms and paperwork and taking informed 
consent. The training sessions took place at Queens Campus in 2 half 
day sessions. 
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5.2.4 Participants and setting 
All optometry practices in the Teesside area were invited to take part. 
Letters giving an outline of the aims of the study were sent to the 
managers of practices listed on PCT websites. The letter described the 
aims of the study and how the practices would be involved. Practice 
managers and optometrists were asked to contact us by telephone or 
email if they were interested in finding out more.  Meetings were arranged 
with staff of practices who expressed an interest in taking part and the 
processes explained in more detail and the equipment and forms to be 
used were demonstrated. These meetings took place in the practice, so 
that the researcher could ensure that there were sufficient facilities in the 
practice for the study to take place. At this meeting, we discussed the 
involvement of the practice, time commitment on their behalf and what 
facilities they would need to provide, including secure storage for 
participants’ personal detail forms. Suitable dates for participation in the 
study were discussed if they were willing to allow their practice to be used 
as a setting for the study. 
 
5.2.5 Protocol 
When subjects attended the optometry practice for a sight test, they were 
provided with an information sheet explaining the study and a list of risk 
factors for inclusion in the study by practice staff, who asked them to read 
the information and let the optical assistant who would register them for 
the sight test know if they were interested in taking part or wished to ask 
any questions about the study. The information sheet was developed to 
give the participants information about the study, their involvement in it 
and general information about diabetes. The information sheet and risk 
questionnaire were piloted on a small group of people who were not 
involved in the study and had no medical background. Changes were 
made where necessary. The information sheet and risk questionnaire 
were approved by the School of Medicine and Health Ethics Committee. 
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The inclusion criteria and information sheet and consent form are 
included in appendices B and C. 
 
Risk Questionnaires 
There are a number of risk questionnaires available that have been 
developed and tested in different countries and on different populations. 
Some rely on the presence of one or more risk factors to determine 
whether a person is at risk (131) (132) (130). Others give each risk factor 
a different score. The total score is calculated and a total above a certain 
level indicates that a person is at risk (129). 
 
Most risk questionnaires include factors such as age and an indicator of 
obesity, either BMI or waist size or both. History of hypertension and 
family history are also commonly included. 
 
Online versions of the questionnaires are available from several national 
diabetes organisations, including Diabetes UK (234), the American 
Diabetic Association (235) and the Finnish Diabetes Association (236). 
 
For this study, I used the factors listed in the Diabetes UK questionnaire. 
Though it is longer than some other questionnaires, it relies on the 
presence of one or more risk factor to determine whether a person is at 
risk instead of requiring an individual to carry out a calculation, which may 
deter some from completing the questionnaire. The time required and 
potential difficulty of the questionnaire is known to deter people from 
completing them (237). Factors included in the online Diabetes UK risk 
questionnaire are also currently used by pharmacists in the UK and is 
included in the guidelines issued by the Royal Pharmaceutical Society of 
Great Britain and Diabetes UK (131).  
 
The risk factors to be included are shown in figure 12. Points A to K are 
based on patients self reporting risk factors as optometrists do not have 
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access to full history and do not normally have equipment to measure 
height, weight and waist size in the practice. General health, history of 
high blood pressure and relevant family history is routinely enquired 
about during the course of an eye examination. BMI is calculated from 
self reported height and weight. Self reported weight and height is known 
to be less accurate than clinical measurements since people tend to 
overestimate height and underestimate weight leading to underestimation 
of BMI (238) (239) (240). The overestimation of height is greater in the 
older population (241). However, this method is more useful than asking 
people if they are classified as overweight or obese. 25% of those with a 
self reported BMI of over 25kg/m2 did not classify themselves as 
overweight or obese (242). Using self reported weight and height 
underestimates the number of people classified as overweight (BMI 
≥25kg/m2). However, if people are asked to report if they are overweight, 
the number of people may be underestimated to a greater extent.  
 
Point L is not part of the Diabetes UK questionnaire and would not be 
given to patients as part of the initial assessment of risk. However, if the 
optometrist determined any of the ocular signs or symptoms during the 
course of the sight test in patients who had not reported any other risk 
factors, they would then be offered the capillary blood glucose test at that 
point.  
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Figure 12 – List of risk factors to determine if a patient should be 
screened for diabetes (from Diabetes UK) 
A. White aged over 40 years or black, Asian and minority ethnic 
groups aged over 25 with first degree family history of diabetes 
B. White aged over 40 years or black, Asian and minority ethnic 
groups aged over 25 with BMI of 25 kg/m2 and above 
C. Waist measurement of ≥94cm (≥37 inches) for white men aged 
over 40 years and black men aged over 25 years and ≥90cm (35 inches) 
for Asian men aged over 25, and ≥80cm (31.5 inches) for white women 
aged over 40 years and black and Asian women aged over 25 years. 
D. People who have ischaemic heart disease, cerebrovascular 
disease, peripheral vascular disease or treated hypertension 
E. People who are known to have impaired glucose tolerance or 
impaired fasting glycaemia  
F. People with severe mental illness (SMI)  
G. People who have raised cholesterol. 
H. Women who have had gestational diabetes who have tested 
normal following delivery  
I. Women who have given birth to a baby weighing more than 4kg 
(8lb 8oz) 
J. Women with polycystic ovary syndrome and a BMI ≥ 30 kg/m2   
K. People experiencing symptoms of diabetes (Increased thirst, 
going to the toilet all the time, extreme tiredness, weight loss, genital 
itching or regular episodes of thrush, slow healing of wounds, blurred 
vision) 
L. Ocular signs/symptoms of diabetes – dot/blot haemorrhages, 
recurrent infections, variable refraction, complaints of visual disturbances, 
early appearance of cataract. 
 
If the patients reported that they had no risk factors present, the 
registration and sight test continued as normal. 
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If patients reported any risk factors, they were offered the opportunity to 
talk to the researcher regarding participation in the study. If they were 
interested in taking part, they were handed over to the researcher. In 
some practices, this occurred before the sight test and after the normal 
pre-screening checks. In other practices, this was done immediately after 
the sight test had taken place. The timing of the test was different in 
different practices to fit in with the way they would normally operate. In 
some practices, field tests and IOP measurements would be routinely 
measured by optical assistants prior to the sight test. In other practices, 
these tests would be done only if the optometrist requested them after the 
sight test.  
 
If optometrists found any ocular signs possibly indicative of diabetes 
(Point L in figure 12), they could offer the blood test at the end of the eye 
examination. If patients participating in the study were found to have any 
signs or symptoms of ocular conditions unrelated to diabetes during the 
course of the eye examination, they were referred to their GP in the 
normal way for the practice by the optometrist.  
 
If patients agreed to participate, they were asked to read the information 
sheet and the study and their study involvement was explained to them 
by the research assistant. Permission was sought to pass the information 
on to the participants’ GP if the rCBG level was shown to be elevated. 
Permission was also sought for the researcher to contact those 
participants who were referred in order to determine the outcome of any 
investigations by the GP following the referral. The participants were 
asked to complete a consent form and some demographic details. 
 
Capillary blood glucose measurement was taken using the Bayer Acensia 
Contour® monitor.  These monitors were checked with control solutions 
(high, low and normal) each morning before testing began, and again if a 
  
126
new box of test strips was opened. Results of quality control tests are 
given in appendix F.   
Cut off points for random capillary blood glucose levels 
Tests that can be used to screen for diabetes can also be used to screen 
for pre-diabetes, which is defined as either impaired glucose tolerance 
(IGT) or impaired fasting glucose (IFG) or both. It has been recognised 
that people with IGT and IFG are at risk of going on to develop diabetes 
(99). BMI and waist size have been shown to be predictors of the 
development of diabetes in people with IGT in some studies (98). As 
these are modifiable risks, it suggests that the identification of people with 
IGT can be of benefit. It has been shown that lifestyle intervention can 
successfully reduce some risk factors for diabetes such as BMI and 
improve activity and diet (243) and reduce the risk of progression to 
diabetes (104) (102) (103).  
 
It has been calculated that a cut off point of 6.7 mmol/l (whole blood 
(WB)) is the most efficient to screen for diabetes, while 5.6 mmol/l is the 
most efficient for screening for diabetes and pre-diabetes (149). Using a 
cut off of 6.7 mmol/l on a random capillary blood glucose test is 
calculated to have a sensitivity of 68% and specificity of 89% for diabetes 
(149). The lower cut off point of 5.6 mmol/l has been found to be 62% 
sensitive and 70% specific for diabetes and pre-diabetes (149). For 
diabetes alone it is calculated to have sensitivity of 83% and specificity of 
63%(149).  The Diabetes UK ‘Measure Up’ campaign recommends that 
people with a random capillary blood glucose of 5.6 mmol/l or more 
should have further investigation as there is the possibility of IFG, IGT or 
diabetes. UK Pharmacy guidelines state that, for random blood glucose 
levels between 5.6 and 11.0mmol (WB), patients should be retested 
using fasting blood levels. The guidance suggests that this should be 
carried out by the GP (244), but some pharmacies carry out the fasting 
test themselves and only refer to the GP if the fasting level is also raised 
(Lloyds Pharmacy, personal correspondence).  
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It would not be always be convenient for optometry practices to carry out 
a repeat fasting blood test.  
 
We selected a cut off point of 5.6 mmol/l (WB) or 6.1 mmol/l (plasma 
equivalent (PE)) for random CBG measurements to screen for diabetes 
and pre-diabetes. The Bayer Acensia® meter uses a whole blood 
sample, but converts the results to a plasma equivalent reading.  
 
Patients with values below this were advised that, though it is unlikely that 
they have diabetes at present, they still have risk factors that increase 
that chances of developing diabetes, so they should be aware of the 
symptoms and see their GP for a regular check or if they have any 
concerns. They were given a copy of their results with this information. 
The results forms are included in appendix D. 
 
Patients with a random CBG level of 6.1 mmol/l (PE) or above were 
referred to their GP using a standardised form (appendix E). This form 
included a recommendation to the GP for the need for further 
investigation.  
 
Random and fasting blood glucose levels 
Random blood glucose tests cannot be used for the purpose of diagnosis. 
In this study, we were not aiming to diagnose diabetes, but establish the 
feasibility of using this method of testing and to determine the range of 
blood glucose levels in adults at risk of diabetes who attend optometric 
practices and identify those who would benefit from further fasting tests. 
 
Fasting tests have the advantage that they can be used in the diagnosis 
of diabetes. However, they are not suitable for opportunistic screening.  
We were aiming to offer this as a service as people come in to a practice 
for routine sight tests. Some patients will not have arranged the sight test 
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in advance and it is not feasible to expect these people to be fasting. 
Random glucose tests are suitable for selecting patients who would 
benefit from a fasting blood glucose measurement.  
 
For the purposes of this study, we did not intend to ask patients whether 
they were fasting. We were using guidelines for referral using random 
blood glucose tests as suggested by Diabetes UK and the Royal 
Pharmaceutical Society of Great Britain (244). A comparison of the 
guideline for random and fasting blood glucose measures is shown in 
figure 13. 
 
Figure 13 - Guidelines for referral using random and fasting capillary 
blood glucose measurements 
 
Results in mmol/l 
(plasma equivalent) 
Fasting Random 
<6.1 Low probability of 
diabetes 
Low probability of 
diabetes 
6.1-6.9  Probability of IFG – 
routine referral to GP 
Retest recommended 
with fasting test. 
Refer to GP 7.0-12.1 Probability of diabetes 
– routine referral to GP 
≥12.2 High probability of 
diabetes – refer 
urgently 
Refer to GP soon 
  
 
Using these guidelines, anyone with a blood glucose measurement of 
6.1mmol/l or over were referred to their GP regardless of whether they 
were fasting at the time of the test.  
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The participants were given a copy of their result along with information 
about action that they should take. Participants with blood glucose levels 
below 6.1 mmol/l were told they had a low probability of diabetes at the 
present time and were given advice about the risk reduction. Those with 
levels between 6.1 mmol/l and 12.1 mmol/l were advised that it was not 
possible to rule out diabetes, IFG or IGT and further testing was required. 
They were asked to see their GP routinely. Those with levels 12.2 mmol/l 
and above were asked to see their GP within 2 days. These referral 
levels were chosen as they are current UK guidelines on referral for 
pharmacists carrying out rCBG tests.  If a person was found to have a 
glucose level of 20 mmol/l or above and symptoms of diabetes, but did 
not have next day access to their GP, they were advised to go to their 
local casualty department or ring NHS Direct,  
 
The pathway that a patient will follow when they attend the practice is 
shown in figure 14. 
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Figure 14  Participant pathway 
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The research assistant carrying out the test recorded the blood glucose 
level, date of birth, gender and risk categories.  Each participant was 
identified by a code, which allowed the researcher to identify the practice 
where the test was carried out, but not the individual participant. The 
personal details of participants were held in the practice with a list of the 
codes and the persons to whom those codes related.  
 
The number of adults seen in the practice each day was recorded so that 
the proportion of the population attending the optometry practice who 
reported risk factors for diabetes could be calculated. The number of 
people who were eligible to take part but refused and the number of 
adults with previously diagnosed diabetes was also recorded. 
 
The study continued until 1000 patients had been screened. From 
previous research, a prevalence of 3% was predicted for undiagnosed 
diabetes and 6% for undiagnosed IGT, IFG and diabetes. To detect a 
prevalence of 6% with an acceptable deviation of 1.5% required a sample 
of 954 people. It was conservatively estimated that between 3 and 5 
participants who are at risk of developing diabetes would be recruited per 
optometrist testing per day.  
 
Testing was carried out in each practice for a 4 week period. This allowed 
several practices to be used so that different practice types (multiple, 
independent) would be included. 
 
Each participant was given a questionnaire immediately following the 
blood glucose test to complete and return to determine the acceptability 
of the service to participants. The questionnaire development and choice 
of method is discussed in chapter 8.   
 
All participants who were referred to their GP were sent a postal 
questionnaire to determine the outcome of the referral. The 
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questionnaires were sent out via the practices as they held a list linking 
the personal details of participant to the code held by the researcher. 
 
Participants were asked whether they visited their GP following the 
results of the blood test. If they did, they were asked if they were 
investigated for diabetes. If any investigations were made, they were 
asked what the outcomes were. The questionnaire is included in 
appendix G. The questionnaire was piloted on a small group of people 
who were not involved in the study, and changes were made to the 
wording and layout where appropriate. The final questionnaire was 
approved by the School of Medicine and Health ethics committee. 
 
A written postal questionnaire to the participant was chosen for this. We 
could have arranged for the further fasting blood glucose tests to be 
carried out at a central location. However, this would not be how we 
would envisage a screening service working, if implemented. The local 
GPs would be involved in carrying out any further testing and in the 
continuing care of the participants if they had the screening carried out at 
other locations. We could also have contacted the GP practice to 
determine the results of follow up testing.  
 
Every participant in the screening service, who had a rCBG measurement 
of 6.1mmol/l or over, received the questionnaire four to eight weeks after 
being given the results of the blood glucose test.  
 
Participants were given a stamped addressed envelope to return the 
questionnaire to the researcher. A second letter was sent to participants 
who had not replied within one month of the first letter, to increase the 
response rate. 
 
Each questionnaire was labelled with the participant’s ID number so 
responses could be linked with the details of their blood glucose tests, 
gender and practice where the screening occurred.  
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The results were entered into a database and analysed in SPSS 15.0. 
Independent samples t-test and Pearsons chi-squared tests were used as 
appropriate.  
 
The pathway for patients who received the capillary blood test is shown in 
figure 15. 
Figure 15 - Pathway for patients who receive a capillary blood 
glucose test 
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5.2.6 Locations and practices 
The screening service was implemented in five optometry practices in 
three towns in North East England: Redcar, Hartlepool and Peterlee. 
 
Redcar is situated in Redcar & Cleveland, which has been designated a 
Spearhead area. These are the 70 Local Authority (LA) areas in England 
with the worst health and deprivation indicators. Life expectancy is 76.0 
years for men and 80.6 years for women (Average for England is 77.7 
and 81.8 years respectively). Indicators for this area which are 
significantly worse that the England average include life expectancy, over 
65s ‘not in good health’, deprivation and early deaths from smoking, 
cancer and heart disease (245).  
 
Hartlepool is also a Spearhead area, with life expectancy for women and 
rates of healthy eating among adults the worst in England. Significantly 
worse rates of obesity, binge drinking, over 65s ‘not in good health’ than 
England as a whole are found in this area (246). 
 
Peterlee is situated in the Easington district in County Durham. The 
Health Profile for Easington designated it a Spearhead area. In 2009, 
Easington was not published as a distinct area, but was included as part 
of County Durham.  Like Hartlepool and Redcar & Cleveland, the rates of 
over 65s ‘not in good health’, binge drinking and life expectancy in County 
Durham and Easington is significantly worse than England average (247). 
 
Health indicators for Easington, County Durham, Hartlepool and Redcar 
& Cleveland are shown in figure 16, alongside average and worst values 
for England. 
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Figure 16 - Health indicators for Redcar & Cleveland, Hartlepool and 
County Durham ( from APHO & Department of Health Health Profile 
2008 and 2009) 
 Redcar & 
Cleveland 
Hartlepool Co. 
Durham 
Easington England 
Average 
England 
Worst 
Life 
expectancy 
– Men1 
76.0 74.5 76.1 74.9 77.7 73.2 
Life 
expectancy 
– women1 
80.6 78.1 79.9 79.2 81.8 78.1 
Deprivation2 33.7% 46.7% 31% 64.0% 19.9% 89.2% 
Adults who 
smoke3 
26.8% 33.2% 24.5% 24.1% 24.1% 40.9% 
Obese 
adults3 
25.3% 26.2% 25.3% 28.9% 23.6% 31.2% 
Over 65s 
‘not in good 
health’4 
26.8% 27.2% 29.8% Not 
available 
21.5% 31.2% 
Diagnosed 
with 
diabetes5 
4.0% 3.7% 4.0% 3.6% 4.1% 6.3% 
1. Life expectancy at Birth 2005-07 for Hartlepool, Redcar & Cleveland, County Durham and 
England. Life expectancy at birth 2004-06 for Easington 
2. % of people living in the 20% most deprived areas of England 2007 (2005 for Easington) 
3. % from modelled estimate from Health Survey for England 2003-05 
4. % self reported general health ‘not good’ 2001 
5. % of people on GP register with diagnosis of diabetes 2007/08 (2005/06 for Easington) 
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The rates of diabetes recorded in figure 16 reflect GP records from 
2007/08 (2005/06 for Easington), so although they indicate that the 
prevalence of diabetes is lower than the national average in these three 
areas, it possibly reflects diagnosed diabetes rather than actual rates of 
disease. Predicted prevalence of Type 2 diabetes is calculated to be 
higher than the diagnosed rate. Figure 17 shows the predicted 
prevalence of Type 2 diabetes, both diagnosed and undiagnosed, in the 
local Authority area of Redcar & Cleveland, Hartlepool, Easington and 
County Durham PCT for 2005. 
Figure 17 - Predicted prevalence of Type 2 diabetes, diagnosed and 
total prevalence (from PBS Diabetes Population Prevalence Model 
and APHO & Department of Health Health Profile 2009) 
 
 Redcar & 
Cleveland 
Hartlepool Co. 
Durham 
Easington 
(Peterlee) 
Type 2 
Diabetes 
prevalence  
2005(diagnosed 
& undiagnosed) 
4.46% 
(Male 
3.66% 
Female 
5.21%) 
4.19% 
(Male 
3.42% 
Female 
4.92%) 
4.32% 
(Male 
3.50% 
Female 
5.10%) 
4.64% 
(Male 
3.75% 
Female 
5.47%) 
Diagnosed 
diabetes 
2007/08 
4.0% 3.7% 4.0% 3.6% 
(2005/06) 
 
Practices A and B are located in Redcar, C and E in Hartlepool and D in 
Peterlee. Practice A, C and D are independent practices, with one 
optometrist testing most days. A also employed a pre-registration 
optometrist who also tested on some days. There were 2 optometrists 
testing on some days in practice C. Practice B and D were both multiple 
franchises, with between one and three optometrist testing at one time. 
Practice B was open 7 days a week, whereas all the others opened 6 
days.  
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Chapter 6 
Detection of diabetes in optometric practice: part 2 – results of 
capillary blood glucose testing 
The results were entered into a database and analysed in SPSS 15.0. 
Independent samples t-test were used to compare means and Pearsons 
chi-squared tests to compare proportions. The independent samples t-
test compares means of two groups and tests the null hypothesis that 
there is no difference between the two groups (248). The chi-squared test 
is a non-parametric test used to compare groups (249). 
 
6.1 Participants 
During the 20 weeks of the study  (4 weeks in each of 5 practices), 1909 
adult sight tests were carried out. Of these 171 (9.0%) adults had 
previously diagnosed diabetes (either Type 1 or 2). 1303 (68.3%, 95% CI 
66.1%-70.3%) of adults attending practices) reported that they had one or 
more risk factor and so were eligible for inclusion in the study. 1002 
(77.9%, 95% CI 74.5%-79.2% of those eligible) agreed to participate.  
 
318 (31.7%, 95% CI 28.8%- 34.7%) had a random capillary blood 
glucose measurement of 6.1mmo/l or more, and so were asked to see 
their GP for further investigations. 
 
Figure 18 shows the numbers of adults attending practices during the 
study period, their eligibility to participate and the outcomes of testing. 
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Figure 18 Numbers of adult sight tests, adults with diabetes and 
adults eligible to participate attending the 5 practices (A-E) during 
the study period 
 
 
 
6.1.1 Demographics of Participants 
Participants had a mean age of 54.40 years, SD=16.3 years. 65.2% were 
female and 99.0% were white. Demographic details of participants are 
shown in figure 19. 
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6.2 Results 
936 participants completed a questionnaire reporting the frequency which 
they attended for sight tests and whether they had been screened or 
tested for diabetes previously. 81.1% reported attending at least every 
two years.  This is shown in figure 20. Independent practices (A, C and E) 
had a larger proportion of people attended for sight tests on yearly basis 
than the multiples (B and D). This may relate to the fact that the mean 
age of people attending independent practices was older than for those 
attending multiples. While most people who are eligible for a reimbursed 
NHS sight test can claim one every two years, those over 70 years of age 
are entitled to receive a reimbursed test every year.  
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Figure 20 Frequency of sight tests for all participants and by 
practice type 
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75% (698) reported that they had never been screened for diabetes 
previously. Figure 21 shows the self-reported occurrence of previous 
diabetes testing among the participants by gender, outcome of the rCBG 
test and the practice type the participants attended. 
 
No significant difference was found in between males and females, with 
75.5% of men and 74.7% of women reporting that they had not been 
screened previously. Similarly there was no significant difference 
  
143
between the whether the rCBG measurement required further 
investigation or not and whether people had ever been screened 
previously. 76.4% of those who were found to have rCGB measurement 
of 6.0 or less had never been screened before compared with 71.9% of 
those with a rCBG of 6.1mmo.l or more. Slightly more people attending 
multiple practices (78.0%) reported that they had never been screened 
compared with 71.1% in independent practices. 
 
Symptoms (53.0%), age and BMI (36.8%) and age and waist size 
(29.4%) were the most commonly reported risk factors.  There was no 
significant difference for the prevalence of most risk factors between the 
genders. The exceptions to this were age and waist size which was 
reported slightly more frequently in women (39.3%) than men (32.5%) 
and hypertension which was reported more frequently by male (33.3%) 
participants than female (27.2%). This is shown in figures 21a and 21b. 
The mean number of risk factors reported was 2.28. 
 
Figure 21a Self reported prevalence of the presence of risk factors 
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The distribution of blood glucose measurements of all participants is 
shown in figure 22.  
 
Figure 22 - Distribution of random capillary blood glucose 
measurements 
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The mean rCBG was 5.78mmol/l (95% CI 5.69-5.86 mmol/l). The 
minimum recorded was 1.9 mmol/l and the maximum 14.4mmol/l. Men 
were found to have a higher mean rCBG measurement (5.91mmo/l) when 
compared with women (5.70mmol/l). However, women tended to report 
more risk factors (2.37) than men (2.13). There was no difference 
between the genders in mean age  (men 55.1 year, women 54.0years). 
 
There was no significant difference between the mean blood glucose 
between the two practice types but the mean age in independent practice 
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(56.8 years) was significantly higher than that in multiple practices (52.5 
years). Details are shown in figure 23. 
 
Figure 23 - Age, blood glucose and risk factors by gender and 
practice type 
 
 
 
 
363 (31.7%, 95% CI 28.8%- 34.7%) had a rCBG of 6.1 mmol/l or more.  
 
There was no significant difference in the proportion of people with a 
rCBG of 6.1mmo/l or more in the two different type of practice, with 
32.1% of those attending independent practices and 31.5% of those 
attending multiple practices requiring further investigation. 
 
There was a significantly larger proportion of men (38.0%) than women 
(28.2%) who required further investigation following the rCBG test. This is 
shown in figure 24. 
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Figure 24 rCBG category by gender and practice type 
 
 
Direct logistic regression was performed to see which risk factors had a 
significant impact on whether a participant had a rCBG of 6.1mmol/l or 
more and required further testing (250). All risk factors (A-L), age and 
gender were entered in a forward regression analysis. Age, gender, risk 
factor A (age and family history) and B (age and BMI) where statistically 
significant predictors of referral. Backward logistic regression was also 
performed and gave the same results. Presence of family history, BMI 
over 25kg/m2 and increasing age increased the probability that someone 
had a rCBG measurement of 6.1mmol/l or more. Females were less likely 
to have a rCBG that required further investigation than men. The odds 
ratio for age indicates that, for each increased year of age, the likelihood 
of having a rCBG of 6.1mmol/l or more increased 1.01 times. Details are 
shown in figure 25. 
 
Figure 25 Logistic regression predicting the likelihood of a rCBG 
measurement of 6.1mmol/l or more 
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6.3 Discussion 
31.7% of the participants had a rCBG of 6.1 mmol/l or more (5.6mol/l 
whole blood). This is a similar referral rate to a Danish stepwise 
screening programme, where high risk individuals were invited to have 
random blood glucose tests and continued to a fasting test if random 
whole blood glucose was greater then 5.5mmol/l. In this study, 30.1% 
required the fasting test (251). An Australian pharmacy study, also using 
5.5mmol/l as the cut off point for further tests, found 38.8% were referred 
for further investigation (130).  
 
The referral rate in this study was lower that that found in a UK pharmacy 
using the same RPSGB/Diabetes UK guidelines as used in our study (1). 
They found a prevalence of rCBG of 6.1mmol/l or more of 42.7% 
compared with 31.7% in our study. However, the populations differed in 
that our population was predominately white, whereas nearly 50% of the 
participants in the pharmacy study were South Asian. They reported the 
prevalence of rCBG of 6.1mmol/l or more of 42.7% for the South Asian 
participants compared with 18.3% among the white participants. 
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Chapter 7 
Detection of diabetes in optometric practice: Part 3 
– results of referral to GP following capillary blood 
glucose measurement 
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Chapter 7 
Detection of diabetes in optometric practice: Part 3 – results of 
referral to GP following capillary blood glucose measurement 
7.1 Participants 
Questionnaires were sent to all 318 participants who had a blood glucose 
measurement of 6.1mmol/l or more between 4 and 8 weeks after the 
initial screening test. Further reminders were sent 4 weeks later to all 
those who had not replied or had replied to say they were waiting for 
results. 
 
228 replies were received following 2 letters (response rate of 71.7%) 
Response rates from individual optometry practices varied from 62.4% to 
81.5%. Response rate and details of respondents and non-respondents 
are shown in figure 26. 
 
Figure 26 Response rate to follow-up questionnaire for each 
practice and characteristics of respondents  
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Non-respondents (mean 49.0 years) were significantly younger than 
those responding (mean 60.7 years) to the questionnaire. 
 
However, there was no significant difference in the mean rCBG between 
the two groups; non-responders 7.10mol/l, responders 7.28mmol/l. The 
mean number of risk factors was also not significant in whether 
participants returned the questionnaire; non-responders 2.52 risk factors, 
responders 2.45. 
7.2 Results 
Figure 27 show the summary of the participants who had a random 
capillary blood glucose level of 6.1mmol or above.   
 
No response was received from 90 participants (28.3% 95% CI 23.4% - 
33.6%).  
 
66 of the 228 respondents (29.0% 95% CI 23.1%-35.3%) reported that 
they did not visit their GP. 71.1% (95% CI 64.7%-76.9%) of those 
responding reported that they did attend their GP.  Of the 162 who did 
visit their GP, 85.2% (95% CI 78.8%-90.3%) reported that the GP carried 
out some form of further testing. 11.6% (95% CI 6.8%-18.1%) of those 
tested by a GP reported that they had been diagnosed with either 
diabetes, pre-diabetes, borderline-diabetes, IGT or IFG. Details are 
shown in figure 27. 
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Figure 27 - Summary of the participants who were referred following 
random capillary blood glucose test 
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Of the 318 participants who had a random capillary blood glucose level of 
6.1mmol/l or more at the screening test, 43.4% reported attending their 
GP and undergoing further investigations. Just under one third (28.9%) of 
those who responded reported that they did not visit their GP. 
 
While there was no significant difference in age of the participants who 
reported that they did attend the GP (60.5 years, 95% CI 58.3-62.7 years) 
and those who did not (61.0 years, 95% CI 57.2-64.8 years), there was a 
significant difference in mean blood glucose. Those who attended the GP 
had a higher mean rCBG (7.44mmol/l, 95% CI 7.21 - 7.68mmol/l), range 
6.1 to 14.3mmol/l) than those who reported that they did not attend 
(6.88mmol/l, 95% CI 6.71 – 7.04mmol/l, range 6.1 to 9.3).  
 
The mean number of risk factors reported did not make a significant 
difference as to whether participants made the decision to visit the GP 
(2.51, 95% CI 2.32-2.71) or not (2.29, 95% CI 1.95-2.63). Gender and 
practice type did not significantly affect whether participants made the 
decision to attend their GP for further investigation. Details are shown in 
figure 28. 
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Figure 28 Mean age, rCBG, risk factors, gender and practice type of 
participants who reported attendance or no attendance at their GP 
 
 
 
Not all of those who reported that they visited their GP received further 
tests. 22 (13.6%, 95% CI 8.7-19.8%) of the 162 who reported that they 
attended their GP, reported that no further investigations were carried 
out. A further two participants (1.2%, 95% CI 0.2-4.4%) were unsure as to 
whether any tests had been done.  There was no significant difference 
between the mean blood glucose of those tested (7.49mmo/l, 95% CI 
7.25 – 7.74mmol/l) or not tested (7.08mmol/l, 95% CI 6.38 – 7.78mmol/l). 
Those not tested had a range of rCBG from 6.1mmol/l to 13.6 mmol/l, 
compared with 6.1 to 14.3mmol/l for those reporting that they underwent 
further investigations. There was also no significant difference noted in 
the mean number of risk factors or mean age of those who were 
investigated further and those reporting that no tests were carried out. 
Details are shown in figure 29.  
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Figure 29 Mean age, rCBG and risk factors for those attending their 
GP who reported further investigations or no further investigations 
carried out 
 
 
Of the 138 who underwent further tests at their GP, 111 (80.4%, 95% CI 
72.8 – 86.7%) reported that they were ‘normal’ or were given no 
diagnosis. 7 (5.1%, 95% CI 2.1-10.2%) were given the diagnosis of 
diabetes. 9 (6.5%, 95% CI 3.0 - 12.0%) reported a diagnosis of a non-
diabetic hyperglycaemic condition (2 IGT, 2 IFG, 1 pre-diabetes and 4 
borderline diabetes). 11 (8.0%, 95% CI 4.1 – 13.8%) were not sure of the 
results of the tests.  
 
Those who were given a diagnosis of a hyperglycaemic conditions have a 
higher mean rCBG (8.90mol/l, 95% CI 7.62 – 10.18mmol/l) than those 
who were not (7.28mmol/l, 95% CI 7.06 – 7.51mmol/l). There was no 
significant difference between the mean age and the mean number of risk 
factors of those who were diagnosed as having normal glycaemic levels 
and those with diabetes or a pre-diabetic condition. Details are shown in 
figure 30. 
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Figure 30 Mean age, rCBG and number of risk factors of those 
diagnosed with hyperglycaemia and normal glycaemic levels 
   
 
All participants with rCBG of 12.2mmol/l or more, who reported being 
tested by their GP, reported a diagnosis of diabetes.  
 
The mean rCBG of those who were subsequently diagnosed with 
diabetes was 10.06mmol/l (95% CI 7.38-12.73 mmol/l). For those 
diagnosed with pre-diabetes the mean rCBG at screening was 
8.00mmol/l (95% CI 6.81-9.19mmol/l). The mean rCBG of those who 
reported that they were normal or had been given no diagnosis was 
7.29mmol/l (95% CI 7.06-7.51mmol/l). Figure 31 shows box plot of the 
blood glucose for those diagnosed as having diabetes, pre-diabetes and 
normal blood glucose. 
 
Those participants diagnosed with diabetes had significantly higher mean 
rCBG(10.06mmol/l) than those who were given no diagnosis 
(7.29mmol/l). However, those diagnosed with a pre-diabetic 
hyperglycaemic condition did not have significantly increased mean rCBG 
when compared with the mean for those diagnosed as normal. 
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Figure 31 Box plot of rCBG measurements for those diagnosed as 
having diabetes, pre-diabetes or normal blood glucose  
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For this study we used a cut off point of 6.1mmol/l to decide whether a 
participant should be referred for further investigations. Other studies 
have used higher cut off limits (145) (144) (146). The effect on the 
number of cases of diabetes and pre-diabetes diagnosed if the cut off 
point for referral was increased is shown in figure 32. 
 
Figure 32 Diabetes and Pre-diabetes for different cut off points 
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If only participants who had a rCBG of 12.1mmol or more were referred 
for further investigation, only 5 would have been referred. We only know 
the outcome of further investigations for two of these participants, both 
were found to have diabetes. Increasing the cut of point by 1 mmol/l to 
7.1mmol results in a reduction of the number of referrals by 43%, but also 
would have resulted in one case of diabetes and 4 pre-diabetes being 
missed. A rCBG of 12.1mmol/l or more has a positive predictive value 
(PPV) of 100% for diabetes and pre-diabetes. This is shown in figure 33. 
 
Figure 33 - PPV of rCBG for pre-diabetes & diabetes and diabetes 
 
 
The characteristics of the individuals diagnosed with diabetes or a pre-
diabetic condition are shown in figure 34. 
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Figure 34 - Characteristics of those diagnosed with diabetes, IGT, 
IFG, borderline diabetes or pre-diabetes 
 
 
There were not enough participants subsequently diagnosed with 
diabetes or pre-diabetes to perform logistic regression analysis to 
determine which factors had a significant impact on whether a participant 
was diagnosed with a hyperglycaemic condition following the rCBG 
screening test. 
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Family history and BMI were both associated with increased likelihood of 
being referred following the rCBG test. 9 of the 16, who received a 
diagnosis, reported either family history, a BMI of 25 kg/m2 or more or 
both factors. Increasing age was also associated with increased 
likelihood of referral. Only two people, one of whom was diagnosed as 
having diabetes and one who was diagnosed as having IFG, were are 
aged under 40 years. One of these reported symptoms, while the other 
reported no risk factors but was found by the optometrist to have ocular 
finding suspicious of diabetes.  
 
Of the 1909 adults who attended the participating practices during the 
study period, 171 had previously been diagnosed with diabetes. 16 
participants reported IFG or IGT as a risk factor. With these new case of 
diabetes and pre-diabetes discovered as a result of screening, 178 adults 
had diabetes and 25 pre-diabetes, 9.3% and 1.3% respectively of the 
total adults population attending the practices. 
 
7.3 Discussion 
Just under a third of those who responded to the questionnaire reported 
that they did not go the GP for further investigation. These tended to have 
lower rCBG than those who did attend their GP. 
 
In this study 1.3% of all adults attending the optometry practices had 
some form of non-diabetic hyperglycaemia (IGT, IFG or pre-diabetes) and 
9.3% diabetes, either previously diagnosed or newly diagnosed as a 
result of participating in the screening service. 16 (8%) of the 203 who 
had some form of hyperglycaemia were diagnosed as a result of the 
screening and represent a new hitherto undetected group. Reported 
prevalence of IGT is 15.8% in US adults aged between 40 and 65 years 
(95). The prevalence of diabetes (both type 1 and 2, diagnosed and 
undiagnosed) in the UK in 2001 was 4.41%(10). 
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The prevalence of diabetes among the adults attending the participating 
practices is higher than in the general population. People with diabetes 
are often made aware of the risk of ocular complications of diabetes and 
the need for frequent eye examinations. They are also entitled to a 
reimbursed NHS test yearly, whereas most other groups are only entitled 
to a test every two years.  
 
Though the prevalence of diabetes was higher than among the general 
population, the prevalence of pre-diabetes was lower. 1.3% were found to 
have a non-diabetic hyperglycaemic condition, 0.8% previously 
diagnosed and 0.5% newly diagnosed. While we found that those 
diagnosed with diabetes had significantly higher mean rCBG results than 
those who were classified as normal, the mean rCBG results for those 
diagnosed with pre-diabetes was not significantly higher. Though there 
may be no significant difference, it may be that some people who had a 
pre-diabetic condition were classified as normal causing more overlap 
between the two groups. It may be that this is a factor of using random 
blood glucose measurements instead of fasting. However, it is possible 
that the lack of a significant difference is due to some participants who do 
have some form of pre-diabetic hyperglycaemia have been described as 
normal. This may be due to GPs not diagnosing these conditions, or to 
the participants’ interpretation of the result. If the participant interprets the 
result of having pre-diabetes as meaning they do not have diabetes and 
so it is a normal result for present, they may report the incorrect diagnosis 
on the questionnaire. 
 
In this study, we did not specify what further investigations should be 
carried out. Letters sent to the GPs suggested that further tests should be 
carried out. However, we did not prompt them to consider IGT or IFG 
when carrying out the tests.  We do not know what tests were carried out 
and what the results were. If we had carried out fasting blood glucose and 
OGTT on all participants we could have ensured that pre-diabetic 
conditions were considered as well as diabetes. An investigation of 
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attitudes of GPs in the North East toward IGT found that awareness of 
the condition was low and there is some reluctance to screen for the 
condition (252). Similar attitudes were found among GPs and practice 
nurses in Wales. (253).  Concerns about medicalisation of people with 
non-diabetic hyperglycaemia and reluctance to divert overstretched 
resources to this area have been reported. This may lead to the low 
prevalence of pre-diabetic hyperglycaemia found in this study, with 
people with IGT and IFG not being diagnosed as such.   
 
Retrospective analysis of patients attending a district hospital over a one 
month period, who were found to have a random plasma glucose levels 
between 6.0 and 11.1mmol/l, found that only 95 out of the 518 patients 
received formal investigations for diabetes, with 92 receiving fasting tests 
and 3 OGTT. Of the 95 investigated 18 (18.9%) were found to have IGT 
or IFG, and 3 (3.1%) diabetes (254). We found that around 5% of those 
who received further investigations where diagnosed with diabetes 
compared with 3.1% in the hospital study. However, we found a much 
smaller proportion diagnosed with a pre-diabetic condition, 6.5% 
compared with 18.9%. It may be that there was a lower proportion of IGT 
and IFG in our population, as a hospital population may have multiple co-
morbidities compared with a population attending screening in the 
community. Hospital populations may also be more likely to be prescribed 
drugs that are known to increase the risk of diabetes compared with our 
population. However, we relied on patients reporting the outcome, 
whereas Doyle et al. (254) had access to the patients’ records and had 
the results of the blood tests and were able to report diagnosis from those 
results.  We do not know what tests were carried out and what the blood 
glucose measurements were in those who reported a diagnosis of 
normal. We cannot differentiate between those who considered the 
outcome normal as they did not have diabetes, but may have had some 
form of impaired glucose regulation and those who did not have any form 
of hyperglycaemia. 
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We do not know who initiated the appointment for further investigations. 
Participants were told that further investigation was recommended and 
the GP was sent a copy of the results, recommending that fasting tests 
should be carried out. The GP appointment could then have been 
initiated either by the participant contacting the GP for follow up or by the 
GPs’ practice inviting the participant to attend for follow up. We know that 
around half the people who had rCBG of 6.1mmol or more visited their 
GP and a further 20% did not. The 66 who reported that they did not 
attend for any further investigation received verbal and written 
instructions that they should visit their GP for further investigation at the 
time of participating in the study. They also received the questionnaire 
about the outcomes of any investigations, which prompted them that they 
should seek further investigation. It would be interesting to know if they 
also received a invitation from the GPs’ surgery to attend. It may be that 
more people attended for further follow up if the GP issued an invitation. 
Previous qualitative investigations into people experience of screening for 
diabetes has shown that, while participants feel it a good thing that 
people are screened and can be diagnosed and treated earlier, they do 
not feel that they are likely to have the disease themselves (142). This 
feeling among participants that they won’t have diabetes themselves may 
be reinforced if, though they screen positive, the GP does not invite the 
participant for further tests. It may be that, as participants were aware that 
the GP had been notified of the results, if the GP did not initiate any 
further tests, the participant felt that the rCBG results were not serious 
enough to warrant further investigation. If they felt that the GP did not act 
on it, then there was no need for them to. A qualitative study of people 
newly diagnosed with diabetes showed that if there was a long wait 
between the initial GP contact and hospital appointment for investigation 
of diabetes, the patient believed that the diagnosis could not be serious 
(255). However, we did not collect any information on who initiated the 
appointment with the GP.  
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There were a number of people who reported that they did attend the GP 
but no tests were carried out. This would suggest that this group initiated 
the appointment without a prompt from the GP.  
 
For screening in optometry practices to be effective, communication 
between the health care professions needs to be seen to be consistent. If 
a person is told by one profession that they may have a health issue and 
then told no further tests are required by the next, this will send conflicting 
information to the patients. In our study, there was no significant 
difference in the mean rCBG measurement between those who were 
tested by the GP and those who were not. The range of rCBG of those 
who attended the GP and were not investigated further was from 
6.1mmol/l to 13.6mmol/l. It would be interesting to see why the GP made 
the decision not to investigate further these patients, despite them 
attending.  
 
5 participants in the study had a rCBG measurement of 12.2mmol/l or 
more and were told that they should see a GP urgently. We received 
responses from three of these participants, 2 received a diagnosis of 
diabetes and the third reported that GP did not carry out any 
investigations.  
 
If it is assumed that all the people who did not respond to questionnaire 
did not attend their GP, around half the participants who we suggested 
should consider further investigations did not act on that suggestion, and 
so are not receiving benefit from participating in the screening. 
 
The links that optometrists have with other professionals are vital in the 
effective running of any shared care or screening service. In the previous 
qualitative work in chapter 4, optometrists felt that the relationship they 
had with GPs varied. While some think of optometrists as clinical 
professionals, others think of optometrists as primarily business people. 
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The views of GPs on the role and knowledge of optometrists may have 
an effect on the way they treat referrals from them.  
 
7.3.1 Limitations and strengths 
By using a postal questionnaire to contact the participants we risked a 
high non-response rate which is a common issue with postal surveys. 
 
By sending the questionnaire to the participants, we relied on them going 
the GP and reporting the results of any investigations. We do not know 
how accurately the participants are reporting the outcomes.  
 
We could have sent to questionnaires to the GPs to complete. However 
the GP named by the patient may not be the GP the patient sees so the 
response rate may have suffered. We referred participants to the GP on 
the basis that they were at risk of diabetes or pre-diabetes. The 
prevalence of diagnosed pre-diabetes, borderline diabetes, IGT and IFG 
was lower than we would have expected, suggesting that GPs are either 
not diagnosing these conditions or not communicating it to patients, or 
that the patients are not understanding these conditions. If we had sent 
equivalent questionnaires to GPs giving the option of these non-diabetic 
hyperglycaemic states, we may have prompted them to consider them 
when carrying out further testing. If a screening service in optometry 
practices was implemented and run in a way similar to pharmacy 
screening, the GPs would not have to report results to anyone except the 
patient. 
 
To determine whether the extent of diabetes and pre-diabetes was 
accurate, we could have arranged to carry out the fasting blood glucose 
investigations ourselves. This would have required the participants to 
come to a central location for the further tests, thereby negating the 
convenience of them attending their local optometry and GPs practice. 
Unlike with GP practices, people do not have to register with a local 
optometry practice. They may attend a practice that is distant from their 
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home, but convenient for that particular time, whether they are working 
away from home or on holiday. For these people it would be more 
convenient to visit their own GP when they returned home than attending 
a location in the North East for further fasting tests. 
 
Had we carried out the follow up testing ourselves and used a constant 
test procedure and diagnosis protocol we would have got a more 
accurate determination of the rates of pre-diabetes and diabetes among 
the population we tested. The method we have used to determine the 
outcomes of further testing does not give us the most accurate 
prevalence, however, it does show how the participants interpret the 
results they are given. The strength of using this method is that it reflects 
real life and demonstrates how a screening service would run if 
implemented in high street practices. We know that lifestyle changes can 
slow the progression of pre-diabetic conditions to diabetes (99) (98) 
(256). As diabetes is a condition that is affected by lifestyle choices, 
people need to be aware of diagnosis of diabetes and pre-diabetes so 
they can consider making changes they need to.  
 
We could consider following up all those who reported that they did not 
attend their GP or had no investigations done to invited them to have 
fasting blood glucose tests. 
 
There were a large number of participants who either did not attend their 
GP, attended but were not investigated or did not reply to the 
questionnaire. We do not know whether any of these may still have 
undiagnosed disease even through they have participated in screening. 
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Chapter 8 
Acceptability of capillary blood glucose tests to users in high street 
opticians practices 
Abstract 
Background 
A screening service offering people with risk factors or symptoms of 
diabetes random capillary blood glucose (rCBG) tests was piloted in high 
street opticians’ practices in North East England. 
Aim 
To determine acceptability to the users of a screening service using rCBG 
tests to detects raised blood glucose levels in the “at risk” populations 
attending optometry practices 
Methods 
1002 people used the screening service in 5 practices. Each was given a 
questionnaire to complete and return following a screening finger-prick 
test.  
Results 
939 questionnaires were returned (return rate 93.7%). The mean age of 
respondents was 54.5 years; 63.3% were female. 
 
99.1% agreed or strongly agreed that the location was convenient for 
them. 95.1% disagreed that the test procedure was uncomfortable. 98.0% 
would recommend others to use the screening service. 82.9% felt that 
optometrists should be able to detect health problems. 83.8% of the 
participants would not have gone elsewhere to have any tests done. 148 
(15.7%) responded that they would have sought a test elsewhere; of 
these 91.5% would have sought tests at their GP, 4.7% at a pharmacy 
and 3.5% elsewhere. 
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Conclusions 
Opticians’ practices provide an acceptable and convenient place to 
provide screening services to the general public who may not access 
services elsewhere. This provides an opportunity to identify people at risk 
of diabetes in a hitherto unutilised setting. 
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8.1 Introduction 
To be suitable for screening a disease must be common, have a suitable 
test, and have an effective treatment or management. However, 
screening cannot be effective unless the target population takes up the 
screening test. For a screening programme to be successful, it needs to 
be accessible and acceptable to the population who are at risk of the 
disease. 
 
A screening programme was implemented in high street optometry 
practices in North East England, offering random capillary blood glucose 
(rCBG) tests to those reporting risk factors for developing Type 2 
diabetes. 
 
Previous studies, such as the ADDITION study, have used rCBG tests as 
the initial part of a screening procedure to identify those who would 
benefit from further fasting test. People who were identified as high risk of 
developing diabetes were invited to participate. Uptake of rCBG testing 
was between 44% in the Danish arm of the study (257) up to around 
three quarters in the UK arm (258) (259).  The psychological impact of 
screening in these studies was assessed qualitatively and quantitatively 
and the authors concluded that there was limited negative psychological 
impact of screening, both short and long term (142) (218). 
 
8.2 Methods 
Adults aged 18 years and over attending one of 5 high street opticians 
practices in North East England were offered a rCBG test if they self 
reported on a questionnaire the presence of risk factors or symptoms of 
diabetes. 1303 adults were offered the opportunity to participate, with 
1002 (77.9%) consenting to take part. After participants took part in the 
screening procedure described in the previous chapter, they were given a 
written questionnaire to complete. The screening procedure is described 
in chapter 5. 
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8.2.1 Choice of Method 
A written questionnaire was chosen. Written questionnaires have the 
advantage that they are simple method of gaining information from a 
large population.  They are simpler in terms of scheduling and time 
commitment when compared with face-to-face interviews. There are 
issues in terms of poor response rate and control over who completes the 
questionnaire, particularly with postal questionnaires (188).  This can be 
overcome by using face-to-face interviews. However, this creates issues 
in terms of cost and time.  Due to time constraints we were aware that we 
would not be able to interview all participants in the screening 
programme. A written questionnaire could be administered immediately 
after the test procedure by the researcher. As the participant could take 
the questionnaire away, they could complete it without the researcher 
who undertook the blood glucose tests seeing the results. This would 
enable a more independent response. 
8.2.2 Questionnaire Development 
The questionnaire aimed to investigate how acceptable the service was 
to users. The initial questions determined demographic data about the 
participants; how frequently they attended for sight tests and whether 
they knew they had been screened or tested previously. 
 
Previous qualitative research indicated that optometrists believed that the 
public would accept screening in opticians’ practices if it was convenient, 
and they felt that the there was a difference in expectations between 
people attending an independent practice and those attending a multiple 
practice. Questions on convenience and expectations of optometrists’ 
ability to detect health problems were included to investigate those 
concepts and constructs developed in chapter 4. 
 
The questions were piloted with 15 adults who were not involved in the 
project design and had no background in optometry or diabetes. They 
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were asked to provide their views on completing the questionnaire and 
changes were made to the wording and layout as a result. 
 
Participants were asked to report the frequency with which they attended 
opticians’ practices, whether they had been screened previously, and 
whether they would have gone elsewhere to be screened. They were also 
asked to rate how convenient they found the location, how uncomfortable 
the procedure was, whether they would recommend it and whether they 
expected opticians to detect general health care problems, using a 5 
point Likert scale. They were also asked if they would have considered 
going elsewhere for a test and if so, where. They were also given the 
opportunity to write free text comments. The questionnaire is included in 
appendix H. The final questionnaire was approved by the School of 
Medicine and Health Ethics Committee. 
 
8.2.3 Sample size 
Every participant in the screening study (n=1002) received the 
questionnaire immediately after being given the results of the blood 
glucose test.  
 
Participants were given a stamped, addressed envelope, or given the 
opportunity to return it to either the research assistant or practice staff 
member if they wished to complete it while they waited for their sight test 
appointment.  
 
Each questionnaire was labelled with the participants ID number so 
responses could be linked with the details of their blood glucose tests, 
and the practice where the screening occurred.  
 
The results were entered into a database and analysed in SPSS 15.0. 
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8.3 Results 
1909 adults attended optician practices during the study period. 1303 self 
reported the presence of risk factors or symptoms of diabetes in response 
to a questionnaire. 1002 (77.9% of those eligible) consented to receive 
the rCBG test. Demographic details of participants are described in 
chapter 6. 
 
939 questionnaires were returned from all the study locations (overall 
return rate 93.7%). Return rate for individual study locations ranged from 
91.8% to 95.2% (A 93.3%, B 95.2%, C 91.8%, D 93.3%, E 93.9%) 
8.3.1 Demographics 
The mean age of respondents was 54.5 years (54.4 years for the 
participants in the screening study). 36.7% were male; 98.9% were white. 
The average blood glucose of respondents was 5.79 mol/l. There was no 
significant difference between the mean rCBG measurements of those 
who completed the questionnaire (5.79 mmol/l) and those who did not 
(5.51mmol/l). 32.4% were referred for further tests compared with 31.7% 
in the screening as a whole. Details are shown in figure 35. 
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Figure 35 Demographic details for participants returning 
questionnaire and all participants in the screening 
 
 
Figure 36 show the responses to the 4 questions about convenience, 
comfort, recommendation and expectations of optometrists with regards 
to general healthcare. 
  
175
 
Figure 36 Table of participants’ responses 
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Only 2 respondents (0.2%) disagreed or strongly disagreed with the idea 
that the opticians’ practice was a convenient location. The majority felt 
that the location was convenient for them. 99.4% of male and 99.0% of 
female participants agreed or strongly agreed that the practice was 
convenient. Likewise, there was no significant difference between 
responses from the different practice types, with only 0.2% of those 
attending independent and multiple practices disagreeing or strongly 
disagreeing that the location was convenient  
 
Thirty participants, from the 926 who responded to the statement, 
reported that the test was uncomfortable (24 strongly agreed, 6 agreed). 
However, only one of these reported that they would not recommend the 
test to family and friends. Over 95% reported that they would recommend 
participation to other people. 13 disagreed or strongly disagreed that they 
would recommend it to others. The scores were not related to whether a 
person was referred or not following the rCBG test. Again there was no 
difference in responses between the genders, with 2.7% of males 
agreeing or strongly agreeing that the tests were uncomfortable 
compared with 3.6% of female participants. 
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When asked if they would recommend the test to others, 98% agreed that 
they would. Again, this did not significantly vary when the genders were 
considered (male 97.4%, female 98.3%). Similarly, whether a person was 
referred for further investigation following the tests did not influence 
whether they would recommend other to participate in screening, with 
98.2% of those who were not referred and 97.4% of those who were 
referred, agreeing or strongly agreeing that they would recommend 
screening to others. 
 
Over three quarters of participants agreed that opticians should be able to 
detect health problems. Around 4% disagreed with this statement. Again, 
as with the other statements, gender (male 80.5%; female 84.3%), 
practice type (multiple 82.8%; independent 82.8%) and whether someone 
was referred following rCBG tests (not referred 83.4%; referred 82.5%) 
made no significant difference as to the proportion of people who 
indicated that they agreed and strongly agreed with the statement. 
 
148 respondents reported that they would have considered going 
elsewhere for a diabetes screening test, while 768 would not. Of the 148 
who would have considered going somewhere else, 77 had never been 
tested previously and 69 reported that they had undergone screening for 
diabetes prior to participating in the study (no details on previous test 
status for 2 participants). 
 
Nearly two thirds of the population that participated in the screening 
reported that they had never been tested previously and that they would 
not have gone on to seek out screening (n=609). Details of whether a 
participant reported that they would have considered going elsewhere for 
a screening test shown in figure 37. 
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Figure 37 – Responses by gender, previous test, blood glucose 
levels and practice type 
 
 
There was no significant difference in gender, with only 18.6% of women 
and 14.7% of men reporting that they would consider going elsewhere to 
be tested for diabetes. Likewise, whether a person was referred following 
the screening test or the practice type attended did not significantly 
influence whether they reported that they would have gone elsewhere to 
seek out testing if they had not participated in this study. There was a 
significant difference in relation to whether people had been previously 
tested for diabetes. Those who reported that they had been screened in 
the past were more likely report that they would consider going elsewhere 
to ask for a test, with 31% reporting they would go somewhere else 
compared with 11.2% of those who had never been screened previously. 
 
Of the 148 people who reported that they would have gone elsewhere to 
request a screening test, most (87.8%) reported that they would have 
gone to see their GP or practice nurse. 7 (4.7%) would have gone to a 
pharmacy. 5 (3.4%) said they would have gone somewhere else, these 
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included shopping mall (n=1), self testing with friends or family member’s 
machine (n=2), hospital (n=1) or with the off-shore medic at work (n=1). 6 
respondents who reported they would go elsewhere did not specify where 
they would go. Figure 38 shows the responses of whether people would 
seek to be screened if they had not participated in the study and where 
they would have gone. 
 
Figure 38 - Where respondents would seek screening if they had not 
participated in the screening study 
 
Space was given for participants to make any additional comments. 
Around one third (326) made some comment. 
 
The comments fell in to a few broad categories; convenience and 
location, ease and comfort of test, reassurance, raising awareness and 
testing people not previously tested or considering tests, and 
recommendation to other. 
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There were several comments that it was convenient to have the test 
done at the opticians practice. 
 
 ‘It was good to have the test done without making an appointment 
at the doctors, especially as I work out of town and it was a Saturday’  MI 
6.1 
 
 ‘Very convenient to have test when come to opticians regularly 
(annually) to have eyes tested, Less likely to seek a specific test even if 
at a pharmacy’ FI <6.1 
 
Several people felt that the opticians practice was a friendly atmosphere, 
which made the tests less stressful. Several compared the experience to 
attending GPs surgery, both in terms of convenience and atmosphere. 
 
 ‘Quick and comfortable, and not stressed out by waiting at a 
doctors surgery’ FI 6.1 
 
 ‘Convenient, comfortable atmosphere and friendly staff all helped 
keep the experience trauma free’ FI 6.1 
 
Several people liked the idea of a ‘one-stop shop’ for health care, 
combining different tests into one appointment. 
 
 ‘I visit my optician every year. It’s a brilliant idea to have this test at 
the same time. I had the test done while I waited for the optician. It’s a 
great offer, buy one get one free.’ FM <6.1 
 
 ‘I think it’s a good idea to have a ‘one stop shop’ for health issues’ 
FM <6.1 
 
 ‘A very sensible and worthwhile idea to have the test done along 
with optometric test’ FM <6.1  
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Ease and comfort of the test was commented on by many of the 
participants.  
 
 ‘Pain free and very informative’ FI <6.1 
 
 ‘It was quick and painless, Thank you’ MM 6.1 
 
Some people found that the procedure was reassuring, and even if they 
were referred for further investigations, felt that others would find that the 
test could give peace of mind. 
 
 ‘I agree fully with these tests as they can give peace of mind and 
think they should be made compulsory.’ MI 6.1 
 
 ‘Very convenient and having results straight away was reassuring 
– thank you’ MI <6.1 
 
Some people reported that while they were aware of diabetes they would 
not have considered being tested if it had not been offered. Others 
reported that being asked to participate had raised their awareness of the 
disease, and encouraged them to take part, even if they did not feel they 
had symptoms that were worth taking to the GP. 
 
 ‘Test at optician seem to me to be a good idea. Even though 
mother had Type 2 diabetes I would not have bothered to get tested until 
symptoms showed. I did not know about slow healing of wounds, it is this 
that encouraged me to take part’ FI 6.1  
 
 ‘Very convenient and helpful, I would not have booked an 
appointment with my GP just to see about any symptoms unless they 
were very severe’ FM 6.1 
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 ‘Pleased the test was available otherwise I wouldn’t have thought 
about having it done.’ FM 6.1 
 
Some participants commented that they would recommend the test to 
others.  
 
 ‘Felt it was vey convenient, quick and easy. Would recommend to 
family and friends’ FM <6.1 
 
 ‘It was completely painless and only took a few minutes. I would 
therefore recommend everyone to have it done’ FM <6.1 
 
8.4 Discussion 
Some participants voiced concerns over how painful the test would be 
prior to taking part, and reported a dislike of needles. When the 
equipment was demonstrated and they could see that no needle was 
visible they were happy to take part. Around 3% reported that the test 
was uncomfortable. Only one of those who reported discomfort would not 
have recommended others to have the screening test done. This may 
reflect the fact that the participants believe that the test is worthwhile 
even if it does cause some discomfort. However, it is also possible that 
some participants may not have fully read the statements and ticked the 
same agreement level for all four statements. This was true in just over 
half of the thirty cases where they either agreed or strongly agreed that 
the test was uncomfortable (14 strongly agreed with all statements, 3 
agreed with all statements). 
 
The setting of high street optometry practices appears to be convenient 
for this population. This may not be surprising, as people are not tied to a 
specific practice as they would be with a GP, and so can chose a practice 
that is convenient to them at that particular time. Several people 
commented that they liked the convenience of being able to have 
different tests done at the same time and location instead of attending 
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two different places. The Danish arm of the ADDITION study found that 
employed people were less likely to attend screening than other groups 
who were not in employment. They suggested that this may be due to the 
fact that, as they did not feel unwell, the employed did not prioritise 
screening over other demands on their time (257). If attendance at 
screening requires an individual to take time off work, this may affect their 
willingness to take up screening. We did not investigate the employment 
status of participants in this study. All the practices that took part in the 
screening were open 6 days a week, some with early morning or late 
night opening and one testing 7 days a week, in an attempt to provide a 
service to those who were employed and found it difficult to attend in 
normal office hours. Some participants did report that the ability to attend 
on a Saturday was convenient as they were working and were not able to 
attend during the week.  
 
The responses show that offering screening in conjunction with the sight 
test may result in people taking up screening when they would not go out 
and actively seek it. Nearly two thirds of the people who took part 
reported that they had not been screened previously and that they would 
not have considered going elsewhere to be tested. It had been suggested 
by optometrists that the people most likely to accept the offer of screening 
in optometry practices would be those who would have sought healthcare 
from other locations (chapter 4). However, from this data we can see that, 
while some would have been screened before and would consider going 
to the GP or pharmacist for a test, there is a significant number of people 
attending optometry practices who have not considered taking part in any 
form of screening test. Although pharmacies in the UK have been offering 
screening for several years, very few people in this study (4.7% of those 
who reported that they would somewhere else for a test, 0.7% of all 
respondents) considered going to a pharmacist to request a test.   
 
In previous qualitative work in chapter 4, optometrists expressed 
concerns that the public viewed multiple and independent practices 
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differently, treating the large multiple chains more like retail outlet, while 
viewing the smaller independent practices as health care providers.  Over 
three quarters of people who participated in the screening believed that 
optometrists should be able to detect health problems. There was no 
difference between the proportion of people agreeing or strongly agreeing 
with the statement between those attending multiple practices and 
independent practices. 
 
It was also felt that people attending independent practices would be 
those who would take up the offer of screening more willingly, but would 
also be the people most likely to attend elsewhere for screening. There 
was a small difference between the proportion of people screened 
previously between the practice types, 22.0% screened previously in 
those attending multiple practices and 28.9% in independent practices. 
Even though there is a statistically significant difference between the two 
practices type, over 70% of people who were screened in either practice 
type reported that they were not aware of being tested previously, which 
indicates that there is a large population attending both types of practice 
who have risk factors, but have not been screened previously or are not 
aware that they have been tested. Whether people attended a multiple or 
independent practice had no significant effect on whether they would 
have considered going else where for a screening test if they had not 
been tested as part of the screening study.  
 
Though the optometrists felt that there were differences between 
independent and multiple practices in terms of how the public viewed 
them, and how those attending the different practice types accessed 
health care, this was not reflected in the responses to these questionnaire 
to a great extent.  The participants in our study showed little difference in 
responses between those who attended multiples and those attending 
independents.  
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8.4.1 Limitations and Strengths 
This survey was only carried out among people who consented to take 
part in the screening procedure, so is self-selecting toward those who are 
more willing to accept screening. However, only 22% of those eligible 
chose not to participate indicating a generally good acceptance among 
the population attending high street practices. We were unable to record 
details of people who did not wish to participate due to ethical 
considerations, so cannot see how they differ from those who did 
participate. Though we did not ask people why they did not wish to have 
the blood test, people often gave a reason. The two most common were 
that they had been tested recently by their GP or that they did not want to 
know if they had a problem. Some of those who said they had been 
tested recently said they thought it was a good thing to offer screening to 
those who were not accessing it elsewhere so were not refusing it 
because it was not acceptable to them, but felt it was unnecessary for 
them to participate. Other studies have found between 44% and 77% 
attendance after receiving an invitation to attend for rCBG screening 
(257) (259). These studies differed from this in that the invitation was 
delivered by post and required the participants to make a trip to the test 
centre to participate. In our study the invitation was made while the 
person was already at the location were the test would take place and a 
research assistant was on hand to answer any questions they may have 
had.  
 
Though the sample was biased towards those who would accept 
screening, by asking the participants to complete the questionnaire after 
the screening test had been carried out and the results given we could 
explore whether a negative or positive screening result affected the views 
of the participant. No significant differences were found in the attitudes of 
the participants who were advised that they should seek out further tests, 
to those who screened negative. 
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No respondent validation of the results was carried out. We did not 
ascertain whether the scores reported in the questionnaire corresponded 
with the participants’ views. It is not possible to ascertain how strongly 
agree and agree differ from each other.  
 
Further qualitative research would help explore the relationship between 
peoples’ expectations of optometrists’ and different practice types. 
Ascertaining reasons behind non-participation in the blood glucose 
testing service should be considered. 
 
There were a number of people who had never been tested who reported 
that they would consider going elsewhere for a test. Ascertaining why 
these people said they would go for a screening test, but did not, would 
provide an insight to how to target screening willing people. There is likely 
to be a small group of people who recognise the value of screening and 
but do not avail themselves of a service anywhere. 
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Chapter 9 
Detection of diabetes in optometric practice: 
Resource implications and economics 
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Chapter 9 
Detection of diabetes in optometric practice: Resource implications 
and economics 
9.1 Costs of Screening: a ready reckoner 
The cost of carrying out a single blood glucose has three aspects; cost of 
the equipment to carry out the test, the cost of the time taken to 
administer the test and cost of training. 
 
Equipment and time costs are fixed for each test no matter how many are 
carried out. The fixed costs per test are shown in figure 39. 
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Figure 39 - Fixed costs for rCBG screening test 
Equipment    
 Cost per unit No of tests 
provided in 
unit 
Cost per 
test 
Bayer Contour Meter £10.29 (260) 1000 £0.01 
 
Contour test strips £14.74 (260) 50 £0.29 
 
Cotton wool £5.31 (260) 500 £0.01 
 
Hand wash gel, 1000ml 
(3ml per use) 
£7.00 333 £0.02 
Unistix lancet £12.20 (260) 200 £0.06 
Referral letter to GP £0.40 If 33% 
referral - 
0.33 
£0.13 
Information leaflet + 
results information 
£0.10 1 £0.10 
  Total £0.63 
 
Consultation with optometrist   
15 minutes £36 a hour Total £9 
 
Total fixed costs per screening tests £9.63 
  
Training costs will vary depending in how many professionals are 
attending training and how many rCBG tests each can perform between 
reaccreditation points. 
 
1002 tests were carried out over the 20 weeks period. Blood glucose 
testing was carried out on 120 days. The mean number of tests carried 
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out per day was 8.35. Between 1 and 3 optometrists were in a practice 
carrying out sight tests each day. During the study period, the equivalent 
of 212 days of single optometrists sight tests were carried out. The mean 
number of tests carried out each day per optometrist was 4.72. 
 
If it is assumed that an optometrist works 240 days a year, 1133 rCBG 
tests would be carried out by one person during the course of one year. If 
a one-day training course is required to validate an individual for 2 years, 
training one person will allow 2266 tests to be carried out over a 2 year 
period.  If 10 optometrists attend one one-day training session, the cost of 
developing the course materials and running the course will be shared 
between 22656 rCBG tests. A summary of training costs is shown in 
figure 40. 
 
Figure 40 - Cost of training courses assuming 4.72 tests per day 
  No of 
tests 
Cost per 
test 
Cost of developing and running one 
one-day course for 10 optometrists 
£1000 22656 £0.04 
 
Cost of optometrist cover for one day £500 2265.6 £0.22 
  Total £0.26 
 
 
The estimated total cost for carrying out a rCBG test would be £9.90. By 
far the most important cost component is the optometrists time, costing is 
not sensitive to the other variables in the other cost components. 
 
We carried out 1002 rCBG, which subsequently led to 318 people being 
discovered who would benefit from further investigations as the had a 
rCBG of 6.1mmol/l. This results in a cost of case requiring further 
investigation detected of £32. 17 people where then subsequently 
diagnosed with diabetes or pre-diabetes after visiting the GP. This results 
in a cost per case of hyperglycaemia detected of £620.  
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9.2 Different screening strategies 
A range of different strategies to identify those at risk who would benefit 
from screening have been explored.  
9.2.1 55-75 years with hypertension 
Hoerger et al. suggested that the most cost effective strategy would be to 
screen only hypertensive people aged between 55 and 75 years (120). 
Among the 1002 people who participated in our study, 295 reported 
hypertension. 163 were aged between 55 and 75 at the time of 
participating. Had we used this criteria we would have reduced the 
number of rCBG tests carried out by around 6 times and resulted in a 
cost per case of rCBG of 6.1mmol/l detected of £27. 
 
67 (41.1% of the people aged between 55 and 75years with 
hypertension) had a rCBG results of 6.1mmol/l or more. 3 of these had a 
blood glucose measurement of 12.1mmol/l or more, so by just testing this 
group we would have identified 3 out of the 5 who fell in to the urgent 
referral category. There was a higher rate of referral among this group 
than the population who participated as a whole (31.7%). 
 
Of the 16 people who subsequently received a diagnosis following the 
screening, six were aged between 55 and 75 years and were diagnosed 
with hypertension. Two of this group were diagnosed as having diabetes, 
one with IGT and three with borderline diabetes. If this screening strategy 
had been adopted, 163 people would have been tested, and 6 (3.7%) 
subsequently diagnosed with hyperglycaemia.  27 tests would be carried 
out for every case of hyperglycaemia discovered.  
 
Using these criteria to identify people to be screened, fewer tests would 
have been carried out with the average per optometrist per day being 
0.77. Over 2 years, one optometrist would carry out 370 rCBG tests. This 
result in an increase in the training cost per test from  £0.26 to £1.57, and 
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a total cost per test to £11.20. However, while the cost per test is 
increased using this strategy, the cost per case of hyperglycaemia 
detected is reduced from £620 to £304. 
 
Though the cost per case detected is less using this strategy, we would 
have missed 10 cases of hyperglycaemia. Only screening people with 
hypertension may be an effective and cost effective screening strategy, it 
relies on reliable diagnosis of hypertension. If they are aware of the 
diagnosis, it is likely that they are accessing healthcare via their GP.   
 
Screening in optometry practices would be an ideal opportunity to find the 
‘hard to reach at risk’ population who would not access other forms of 
health care. If we only screen those with pre-existing medical diagnoses, 
we would miss hard to detect disease which may be still considered to be 
cost-effective care. 
 
9.2.2 Age, Family History and BMI 
Logistic regression analysis of the risk factors showed that age, family 
history and BMI increased the likelihood of having a rCBG measurement 
of 6.1mmol/l or more, while female gender reduced the likelihood of 
referral for further investigations.  
 
If we chose a strategy of screening only those aged 40 and over with 
either a family history of diabetes, a BMI of 25kg/m2 or both, we would 
have tested 507 of the participants (2.4 tests per optometrist per day). 
193 were subsequently referred (38.1%), three urgently as they had a 
rCBG measurement of 12.2mmol/l or more. Eleven of those aged over 40 
and reporting family history or BMI over 25kg/m2 responded that they had 
been given a diagnosis of hyperglycaemia (4 borderline diabetes, 1 IFG, 
1 IGT, 1 pre-diabetes and 4 with diabetes).   
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This method results in a cost per test of £10.14, cost per case of rCBG 
6.1mmol/l detected of £26 and cost per case of diagnosed 
hyperglycaemia detected of £467. 
 
9.2.3 Age, Family History, BMI and symptoms 
It is often suggested that screening asymptomatic people for diabetes has 
not been shown to be worthwhile (261). A large number of participants 
reported symptoms, some of who did not report having any other risk 
factors. Many of them reported not having been screened earlier. If we 
propose to use optometrists’ practices in order to find those ‘hard to 
reach’ people who have not presented to other providers, then screening 
those who report having symptoms may be an obvious step.  
 
If we use those risk factors that were shown to be significant and also 
include those aged over 40 years and reporting symptoms, we would 
have tested 675 people, 237 (35.1%) of who had a rCBG of 6.1mmol/l or 
more.  
 
14 of the 16 people who received a diagnosis were aged over 40, with at 
least one of family history, BMI over 25 kg/m2 and symptoms. This 
strategy would have identified all of the participants who were diagnosed 
with pre-diabetes, IGT or borderline diabetes and six out of the seven 
who were discovered to have diabetes and one of the two who reported a 
diagnosis of IFG. 
 
The mean number of tests carried out per optometrist per day using this 
strategy would be 3.18, resulting in training costs per test of £0.51. The 
total cost per test would be £10.02, cost per case of rCBG 6.1mmol/l 
detected of £28.06 and the cost per case diagnosed would be £483.11. 
 
A summary of the outcomes and costs of different strategies for 
identifying those to be screened is shown in figure 41. 
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Figure 41 - Comparison of 4 strategies for identifying people at risk 
to undergo screening 
 Strategy for identifying those to be screened 
 All 
Participants 
55-75yrs and 
hypertension 
≥40years with 
BMI of 
≥25kg/m2 
and/or Family 
history of 
diabetes 
≥40years with 
at least one of 
BMI of 
≥25kg/m2, 
Family history 
of diabetes, or 
symptoms 
Number of tests 1002 163 507 675 
Tests per optometrist 
per day 
4.73 0.77 2.39 3.18 
rCBG ≥6.1mmol/l (% of 
those tested) 
318 (31.7%) 67 (41.1%) 193 (38.1%) 237 (35.1%) 
     
Diagnosed with a 
hyperglycaemic 
condition (% of  all 
participants diagnosed)  
16 6 (37.5%) 11 (68.8%) 14 (87.5%) 
       Diabetes 7 2 (28.6%) 4 (57.1%) 6 (85.7%) 
        Borderline                  
diabetes 
4 3 (75.0%) 4 (100%) 4 (100%) 
        IFG 2 0 (0.0%) 1 (50.0%) 1 (50.0%) 
        IGT 2 1 (50.0%) 1 (50.0%) 2 (100%) 
        Pre-diabetes 1 0 (0.0%) 1 (100%) 1 (100%) 
     
Number of screening 
tests per case of rCBG 
6.1mmol/l detected 
3.2 2.4 2.6 2.8 
Number of screening 
tests per case of 
hyperglycaemia 
diagnosed 
62.6 27.2 46.1 48.2 
Cost per test £9.90 £11.20 £10.14 £10.02 
Cost per case of rCBG 
6.1mmol/l detected 
£31.68 £26.88 £26.36 £28.06 
Cost per case of 
diabetes/prediabetes 
diagnosed 
£619.99 £304.27 £467.36 £483.11 
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9.3 Resource and economic implications of screening 
Screening those aged 40 years or over with a BMI of 25kg/m2 and over or 
a family history of diabetes or both appears to be a cost effective method 
of screening for diabetes in optometric practices. If we had used this 
method, the number of tests carried out in the 20 week period would have 
been reduced from 1002 costing £9,920 to 507 costing £5,140.  
 
Using this strategy to indentify those who would benefit from screening 
resulted in 25 screening tests each week. We used several different sized 
practices, with different numbers of optometrists testing and with different 
opening times. We did not include any of the very large city centre 
practices with 5 or more optometrists practicing. We also did not choose 
any of the smaller practices where optometrists may only test 2 or 3 days 
a week. However, neither of these type of practice are the norm. For the 
purposes of this analysis, it is assumed that the participating practices are 
typical. If, on average, 25 screening tests are carried out in a practice 
each week, with a practice testing for 50 weeks of the year, a single 
practice would carry out 1250 tests costing £12,675. If a new case of 
diabetes or pre-diabetes was detected, on average, every 46 tests, a 
single practice would potentially discover 27 new cases each year  
 
We used practices located in three different Primary Care Trusts (PCTs), 
County Durham, Redcar & Cleveland and Hartlepool. Hartlepool PCT has 
a population base of 91,000 (246), Redcar & Cleveland a population of 
139,500 (245) and County Durham 504,900 (247). There are 9 optometry 
practices in Hartlepool, 11 in Redcar & Cleveland and 54 in County 
Durham. There is approximately 1 practice for every 10,000 people. 
Figure 42 shows the potential number of screening tests and cost to the 
PCT if every practice in the PCT offers screening. The approximate costs 
for extending the service to the whole of England has been estimated 
assuming a population of 51 million and one practice serving 10,000 
people. If the cost per test is £10.14 and 1,250 tests are carried out per 
year by each practice, there is the potential to carry out 6,375,000 
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screening tests in England costing £64,642,500. If, on average one new 
case of diabetes or pre-diabetes are found for every 46 cases, around 
138,000 new case could be found in a year. 
 
Figure 42 Costs to PCT and England of screening those aged 40 
years or over with or BMI of 25kg/m2 and over and/or a family 
history of diabetes 
 Hartlepool Redcar & 
Cleveland 
County 
Durham 
England 
Population 91,000 139,500 504,900 51,000,000 
Number of 
optometry 
practices 
9 11 54 5,100 
Population per 
practice 
10,111 12,681 9,350 10,000 
No of screening 
tests each year 
(1250 per practice 
per year) 
11,250 13,750 67,500 6,375,000 
Cost to PCT for 
screening in all 
practices for 1 
year 
£114,075 £139,425 £684,450 £64,642,500 
Potential new 
diagnosis of 
diabetes/pre-
diabetes per year 
243 297 1,458 138,586 
 
 
These estimates assume all practices will offer the screening tests. 
However, this is unlikely to be case. If only half the practices in England 
take up the screening programme offering screening to those aged 40 
years and over with either family history of diabetes or a BMI of 25kg/m2 
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or more, the total cost for one year of screening would be just over £32 
million, with nearly 70,000 new cases of diabetes or pre-diabetes 
discovered.  
 
The cost of £64 million also assumes that the whole procedure would be 
carried out by an optometrist. When calculating the cost, it has been 
assumed that the optometrist will administer all parts of the test, as this is 
the most expensive option. It should be possible for optical assistants to 
carry out some of the paperwork prior to the test. Currently optical 
assistants collect information from the patients and carry out some 
routine screening tests for optometrists. If the 15 minutes taken for the 
test is broken down into 10 minutes with the optical assistant and 5 
minutes with the optometrist, the cost of time is reduced to £6 (assuming 
£18 per hour for optical assistants) and the overall fixed cost of time and 
equipment to £6.63, compared with £9.63; a reduction of £3 per test. If 
the screening strategy of offering tests to only those who are over 40 
years with either a family history of diabetes or a BMI of 25kg/m2 and it is 
assumed that the training costs are unchanged, the cost per test would 
be reduced to £7.14. This reduces the cost per cast detected from £467 
to £329.  
 
The costs to the PCTs are shown in figure 43, assuming 50% of practices 
participating and optical assistants and optometrists perform the tests. 
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Figure 43 - Costs to PCT and England of screening those aged 40 
years or over with one of the following risk factors: BMI of 25kg/m2 
and over, a family history of diabetes if 50% take up and optical 
assistants and optometrists carry out tests 
 Hartlepool Redcar & 
Cleveland 
County 
Durham 
England 
Population 91,000 139,500 504,900 51,000,000 
Number of 
optometry 
practices 
9 11 54 5,100 
Number of 
practices offering 
screening 
(assume 50%) 
4 5 27 2,550 
No of screening 
tests each year 
(1250 per practice 
per year) 
5,000 6,250 33,750 3,187,500 
Cost to PCT for 
screening in all 
practices for 1 
year 
£35,700 £44,625 £240,975 £22,758,750 
Potential new 
diagnosis of 
diabetes/pre-
diabetes per year 
108 136 732 69,143 
 
The cost of the time taken to administer the screening tests is the most 
significant factor affecting the total cost of screening. One way sensitivity 
analysis, adjusting who is to carry out the tests, while keeping the 
strategy for identifying those to be screened and the number of practices 
participating shows that the cost of implementing a scheme in 50% of the 
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practices in England could range from £18 million to £32 million. Figure 
44 shows details, assuming a take up of 50% and screening those aged 
40 years and over with a BMI of 25kg/m2 or more or a family history of 
diabetes. 
 
Figure 44 – Costs of screening if tests are carried out by different 
people within optometry practices  
 Testing by 
optometrists 
Testing by 
optometrists and 
optical assistant 
Testing by 
optical 
assistants 
Cost of time £9.00 £6.00 £4.50 
Cost per test £10.14 £7.14 £5.64 
Cost per case of rCBG 
6.1mmol/l detected 
£26.36 £18.56 £11.70 
Cost per case of 
diabetes/prediabetes 
diagnosed 
£467.36 £329.15 £260.00 
Cost of screening in 
England 
£32,321,250 £22,758.750 £17,977,500 
 
9.4 Discussion 
An Australian pharmacy study, using similar methods and equipment 
estimated the price per test to be Aus$11.83 (£7.18) (130). An analysis of 
the use of rCBG as a method of opportunistic screening at US physicians 
offices calculated the cost per test to be $32.68 (£21.85) (262). As yet the 
cost of screening for diabetes in the UK as part of the National Health 
checks has not been determined. When this data are available it would 
be possible to compare the costs of screening using these different 
methods.   
 
The pharmacy estimated the cost of the consumables for the test to be 
Aus$5.00 (£3.03) and the cost of time to be Aus$6.41 (£3.89), with further 
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fixed costs assuming 5 tests a day over one year to be Aus$0.43 (£0.26). 
The time was broken down into 10 minutes with a pharmacy assistant 
and 5 minutes with the pharmacist. 
 
The cost to the practice in carrying out the test would be around £10 a 
test with most of this being the cost of the time used to carry out the 
testing. The equipment to carry out the testing costs less than £1 per test, 
and does not require a large initial investment. It also does not require a 
great deal of space to be stored, when compared with other equipment 
that optometry practices often used for other screening services, such as 
field machines for glaucoma screening and fundus cameras. Time would 
be the major consideration for the practices, both the time for carrying out 
the testing and time involved in training. The training time would involved 
could be covered in an initial one day training session followed by ½ day 
re-accreditation after 2 years. We have considered the costs involved in 
the initial 2 years of screening. Further evaluation of the cost of 
reaccreditation and re-screening strategies will have to be considered in 
future work to determine long-term strategies and costs. 
 
In our study, we used a large number of inclusion criteria compared with 
some other methods of screening. Had we used fewer inclusion criteria 
and been more selective about who we included in the screening we 
could have reduced the number of screening tests carried out. This 
increases the overall cost per test, but decreases the cost per case 
detected and may mean that some of those who were diagnosed would 
not have participated in the study and have been missed 
 
The National Screening Committee does not recommend universal 
screening. They do, however, suggest that targeting ‘at risk’ groups’ is 
justified (117). Different strategies have been suggested at identifying 
‘risk groups’.  
 
  
200
The strategy of screening those aged 55 to 75 years with hypertension 
has been suggested to be an cost effective method of identifying those 
who would benefit from screening (120). In our study population, using 
this strategy would have resulted in far few tests being carried out, and 
reduction of half in the cost per case detected. However, only 6 people 
would have been identified as having a hyperglycaemic condition 
compared with 16, and 5 people with diabetes would have remained 
undiagnosed. 
 
Using optometrists’ practices as a location for screening, instead of a 
GPs practices, may allow people who are not accessing their GP to 
participate in screening. Using medical diagnosis as a sole inclusion 
criteria results in only those people who have attended other healthcare 
providers, usually GPs, being able to participate in screening. While this 
method of deciding who to screen may be cost-effective in medical 
practices, if we are to find those hard to reach people who are not 
regularly accessing other services, this would not be an effective strategy 
to use in optometrists practices. 
 
If we are to fully utilise this location for screening, using criteria that does 
not rely on a previous medical diagnosis would be preferable. Logistic 
regression showed the BMI of 25kg/m2 or more, family history of diabetes 
and increased age increased the likelihood of having a rCBG of 6.1mmol/l 
or more. None of these risk factors require the participants to have 
previously attended a GP. Though people may misreport their weight and 
height (238) (241), resulting in underreporting of obesity levels, over 40% 
of participants in our study reported that they had a BMI of 25kg/m2 or 
more, suggesting that people are willing to report this as a risk factor. 
Only screening those aged 40 years or more with either a family history of 
diabetes or self reported BMI of 25kg/m2 or more would have halved the 
number of tests carried out, and identified around two thirds of those who 
were diagnosed with hyperglycaemia following participation in the study.  
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An argument made against screening is that there is insufficient evidence 
that testing asymptomatic people is worthwhile (261). This assumes that 
people with symptoms will seek out medical attention, however over half 
the participants reported symptoms in response to a questionnaire and 
only a quarter of participants reported that they had been tested for 
diabetes previously. People with mild symptoms may not be attending 
their GP as they do not realise that their symptoms my be indicative of 
diabetes, or that they do not perceive their symptoms as being serious 
enough to warrant medical attention. Including symptoms in the strategy 
to identify those at risk, along with age, BMI and family history is more 
cost effective than the method we used. However, it is more expensive 
than the other strategies (age and hypertension and age, BMI and family 
history), but it identifies more people who have diabetes or pre-diabetes. 
 
The cost per case of diabetes or pre-diabetes diagnosed using the four 
strategies considered ranged from £304 to £620, while the cost per case 
of rCBG of 6.1mmol/l or more detected, as recommended by Diabetes 
UK (244), ranged from £26.40 to £31.70. 
 
 It was assumed that all those who did not reply to the postal 
questionnaire did not visit their GP, and so did not receive any diagnosis. 
It may be that some of the non-respondents did receive the diagnosis, but 
did not communicate the information to us. If more people who 
participated in the screening attended the GP for further tests, more 
cases may be diagnosed and thereby reducing the cost per case 
detected and increasing the number of new cases diagnosis. Two factors 
could improve the cost effectiveness of these screening methods: firstly, 
to encourage the diagnosis of pre-diabetic hyperglycaemia which 
currently appears to be under-diagnosed: and secondly, both professions, 
optometrists and GPs, must be working together for the same goals. We 
know that some people attended the GP, but were not investigated 
further. These people are potentially missing out on receiving a diagnosis. 
If these people, who were willing to undergo further tests but were not 
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given the opportunity, were investigated further, this may have resulted in 
more cases being detected and therefore a decrease in the cost per case 
detected, while not changing the overall cost of the service.  
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Chapter 10 
Discussion and conclusions 
Diabetes is known to be a common problem affecting around 4.4% of the 
population of England (15) and the prevalence is set to increase. 
Impaired glucose tolerance and impaired fasting glucose, precursors to 
diabetes, are also becoming increasingly common, with an estimated 
11.2% and 6.9% prevalence respectively in USA (95) (96). Large 
numbers of these are undiagnosed. 
 
Despite these high rates of disease and the introduction of screening 
services outwith general practitioner surgeries, such as in high street 
pharmacies, there are people who fail to present to any of the available 
services. This may be due to lack of knowledge on their part, 
unwillingness to be diagnosed with a disease, or lack of access or 
unwillingness to present to the current providers. 
 
Current literature describes screening services provided by a number of 
healthcare providers, using different methods and with different 
outcomes. The role of optometrists in these services has not been 
previously considered. 
 
Firstly, the willingness of optometrists to undertake such a task must be 
considered, and the barriers concerns addressed. Secondly, the 
feasibility of running a service evaluated. Screening in optometry 
practices can only be effective if there is a population presenting in that 
location willing to be screened and would benefit from screening, and 
may not be presenting elsewhere. 
 
10.1  Attitudes of optometrists and professional roles and 
relationships 
The focus groups and interviews described in chapter 3 and 4, as well as 
considering optometrist knowledge and understanding of diabetes and 
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screening, also raises questions about the role and position of the 
optometry profession in UK healthcare.  
 
From this study it is clear that optometrists have some uncertainty about 
their professional role. While they seemed to feel that their role was 
primarily clinical, they were also aware of the business aspects of the 
profession and the conflict between the two roles. This conflict affected 
their ability to take on extended care roles. Some reported that they 
would like to offer services, but felt that the business pressures would 
prevent them from being able to do so. This conflict between healthcare 
and business leads to optometrists being unsure how others perceive 
them.  
 
During the interviews and focus groups, some optometrists reported good 
relationships between themselves and GPs. However, others felt that the 
GPs did not appreciate optometrists’ clinical training and viewed them as 
businessmen in high street shops. There is a feeling among optometrists 
that they are over-trained for simply carrying out sight tests. However, 
they also felt that other healthcare professionals did not appreciate the 
clinical knowledge and training they have and they feel they are 
sometime excluded from proposed schemes. 
 
Relationships between optometrists and other health care professionals 
are critical for the evolution of any shared care scheme. Current 
perceptions of optometrists are that, while some GPs work well with 
optometrists, not all understand the role of optometrists. It is felt that there 
was a lack of communication between the professions when it comes to 
routine referrals. For screening programme to be effective, we need to 
ensure as many people who would benefit from further testing receive 
that care. Optometrists can only suggest to the patients that they should 
go to the GP and contact the GP with the results if the patient consents. 
However, they cannot coerce the patient to attend for further tests, or 
make the GP carry them out. If the GPs are not involved with the 
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implementation of screening service, they may not be as willing to follow 
up results that they see as borderline.  
 
This is particularly true of those with the lower levels of rCBG levels who, 
while it is unlikely that they have diabetes, may have IGT or IFG. If GPs 
are not routinely diagnosing these conditions, they may not feel that is 
worth investigating people who report a rCBG level of under 7.0mmol/l. 
Most of the people who did attend the GP, but were not investigated 
further, had blood glucose measure measurements at these levels. 
However, there was one with a rCBG falling in to the category of 
12.2mmol/l or more who was not investigated. If GPs are not investigating 
people who are referred for further investigation, we need to know why, 
and how the communication between the two professions could be 
improved so that the people who are screened benefit from the service.  
 
Screening can only benefit the individuals who participate if the initial 
screening test result is acted on by that individual, and if the medical 
professional they go to also acts on that result in an appropriate way.  
 
10.2  Attitudes and acceptance of the public 
99.1% of participants agreed that the location was convenient for them. 
98.0% would recommend the screening service to others. Only 3.2% 
agreed that the test was uncomfortable. 82.9% felt that optometrists 
should be able to detect health problems. 15.7% said they would have 
considered going elsewhere to be screened, either at the GPs, 
pharmacists or elsewhere. 
 
This study achieved a take-up rate of around three-quarters of eligible 
adults, with around 300 (23.1%) people turning down the opportunity to 
participate. While in some cases this was because people had recently 
undergone tests with their GP others refused to participate as they did not 
want to know if they had a medical condition. This was not always 
through lack of knowledge as some were aware of the risks, but they 
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preferred not to know. However, others, while aware of the disease, were 
not aware of the risks until they participated in the study. 
 
Optometrists thought that the views of the public varied, with a divide of 
opinion between those in independent and multiple practices. They felt 
there was a clear distinction between the expectations and characteristics 
of people attending different practice types. When carrying out the 
screening, we found that those attending independent practices were 
more likely to attend yearly compared with two yearly as in multiple 
practices, but they were also slightly older than participants from multiple 
practices. As those aged over 70 years are entitled to a reimbursed NHS 
test every year, unlike most other groups who are entitled to a two yearly 
test, the increase in age will be reflected in an increase in people 
attending on a yearly basis. 
 
Optometrists felt that those attending independent practices would be 
more likely to take up the offer of screening, but would be more likely to 
have been tested elsewhere before. We found that the take up rate of 
screening was similar in all practices. There were slightly more people 
attending multiples who reported that they had never been screened 
before, but over 70% of participants from either practice type had never 
been screened before. The optometrists also believed that those 
attending multiple practices viewed optometrists’ as shops, whereas 
those attending independent practices would view the optometrist as a 
health care provider. Our questions to participants about whether they 
thought optometrists should be able to detect health problems showed no 
great difference between participants from the different practices. 
However, while we based our study in several different practices, 
including independent practices with one optometrist to larger multiples 
with up to three optometrists testing at one time, we did not include any of 
the very large city centre practices where they may be seven or more 
optometrists testing at one time. 
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Some members of the public are aware of diabetes screening and of 
diabetes itself, but don’t always take up opportunities unless confronted 
directly. There was a significant minority of participants who said that they 
had never been tested before, but also said they would consider going 
elsewhere for tests. Whilst they knew about diabetes, were aware that 
they were at risk and that screening would be available if they asked for it 
at a pharmacist or GP, they did not actually participate in a screening 
programme until asked directly 
 
10.3  Findings of the screening study 
During the 20 weeks of the screening study, 1909 adults attended the 
practices. The prevalence of self-reported diagnosed diabetes in this 
population was 9% (171 people with type 1 or 2 diabetes). 1303 (68.3% 
of adults attending practices) reported risk factors making them eligible to 
participate in the study. 1002 (77.9% of those eligible) agreed to 
participate. 75% of participants had never been screened before. 318 
(31.7%) were found to have a rCBG measurement of 6.1mmol/l or more. 
5 (0.5%) were found to be at high risk of having diabetes, with a rCBG 
measurement of 12.2mmol/l or more. This is similar to referral rates found 
in a Danish programme (247) and an Australian pharmacy programme 
(129). However, there was a lower prevalence of raised rCBG than found 
in an UK pharmacy based study, though this may be due to a higher 
number of South Asian participants in the pharmacy study (1). 
 
Of the 318 people who we suggested should visit their GP for further 
investigation, 162 (50.9%) reported that they visited their GP and 66 
(20.8%) did not. No response was received from the remaining 90 
(28.3%). 138 (43.4% of those referred) were tested by their GP. 9 (0.9% 
of all participants) were subsequently diagnosed with pre-diabetes and 7 
(0.7% of all participants) with diabetes. 22 participants (6.9% of those 
referred) reported that they attended their GP, but were not investigated 
further. This may reflect the difficulties in relationships and 
communication between optometrists and some medical practitioners. 
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Though optometrists can suggest that the participants may benefit from 
further investigation, it is then up to the GP to decided whether they feel it 
is appropriate to act on that information. 
 
10.4 Cost consequences of screening and organisational 
challenges 
The screening strategy we used resulted in a cost of £9.90 to carry out 
each rCBG test when costs of the equipments, time and training costs are 
considered. This results in a cost of £31.70 per case of rCBG of 
6.1mmol/l or more found. Altering the strategy to offer screening tests to 
only those aged 40 years or more and with either a BMI of 25kg/m2 or 
more pr a family history of diabetes increases the cost of each test to 
£10.14, but reduces the cost per case of rCBG of 6.1mmol/l or more to 
£26.36. If the strategy to identify those at risk who would benefit from 
screening was simplified to the risk factors of age, family history of 
disease and BMI, the cost of screening in the 20 weeks that the study ran 
for would have been reduced from £9,220 to £5,141. 
 
The most significant factor in the cost of screening is the cost of time 
involved.  If optical assistants were to carry out the majority of the 
preparation for the tests, the cost would be reduced by £3 for each rCBG 
resulting in a cost per case of RCBG of 6.1mmol/l or more detected of  
£18.69 if the reduced number of risk factors are used to identify those at 
risk. This would have reduced the screening costs for the 20 weeks to 
£3,620. The cost of carrying out the screening using optometrist and 
optical assistants is comparable to screening using other locations, such 
as pharmacies (129). 
 
If a screening programme was to be implemented on a wider scale, 
organisation challenges occur at three levels; in the practice, PCT and 
finally nationally. 
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The equipment involved in screening in not extensive, and will not require 
significant space when compared with other equipment used for 
screening for glaucoma and retinopathy. The main considerations on the 
practice level would be determining who would carry out the tests and 
how this would fit in to the current practice procedures. In most practices 
optical assistants are trained to carry out screening tests, such as intra-
ocular pressures and field tests for glaucoma screening. Diabetes 
screening tests could be offered alongside the other screening 
procedures that are currently offered. Using trained assistants would be 
more cost-effective and would fit in with many practices current 
procedures. 
 
Financial barriers to screening in optometric practices would need to be 
overcome on a PCT level. Currently, most extended care roles are 
implemented initially on a local level. The Association of Optometrists 
provides guidance on the commissioning of enhanced services and 
advice on how local optical associations can work with their local PCT to 
develop contracts to provide these services (263). This would be the next 
stage in developing the service. If a PCT based service is successful, the 
protocols and procedures can then be shared on a national basis. 
 
10.5  Feasibility 
For a screening service to be feasible, we must be able to identify a 
population to target, ensure that the test is accessible and acceptable to 
that target population and that the service is cost-effective and can 
identify people who would benefit from further testing. 
 
We have shown that the location is feasible, with around two-thirds of 
adults attending the practices having at least one risk factor for 
developing diabetes, and nearly 80% of those at risk taking up the offer of 
screening. Those participating in the screening service found it 
acceptable and accessible. Almost one-third of those participating had a 
rCBG level that required further investigation. Three-quarters of those 
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who participated had never been screened previously. Optometry 
practices are a feasible location for providing a screening service to those 
who may not be accessing other services. 
 
We found a lower prevalence of pre-diabetes than may have been 
expected, 1.3% prevalence of non-diabetic hyperglycaemia (self-reported 
diagnosis of IFG, IGT, pre-diabetes or borderline diabetes) in this study 
compared with reported prevalence of IGT of 11.2% in US adults (96) and 
a prevalence of IFG of 6.9% in adults over 20 years (95). Though it is 
known that lifestyle changes can slow the progression to diabetes in 
people with non-diabetic hyperglycaemia, these changes are unlikely to 
be made if a person is unaware of the condition.  
 
An argument against the use of screening for diabetes is the apparent 
lack of evidence showing benefit of screening asymptomatic people 
(261). This assumes that people with symptoms will seek out health care 
themselves. We found that just over half the participants reported that 
they had some symptoms of diabetes, but only one quarter had been 
screened before. Of the 531 people (53% of participants) who reported 
symptoms less than a quarter had been screened previously and only 71 
(13.8%) reported that they would have considered asking for a test if they 
had not participated in the study. Some participants commented that they 
were not aware of all the symptoms of diabetes until they read the 
information provided in the study, or that, while they were aware of the 
symptoms, they would not have gone to the GP unless the symptoms 
were very severe.  
 
There are a number of ways that have been suggested to identify people 
at risk of diabetes who would benefit from screening. We used a large 
number of risk factors, but it may be that the criteria for inclusion in a 
screening programme can be refined. Though performing fewer tests 
increases the cost per test slightly in terms of training costs, it will reduce 
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the overall cost by the virtue of fewer tests and decreases the cost per 
case detected.  
 
Utilising medical conditions as method of identifying people who would 
benefit from screening, while useful in a GPs surgery, may be of less use 
in the optometrists practice. Using known hypertension as an indicator of 
who should be screened may be a cost effective strategy, but will only 
benefit those who have already accessed health services. This reduces 
the value of testing in optometry practices; the new approach is partly 
designed to reach people who have not been tested elsewhere. 
 
10.6  Reflections 
Prior to beginning this study, I felt that, in day-to-day routine practice, 
optometrists’ skills and training was underutilised and that practices were 
ideally located to provide more services that currently undertaken. The 
educational role that an optometrist can provide seemed to be 
underestimated. During the course of routine sight tests, I have seen 
numerous people who did not believe that they were at risk of diabetes, 
despite having a family history of diabetes among other risk factors. It 
was often believed that as the family member had diabetes that was 
diagnosed in later life and was controlled by diet or medication, it would 
not be significant, unlike having diabetes from childhood and needing 
insulin. These were often people who reported that they did not go to their 
GP, and were often coming to optometrist as they had started to notice 
visual problems, usually with reading. Diabetes seemed to be an ideal 
disease for optometrists to have a role in detecting as is a condition about 
which they receive training and the public is aware of the link between 
diabetes and eye disease to some extent. The risk of developing diabetes 
increases with age, with screening recommended for those aged 40 
years and over. Presbyopia begins to affect near vision from this age and 
so people may see an optometrist when they may not have any other 
problems that they would see other healthcare providers for and so 
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optometrists may be effective in reaching those who are not accessing 
other services.  
 
The focus groups and interviews with optometrists confirmed that there 
are optometrists who would like to develop their underused skills, but that 
some feel that they are prevented from doing so by the attitudes of other 
professionals towards them. As a profession, optometrists can be isolated 
from other health care providers and interaction can be limited. 
Optometry has developed in a relatively short time, and while the public 
seem to have accepted changing roles, other heath professionals do not 
always accept or understand the developments. Optometrists sometime 
miss out on the opportunity to take on extended care roles as other 
professionals do not appreciate how optometrists can participate. 
However, optometrists may sometimes be the ones preventing 
themselves from taking on roles as they expect opposition from others, so 
do not wish to make the first steps themselves. During the course of this 
study, I have felt that some optometrists would be willing to take on 
schemes, and have been interested in the outcomes of this study to see if 
it is something they can look towards developing if it proved to be 
feasible. However, due to their perceptions of the sometime poor 
relationships with some other health professions, they would be reluctant 
to take on the initial work in setting up protocols and determining cost-
effectiveness as they feel that the idea may be rejected by others. 
 
Although some optometrists were concerned that a screening service 
would only be accepted by people who would have already accessed 
screening at other locations, we have shown that the offering services in 
unconventional settings can successfully reach people who are missing 
out on services currently offered by medical practitioners. Having 
determined that the public will accept new services in optometry 
practices, this can open the door to offering other services, such as 
smoking cessation and hypertension monitoring. 
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10.7  Future work 
From this work we have begun to uncover how the optometrists view 
themselves and how they believe others, both the public and other 
professionals, view them. We have begun to investigate how the public 
views the optometry profession, but it would be interesting to know more 
about the publics’ expectations of optometrists. GPs’ views and attitudes 
towards optometrists could also be investigated. We know that not all 
those who presented to the GP following participating in screening were 
investigated further. It would be interesting to know why GPs chose not to 
investigate these people, as this has implications for the success of 
screening programmes.  
 
We have shown that some optometrists are willing to carry out screening 
and that there is a population at risk of developing diabetes not being 
screened elsewhere but are willing to be screened at the optometry 
practice. The next step would be to begin a larger scale, PCT wide study, 
with optometry practice staff carrying out the screening themselves, as a 
possible precursor to implementation of a national policy. Following the 
results of the regression analysis, the inclusion criteria for this larger 
study could be reduced to those aged 40 years and over, who have a 
BMI of 25kg/m2 or more or a family history of diabetes. 
 
10.8 Limitations 
We did not demonstrate any significant difference between the practice 
types, either in screening take up or participants’ attitudes to optometrists’ 
role in general health problems. However, while we based our screening 
study in several different practices, including independent practices with 
one optometrist to larger multiples with up to three optometrists testing at 
one time, we did not include any of the very large city centre practices 
where they may be seven or more optometrists testing at one time. 
 
We demonstrated that the service was acceptable to those who 
participated. However, just under one-quarter of eligible adults chose not 
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to participate. We were not able to gain detailed reasons for their 
unwillingness to participate or to determine whether there was any 
difference in the demographics of those not participating. A large number 
of the people who participated in the screening services had never been 
screened before and it is likely that some of those who declined to 
participate had never been screened either. If we could understand why 
some people do not wish to be screened even when the opportunity is 
made convenient, we could target these people more effectively. 
However, the role of personal choice in health care must be considered. 
Some people do not wish to participate in screening despite being given 
information about potential long-term benefits of early detection of a 
disease. It has been suggested that informed choice can reduce the take 
up of breast cancer screening among those who are ‘present orientated’ 
(215), an attitude often associated with deprivation. This can lead to a 
reduced take up in the highest risk groups. Though public health as whole 
may benefit from screening, the rights of the individual to refuse to 
participate should be respected, even though some participants in our 
study did comment that screening should be made compulsory. However, 
we have shown that there are a large number of people attending 
optometry practices who have never been screened, but are willing to 
participate. While we must respect peoples wish not to participate in 
screening schemes, even if we believe the potential long-term benefits 
outweigh the potential short-term risk, we must also make screening 
available to those who would like to participate but do not want to go and 
request it. Though diabetes screening is currently available, it is not 
accessed by all those who be screened if it was offered to them directly.   
 
We know that some did not participate as they reported that they had 
previously been tested by their GP. Some of those who participated also 
reported that they had been tested previously, but we did not ask how 
recently they were screened. Screening is recommended every three 
years by American Diabetes Association (ADA) (112) and has been 
shown to be a cost effective strategy (121).  
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When following up the participant who had a rCBG level of 6.1mmol/l or 
more, around half reported that they had been to see their GP. It has 
been assumed that those who did not respond did not visit their GP, and 
so did not benefit from screening. This included 2 people who had a 
rCBG level of 12.2mmol/l or above, who were at high risk of having 
diabetes.  
 
We could have potentially increased the cases of diabetes and pre-
diabetes diagnosed by carrying out the further testing ourselves, and 
ensuring that investigation and diagnosis was carried out in a standard 
way for all participants. If more cases of pre-diabetes were diagnosed, 
the cost per case detected would be lower than we calculated. This would 
ensure that all those with pre-diabetes would be diagnosed using the 
same criteria and it would not rely on participants to report the results to 
us. However, this would not be how a screening service would work if 
implemented in a larger scale. In this situation GPs would have to 
shoulder the responsibility of carrying out the further investigations and 
participants the responsibility of attending for those tests. 
 
In calculating the economic implications of screening, the costs were 
considered for the initial two years of a screening programme. The 
majority of participants attended for sight tests either yearly or every two 
years. After running the service for 2 years, a large proportion of those at 
risk will have been screened, however, there will be new cohorts of 
people entering the ‘at risk’ group and people who would benefit from re-
screening. 3 yearly retesting has been suggested by ADA, though for 
most people attending optometry practices, screening would have to 
occur on a two yearly or four yearly basis. The time frame for rescreening 
and the implications this has for cost needs to be considered. 
 
Analysis of the results suggests that screening those aged 40 years and 
over with BMI of 25kg/m2 or more or a family history of diabetes is an 
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effective strategy in our population. However, our participants were 
almost exclusively white (99%). The small numbers of Asian and black 
participants means that these results may not be applicable to those 
populations. It is known that the South Asian population has higher 
prevalence of diabetes, often with a younger onset (32) than the white 
population. We took account of this in our inclusion criteria by offering 
screening to those aged 25 years or more with high BMI, increased waist 
size or family history instead of 40 years for the white population. The 
lack of participants from black or South Asian populations was due to 
nature of the populations attending the participating practices, which was 
predominantly white, rather than an unwillingness to take up the offer of 
screening. 
 
10.9 Conclusions 
Optometrists are willing to take on new roles and some are keen to 
advance their clinical roles, but there are barriers to overcome in doing 
so. There is some uncertainty of their role within the health system and in 
how others professionals perceive them. This can make some reluctant to 
take on roles that they would otherwise like to be involved in. Financial 
barriers are a significant concern to optometrists, and have implications 
on how they take on new roles.  
 
Screening in optometry practices would give those hard to reach ‘at risk’ 
individuals, who do not routinely visit their GP, the opportunity to 
participate. Age, family history of diabetes and increased BMI were all 
shown to be significant indicators of whether an individual was likely to 
have a rCBG of 6.1mmol/l or more. These factors do not require an 
individual to have visited their GP, unlike other conditions we asked about 
such as polycystic ovary syndrome and hypertension.  
 
There are a large number of people attending optometry practices who 
have never been screened before and are at risk of developing diabetes. 
Some are unaware of the risks, while others know that they have risk 
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factors, but have not been tested before. Screening is available to them 
currently; all participants were registered with a GP and local pharmacies 
have free screening available if requested, but they had not availed 
themselves of these services. 
 
Screening in optometry practices would seem to be very appropriate to 
target at those who may not be using other services. This may not 
provide the highest yield of new cases of diabetes or pre-diabetes at the 
lowest cost, but it will start to reach those who are not accessing other 
services that are currently in place, such as the NHS Health Checks. 
Screening in optometric practice would not be designed to replace other 
programmes, but would be complementary to these services.  
 
This research has shown that screening is feasible in optometric practice, 
that substantial new numbers of people with pre-diabetes and diabetes 
can be detected. The next question is whether this could be applied to a 
larger set of practices, for example, an entire PCT, and the results more 
reasonably extrapolated for the rest of the UK. This could have significant 
national health policy implications for diabetes and screening. 
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A qualitative evaluation of optometrists’ perceptions, attitudes and 
beliefs towards screening and diagnosing diabetes. 
Information Letter 
Dear Colleague,  
 
I am an optometrist based at Durham University and I am currently involved in a 
research project that aims to explore the optometrists’ perceptions, beliefs and 
attitudes towards screening and diagnosing diabetes.   
 
Diabetes is an increasing problem that may go undiagnosed for up to 7 years. It is 
estimated that the prevalence of all types of diabetes, both diagnosed and 
undiagnosed, is 4.73% in the North East of England. Around one third are 
undiagnosed Type 2 diabetics. Many patients will have developed complications by 
the time they are diagnosed as diabetic, leading to a reduction in quality of life.  
  
I would like to find out local optometrists’ views on screening for diabetes by 
holding some group discussions. It will last between 60 and 90 minutes. It will 
involve between 6 and 12 other optometrists and will be held at Durham University, 
Queen’s Campus in Stockton-on-Tees on xxx at xxx. There is no payment for taking 
part. 
 
The discussions will be tape recorded and transcribed to produce an anonymised 
written document that can be used for the purpose of the study. Thought it is not 
envisaged that any situation would occur where this would be the case, you should 
be aware that information given in confidence may not enjoy legal privilege and 
may be liable to sub poena by a court. Tape recordings of the discussions will be 
held securely for 6 months and the written document for three years before they are 
destroyed. You will also be asked to complete a short questionnaire before the start 
of the discussion. This information in this will be used anonymously. If you are 
willing to take part you will be asked to sign a consent form. You may withdraw at 
any point if you wish. The study is covered by the University public liability policy 
and has been approved by the School of Health Ethics committee. 
 
You will have the opportunity to see and comment on a brief summary of the 
discussions.  
  
I would be very grateful if you would consider being involved in these discussions. 
Please could you read this information letter and then complete and return the 
attached consent form as soon as possible. 
 
If you have any questions or would like further information, please contact myself at 
Durham University on 0191 3340689 or email j.h.howse@dur.ac.uk 
 
Thank you very much for your time and I look forward to hearing from you. 
 
Yours sincerely 
 
 
 
Jenny Howse 
  
222
 
A qualitative evaluation of optometrists perceptions, attitudes and beliefs 
towards screening and diagnosing diabetes. 
 
Please delete as appropriate 
 
I have read the information letter    YES / NO 
 
Have you had the opportunity to ask questions  
and discuss the study if you wish to?    YES / NO 
 
Were you given enough time to consider whether 
you want to participate?     YES / NO 
 
Have you received enough information about 
the study?       YES / NO 
 
Do you consent to participate in the study?    YES / NO 
 
Do you understand that you are free to withdraw 
from the study at any point, and without giving  
a reason?       YES / NO 
 
  
Do you understand that the discussions will be  
tape recorded?       YES / NO 
 
 
Signed…………………………………………………… 
Name…………………………………………………….. 
Address…………………………………………………… 
……………………………………………………………. 
……………………………………………………………. 
 
Telephone Number (Day)………………………………… 
          (Evening)……………………………. 
Email Address …………………………………………… 
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 Feasibility and acceptability of offering finger-prick blood glucose testing in 
optometric practice 
Can I take part in this study? 
You are eligible to take part in this study if you can answer YES to any of these 
questions. If you cannot answer a question, or don’t understand it, just answer NO. 
 
Are you White, aged over 40 years, or Black, Asian or from a minority ethnic group 
and aged over 25 years and: 
  
 A. have a close family member (parent, brother, sister) with type 2 diabetes? 
       YES/NO 
 B. have a body mass index of 25kg/m2 or more (if you’re not sure, have a 
look    on the chart)? 
       YES/NO 
C. have a waist measurement of: 
more than 94cm (37 inches) for white and black men  
more than 90cm (35 inches) for Asian men  
more than 80cm (31.5 inches) for women YES/NO  
          
For people of any age and ethnicity: 
D. Do you have high blood pressure (or taking medication for high blood pressure) 
or have you had a heart attack or a stroke?  YES/NO 
 
E. Have you been told you have impaired glucose tolerance or impaired fasting 
glycaemia?      YES/NO 
 
F.  Do you have a history of severe mental health problems?   
       YES/NO 
 
G. Do you have raised cholesterol?   YES/NO 
 
For women only: 
H. Have you ever developed diabetes while pregnant (gestational diabetes)? 
       YES/NO 
 
I. Have you ever given birth to a baby weighing more than 4kg (8lb 8oz)? 
        YES/NO 
 
J. Do you have polycystic ovary syndrome?  YES/NO 
 
For everyone: 
K. Do you experience any of the following symptoms of diabetes?  
 Increased thirst 
 Going to the toilet all the time, especially at night 
 Extreme tiredness 
 Weight loss        YES/NO 
 Genital itching or regular episodes of thrush 
 Slow healing of wounds 
 Blurred vision        
 If you answer YES to any of these questions you are at risk of developing diabetes. 
The more risk factors that apply to you, the greater your risk of having diabetes. 
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 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
Information Sheet 
Part 1 
We would like to invite you to take part in a research study.  Before you decide 
you need to understand why the research is being done and what it would 
involve for you.   
Please take time to read the following information carefully. Talk to others about 
the study if you wish.   
(Part 1 tells you the purpose of this study and what will happen to you if you take 
part. Part 2 gives you more detailed information about the conduct of the study).    
Ask us if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part. 
What is the purpose of the study? 
This test is part of a study with Durham University looking at the role 
optometrists (opticians) can play in helping in the early diagnosis of type 2 
diabetes. We hope to see if it is worthwhile using opticians as a setting for 
carrying out screening tests. 
Diabetes Mellitus is a condition where the amount of sugar (glucose) in the 
blood is too high. Insulin is a hormone produced by the pancreas that helps the 
body use glucose.  
There are two main types of diabetes, Type 1 and Type 2. Type 2 is the most 
common type of diabetes. It develops when the body does not produce enough 
insulin or if the insulin does not work properly. 
There are around 2.3 million people with diabetes in the UK and around half a 
million people have diabetes but do not know it. Most of these people will have 
Type 2 diabetes. 
Why have I been invited? 
You have been invited to take part in this study as you have reported that you 
have a risk factor for diabetes.  
The risk of type 2 diabetes increases with age. You are at risk if you are white 
and over 40. If you are African-Caribbean or South Asian you are at risk if you 
are over 25 years.  
If you have diabetes in the family you are at risk. The risk is greater the closer 
the relative is, so you are more likely to develop diabetes if your parents or 
siblings have the condition than if aunts or uncles do. 
Many people who are diagnosed with diabetes are overweight, the more 
overweight you are, the greater the risk. 
If you have any problems with your circulation, or have a heart attack or a stroke 
you may have an increased risk. Also if you have high blood pressure or are 
taking medication to control your blood pressure you are at risk of developing 
diabetes. 
 
Other conditions such as raised triglycerides, history of diabetes while pregnant 
(gestational diabetes) and severe mental health problems also increase the risk 
of developing the condition. 
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Do I have to take part? 
It is up to you to decide. We will describe the study and go through this 
information sheet, which we will then give to you. We will then ask you to sign a 
consent form to show you have agreed to take part. You are free to withdraw at 
any time, without giving a reason.  This would not affect the standard of care 
you receive. 
What will happen to me if I take part and what do I have to do? 
We will ask you to read the whole of this information sheet and then sign a 
consent form to say you are happy to take part. If you have any questions 
please ask. We will ask you to indicate which risk factors you have that put you 
at risk of developing diabetes. If you are at risk, we will then give you the 
opportunity to have the finger-prick test.   
We will measure your blood glucose levels using a small machine like the ones 
people with diabetes sometime use to measure their own blood levels. 
It involves a small pinprick on one finger to produce a small drop of blood. A test 
strip is touched against the drop of blood. The machine tells you the blood 
glucose level in a few seconds.  
If your result is above a certain level, there is a risk that you may have diabetes 
or conditions know as Impaired Fasting Glucose (IFG) or Impaired Glucose 
Tolerance (IGT) and we would recommend that you have further tests carried 
out at your doctors. We will let your GP know the results of the test.  
If the result is below this level it is unlikely that you have diabetes at the 
moment. However, you may still be at risk and you may go on to develop it in 
the future. 
We will also give you a short questionnaire to take home with you and complete 
in your own time and return in a stamped addressed envelope.  
If we do suggest that you should see your GP for further tests we will also write 
to you and ask you to complete another short questionnaire about the results. 
What are the possible disadvantages and risks? 
The test will involve taking a very small drop of blood from one finger. It will not 
interfere with normal activities. There is a small risk of infection from the test, 
however this test is routinely used in hospitals and by some people with 
diabetes to monitor their condition. 
What are the possible benefits? 
Type 2 diabetes develops slowly and people can have the condition for up to 12 
years before it is diagnosed and they are treated. Often complications have 
developed by the time someone is diagnosed. If it can be diagnosed and treated 
earlier, complications may be reduced. Diabetes increases the risk of having a 
stroke, heart disease, kidney disease and nerve damage. It can also cause 
damage to the eyes (retinopathy). Good control of blood glucose is important in 
reducing these complications.  The test can also identify IGT and IFG, which are 
conditions that increase the risk of progression to diabetes. There is some 
evidence that if you have these conditions, you can delay the development of 
diabetes by taking simple actions such as losing weight if you overweight or 
increasing your exercise. 
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What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed.  The detailed information on 
this is given in Part 2. 
 
Will my taking part in the study be kept confidential?  
  
Yes.  We will follow ethical and legal practice and all information about you will 
be handled in confidence.  The details are included in Part 2.  
  
This completes part 1.  
  
If the information in Part 1 has interested you and you are considering 
participation, please read the additional information in Part 2 before making any 
decision 
 
Part 2 
What will happen if I don’t want to carry on with the study? 
The study consists of three actions at the most. The blood test, a questionnaire, 
which we will give you when you have the test done, and a further questionnaire 
if you are referred to your GP. If at any point you do not wish to continue with 
the study you can withdraw without giving any reason. We will keep the results 
of the tests you have already completed. Withdrawal will not affect any other 
part of the service you receive from your optician. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to 
the researchers who will do their best to answer your questions.  If you remain 
unhappy and wish to complain formally, you can do this through the School of 
Medicine and Health, Durham University. The address is shown at the end of 
part 2. 
 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will 
be kept strictly confidential, and any information about you that leaves the 
opticians will have your name and address removed so that you cannot be 
recognised. 
Involvement of the General Practitioner/Family doctor (GP)   
If your blood glucose level is above a certain level we will advise you to visit 
your GP. We will also send them a copy of the results. 
What will happen to any samples I give? 
We will be collecting a tiny drop of blood on to a test strip. As soon as the 
machine reads the glucose levels in the blood, we will dispose of the test strip. 
No samples will be kept. 
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What will happen to the results of the research study? 
The results will be written up as part of a thesis. We will also be publishing the 
results in medical journals. We will produce a short report on the results which 
we can send you if you would like. 
Who is organising and funding the research?  
The research is organised and funded by Durham University School of Medicine 
and Health. One of the researchers tuition fees are paid by the Francis J Bell 
fund. 
Who has reviewed the study?  
  
All research is looked at by independent group of people, called a  
Research Ethics Committee to protect your safety, rights, wellbeing and dignity. 
This study has been reviewed and given favourable opinion by Durham 
University School of Medicine and Health Research Ethics Committee.  
Contact details 
For further information regarding this research contact:  
Jenny Howse 
School of Medicine and Health 
Wolfson Research Institute 
Queens Campus 
Stockton on Tees 
TS17 6BH 
j.h.howse@dur.ac.uk 
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 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
Participant number………….. 
 
CONSENT FORM 
        Please initial box  
         
I confirm I have read and understood the information sheet  
dated 23/1/09 version no. 2 for the above study. I have had  
the opportunity to ask questions and have had these answered  
satisfactorily 
   
I understand that my participation is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my  
eye care or legal rights being affected. 
 
I understand that a high blood glucose reading will need further  
investigation and does not mean I necessarily have diabetes. 
 
I am happy for a copy of the test result to be forwarded to my GP 
and for us to contact you to follow up the results if I have a raised  
blood glucose reading. 
 
I agree to take part in this study 
 
Name (please print)…………………………………………………………… 
Signature…………………………………………… Date……………………. 
 
Name of person taking consent………………………………………………. 
Signature……………………………………………  Date…………………… 
 
Time of consent……………………………………………………………….. 
 
Time of blood glucose test…………………………………………………… 
When completed, 1 copy for patient, 1 copy for researcher file. 
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 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
 
Your blood glucose (sugar) level today was…………………..mmol/l 
 
This indicates that you are unlikely to have diabetes at the moment.  
It does not mean you will never develop diabetes. You were offered the 
test today because you said you had at least one factor that puts you at 
increased risk of developing diabetes.  
 
Some risk factors you cannot change, such as family history of diabetes. 
However, there are some that you can change, for example reducing your 
weight if you are overweight. 
 
If you develop any of the symptoms described in the information leaflet 
you should contact you GP.  
 
If you require any further information about diabetes you can visit 
www.diabetes.org.uk or talk to staff at your GPs surgery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0. Results less than 6.1 mmol/l 
 233
 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
 
Your blood glucose (sugar) level today was…………………mmol/l 
 
 
These results show that your blood glucose is a little higher than normal. 
This does not indicate that you definitely have diabetes, but you are at 
risk of having impaired fasting glucose or impaired glucose tolerance, 
which are conditions sometimes referred to as ‘pre-diabetes’ or diabetes. 
It is not possible to say whether or not you have these conditions without 
having further tests. Your GP will be able to carry out these tests for you   
 
People with IFG or IGT are more likely to develop diabetes than people 
without.  
However it has been shown that if you have either of these conditions you 
can reduce the risk or delay the development of diabetes by ensuring you 
have a healthy lifestyle.  
 
We are sending a copy of the results to your GP. We suggest that you 
arrange to see your GP routinely. 
 
We would suggest that you see your GP in the next few weeks to discuss 
these results. You should not change your diet or current medication until 
you have seen your GP.  
 
If you require any further information about diabetes you can visit 
www.diabetes.org.uk or talk to staff at your GPs surgery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Results 6.1-12.1mmol/l 
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 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
 
Your blood glucose (sugar) level today was ……………………..mmol/l 
 
This indicates that you are at high risk of having diabetes. It does not 
mean you definitely have diabetes. Further tests need to be carried out to 
see whether you have diabetes or not.  Your GP will be able to do this for 
you. 
 
We advise that you contact your GP soon so they can investigate to see 
whether you do have diabetes. You should not change your diet or 
current medication until you have seen your GP. 
 
We will send a copy of the results to your GP. 
 
If you require any further information about diabetes you can visit 
www.diabetes.org.uk or talk to staff at your GPs surgery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Results 12.2mmol and above 
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 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
Dear Colleague 
 
I am an optometrist based at Durham University. I am currently involved in a 
research project that aims to look at the feasibility of optometrists carrying out 
screening for diabetes. 
 
The research will be carried out in your area.  I am proposing to carry out random 
capillary blood glucose tests on people attending opticians practices for routine sight 
tests who are found to be at risk of diabetes using the Diabetes UK risk 
questionnaire. 
 
The protocols for referring will be similar to those set out by Diabetes UK and the 
Royal Pharmaceutical Society of Great Britain for screening using random blood 
glucose levels. 
 
Diabetes UK recommend that anyone with risk factors who has a random capillary 
blood glucose whole blood level greater than 5.6mmol/l or plasma level greater than 
6.1 mmol/l should be retested using a fasting test 1 and suggest that this should 
ideally be done by the GP.  People with a random blood levels of 11.1 mmol/l and 
above (12.2mmol/l plasma equivalent) have a high probability of having diabetes 
and they suggest that these individuals should be referred urgently2. 
 
We will be offering the test to anyone who attends a practice for a sight test who 
reports risk factors for diabetes as determined using the Diabetes UK risk 
questionnaire. We will give the patients a copy of the results of the test with 
instructions to visit your practice if necessary.  We will also send you a copy of the 
results if it is found to be 6.1mmol/l or greater. 
 
We will be contacting the patient again around month after the test to determine the 
outcome of the referral. Other than the referral letter, we will have no other contact 
with you and we will not expect you to report any results to us. 
 
If you would like any further information, please contact me on 
j.h.howse@durham.ac.uk or 0191 33408689. 
 
I would like to thank you in advance for your help. 
 
Yours sincerely 
 
Jenny Howse 
 
1. Diabetes UK (2007) Measure Up Campaign. Information for health care professionals: who should be screened for 
diabetes and how?  
2. RPSGB (2004) Practice guidance on the care of people with diabetes (incorporating ‘Early Identification” guidance) 
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 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
 
 
To Dr       Date 
Surgery 
 
Patients Name 
Address  
DOB 
 
This patient presented with risk factors of diabetes and was found to have 
a random blood glucose level of  …………….  on testing. 
 
Diabetes UK guidelines recommend the following action. 
 
……… Retested using fasting test (results between 6.1-12.1mmol/l) 
 
……… High risk of diabetes, further investigation required (≥12.2mmol/l) 
 
I have asked them to see you for further investigation 
 
Signed (Optometrist/researcher) 
 
 
 
Practice Details 
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Practice A 
Meter 33771032 
Date Test Solution Strip lot Result Expected 
range 
Tester 
 
18/5/09 1597 Low 8KC3A07 2.3 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.7 5.8-8.1 JH 
 1615 High 8KC3A07 21.7 16.8-23.3 JH 
19/5/09 1597 Low 8KC3A07 2.4 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.6 5.8-8.1 JH 
 1615 High 8KC3A07 21.9 16.8-23.3 JH 
20/5/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.3 5.8-8.1 TL 
 1615 High 8KC3A07 20.9 16.8-23.3 TL 
21/5/09 1597 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.3 5.8-8.1 SB 
 1615 High 8KC3A07 20.6 16.8-23.3 SB 
22/5/09 1597 Low 8KC3A07 2.4 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.6 5.8-8.1 JH 
 1615 High 8KC3A07 22.1 16.8-23.3 JH 
23/5/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 8.1 5.8-8.1 TL 
 1615 High 8KC3A07 21.3 16.8-23.3 TL 
26/5/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.2 5.8-8.1 TL 
 1615 High 8KC3A07 21.3 16.8-23.3 TL 
27/5/09 1597 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.3 5.8-8.1 SB 
 1615 High 8KC3A07 21.0 16.8-23.3 SB 
28/5/09 1597 Low 8KC3A07 2.4 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.8 5.8-8.1 JH 
 1615 High 8KC3A07 22.6 16.8-23.3 JH 
29/5/09 1597 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 SB 
 1615 High 8KC3A07 21.7 16.8-23.3 SB 
1/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.4 5.8-8.1 TL 
 1615 High 8KC3A07 21.2 16.8-23.3 TL 
2/6/09 1597 Low 8KC3A07 2.5 1.8-2.7 SB 
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 1553 Normal 8KC3A07 7.8 5.8-8.1 SB 
 1615 High 8KC3A07 22.8 16.8-23.3 SB 
3/6/09 1597 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.6 5.8-8.1 TL 
 1615 High 8KC3A07 21.6 16.8-23.3 TL 
4/6/09 1597 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.0 5.8-8.1 TL 
 1615 High 8KC3A07 20.3 16.8-23.3 TL 
5/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.4 5.8-8.1 JH 
 1615 High 8KC3A07 22.1 16.8-23.3 JH 
6/6/09 1597 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.2 5.8-8.1 SB 
 1615 High 8KC3A07 21.4 16.8-23.3 SB 
8/6/09 1597 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.2 5.8-8.1 SB 
 1615 High 8KC3A07 21.4 16.8-23.3 SB 
9/6/09 1597 Low 8KC3A07 2.2 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.3 5.8-8.1 TL 
 1615 High 8KC3A07 21.0 16.8-23.3 TL 
10/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.5 5.8-8.1 JH 
 1615 High 8KC3A07 21.3 16.8-23.3 JH 
11/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.3 5.8-8.1 SB 
 1615 High 8KC3A07 21.6 16.8-23.3 SB 
12/6/09 1597 Low 8KC3A07 2.5 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.8 5.8-8.1 TL 
 1615 High 8KC3A07 23.1 16.8-23.3 TL 
 
Practice B 
Meter 3771040 
 
Date Test Solution Strip lot Result Expected 
range 
Tester 
 
15/6/09 1597 Low 8KC3A07 2.3 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.2 5.8-8.1 JH 
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 1568 High 8KC3A07 21.9 16.8-23.3 JH 
16/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.2 5.8-8.1 JH 
 1615 High 8KC3A07 21.9 16.8-23.3 JH 
17/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.1 5.8-8.1 SB 
 1615 High 8KC3A07 21.0 16.8-23.3 SB 
18/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.3 5.8-8.1 TL 
 1615 High 8KC3A07 20.6 16.8-23.3 TL 
19/6/09 1597 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.2 5.8-8.1 SB 
 1615 High 8KC3A07 21.1 16.8-23.3 SB 
20/6/09 1597 Low 8KC3A07 2.5 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.3 5.8-8.1 TL 
 1615 High 8KC3A07 21.8 16.8-23.3 TL 
21/6/09 1597 Low 8KC3A07 2.6 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 SB 
 1615 High 8KC3A07 22.6 16.8-23.3 SB 
22/6/09 1597 Low 8KC3A07 2.6 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.9 5.8-8.1 JH 
 1615 High 8KC3A07 22.6 16.8-23.3 JH 
23/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 DH 
 1553 Normal 8KC3A07 8.1 5.8-8.1 DH 
 1615 High 8KC3A07 23.2 16.8-23.3 DH 
24/6/09 1597 Low 8KC3A07 2.6 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 SB 
 1615 High 8KC3A07 22.8 16.8-23.3 SB 
25/6/09 1597 Low 8KC3A07 2.5 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.8 5.8-8.1 TL 
 1615 High 8KC3A07 22.4 16.8-23.3 TL 
26/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 SB 
 1615 High 8KC3A07 21.6 16.8-23.3 SB 
27/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 8.1 5.8-8.1 TL 
 1615 High 8KC3A07 21.7 16.8-23.3 TL 
28/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 RM 
 1553 Normal 8KC3A07 7.9 5.8-8.1 RM 
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 1615 High 8KC3A07 22.9 16.8-23.3 RM 
29/6/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.6 5.8-8.1 SB 
 1615 High 8KC3A07 22.3 16.8-23.3 SB 
30/6/09 1597 Low 8KC3A07 2.6 1.8-2.7 SB 
 1553 Normal 8KC3A07 8.1 5.8-8.1 SB 
 1615 High 8KC3A07 23.0 16.8-23.3 SB 
1/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.4 5.8-8.1 TL 
 1615 High 8KC3A07 20.4 16.8-23.3 TL 
2/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.6 5.8-8.1 SB 
 1615 High 8KC3A07 21.1 16.8-23.3 SB 
3/7/09 1597 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.5 5.8-8.1 TL 
 1615 High 8KC3A07 21.4 16.8-23.3 TL 
4/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 8.0 5.8-8.1 SB 
 1615 High 8KC3A07 23.2 16.8-23.3 SB 
5/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.8 5.8-8.1 TL 
 1615 High 8KC3A07 22.3 16.8-23.3 TL 
6/7/09 1597 Low 8KC3A07 2.6 1.8-2.7 TL 
 1553 Normal 8KC3A07 8.1 5.8-8.1 TL 
 1615 High 8KC3A07 22.9 16.8-23.3 TL 
7/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.9 5.8-8.1 SB 
 1615 High 8KC3A07 22.3 16.8-23.3 SB 
8/7/09 1597 Low 8KC3A07 2.5 1.8-2.7 JH 
 1553 Normal 8KC3A07 8.0 5.8-8.1 JH 
 1615 High 8KC3A07 22.4 16.8-23.3 JH 
9/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.3 5.8-8.1 TL 
 1615 High 8KC3A07 21.8 16.8-23.3 TL 
10/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.3 5.8-8.1 SB 
 1615 High 8KC3A07 21.7 16.8-23.3 SB 
11/7/09 1597 Low 8KC3A07 2.4 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.4 5.8-8.1 TL 
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 1615 High 8KC3A07 21.6 16.8-23.3 TL 
12/7/09 1597 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.5 5.8-8.1 TL 
 1615 High 8KC3A07 21.9 16.8-23.3 TL 
 
 
Practice C 
Meter 3771137 
Date Test Solution Strip lot Result Expected 
range 
Tester 
 
6/7/09 1549 Low 8KC3A07 2.5 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.9 5.8-8.1 JH 
 1610 High 8KC3A07 21.6 16.8-23.3 JH 
7/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 SB 
 1610 High 8KC3A07 20.8 16.8-23.3 SB 
9/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.5 5.8-8.1 SB 
 1610 High 8KC3A07 21.1 16.8-23.3 SB 
10/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.1 5.8-8.1 TL 
 1610 High 8KC3A07 21.6 16.8-23.3 TL 
11/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.6 5.8-8.1 SB 
 1610 High 8KC3A07 22.7 16.8-23.3 SB 
13/7/09 1549 Low 8KC3A07 2.5 1.8-2.7 JB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 JB 
 1610 High 8KC3A07 21.2 16.8-23.3 JB 
14/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 DH 
 1553 Normal 8KC3A07 7.9 5.8-8.1 DH 
 1610 High 8KC3A07 22.4 16.8-23.3 DH 
15/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.4 5.8-8.1 SB 
 1610 High 8KC3A07 21.1 16.8-23.3 SB 
16/7/09 1549 Low 8KC3A07 2.5 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.6 5.8-8.1 TL 
 1610 High 8KC3A07 22.3 16.8-23.3 TL 
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17/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 JB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 JB 
 1610 High 8KC3A07 21.9 16.8-23.3 JB 
18/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 RM 
 1553 Normal 8KC3A07 7.6 5.8-8.1 RM 
 1610 High 8KC3A07 23.1 16.8-23.3 RM 
20/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.7 5.8-8.1 SB 
 1610 High 8KC3A07 21.6 16.8-23.3 SB 
21/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 DH 
 1553 Normal 8KC3A07 8.0 5.8-8.1 DH 
 1610 High 8KC3A07 22.4 16.8-23.3 DH 
22/7/09 1549 Low 8KC3A07 2.6 1.8-2.7 JB 
 1553 Normal 8KC3A07 8.1 5.8-8.1 JB 
 1610 High 8KC3A07 22.1 16.8-23.3 JB 
23/7/09 1549 Low 8KC3A07 2.6 1.8-2.7 DH 
 1553 Normal 8KC3A07 7.8 5.8-8.1 DH 
 1610 High 8KC3A07 21.7 16.8-23.3 DH 
24/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.5 5.8-8.1 SB 
 1610 High 8KC3A07 22.0 16.8-23.3 SB 
25/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 JH 
 1553 Normal 8KC3A07 7.6 5.8-8.1 JH 
 1610 High 8KC3A07 21.3 16.8-23.3 JH 
27/7/09 1549 Low 8KC3A07 2.6 1.8-2.7 DH 
 1553 Normal 8KC3A07 7.7 5.8-8.1 DH 
 1610 High 8KC3A07 22.5 16.8-23.3 DH 
28/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 JB 
 1553 Normal 8KC3A07 7.2 5.8-8.1 JB 
 1610 High 8KC3A07 21.5 16.8-23.3 JB 
28/7/09 1549 Low 9CC3B31 2.4 1.9-2.7 JB 
 1553 Normal 9CC3B31 7.8 6.0-8.3 JB 
 1610 High 9CC3B31 22.8 17.3-23.9 JB 
29/7/09 1549 Low 9CC3B31 2.5 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.7 6.0-8.3 TL 
 1610 High 9CC3B31 21.8 17.3-23.9 TL 
30/7/09 1597 Low 9CC3B31 2.4 1.9-2.7 JB 
 1553 Normal 9CC3B31 7.5 6.0-8.3 JB 
 1615 High 9CC3B31 22.2 17.3-23.9 JB 
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31/7/09 1597 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.3 6.0-8.3 TL 
 1615 High 9CC3B31 21.6 17.3-23.9 TL 
1/8/09 1597 Low 9CC3B31 2.4 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.5 6.0-8.3 JH 
 1615 High 9CC3B31 22.3 17.3-23.9 JH 
 
 
Practice D 
Meter 3771044 
Date Test Solution Strip lot Result Expected 
range 
Tester 
 
20/7/09 1549 Low 8KC3A07 2.7 1.8-2.7 JH 
 1553 Normal 8KC3A07 8.1 5.8-8.1 JH 
 1615 High 8KC3A07 23.2 16.8-23.3 JH 
21/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 SB 
 1553 Normal 8KC3A07 7.6 5.8-8.1 SB 
 1615 High 8KC3A07 23.3 16.8-23.3 SB 
22/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.4 5.8-8.1 TL 
 1615 High 8KC3A07 21.0 16.8-23.3 TL 
23/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 JB 
 1553 Normal 8KC3A07 6.9 5.8-8.1 JB 
 1615 High 8KC3A07 21.1 16.8-23.3 JB 
24/7/09 1549 Low 8KC3A07 2.3 1.8-2.7 TL 
 1553 Normal 8KC3A07 7.6 5.8-8.1 TL 
 1615 High 8KC3A07 20.9 16.8-23.3 TL 
25/7/09 1549 Low 8KC3A07 2.4 1.8-2.7 RM 
 1553 Normal 8KC3A07 7.8 5.8-8.1 RM 
 1615 High 8KC3A07 21.9 16.8-23.3 RM 
28/7/09 1549 Low 9CC3B31 2.5 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.9 6.0-8.3 SB 
 1615 High 9CC3B31 21.8 17.3-23.9 SB 
29/7/09 1549 Low 9CC3B31 2.4 1.9-2.7 JB 
 1553 Normal 9CC3B31 7.8 6.0-8.3 JB 
 1615 High 9CC3B31 21.78 17.3-23.9 JB 
30/7/09 1549 Low 9CC3B31 2.4 1.9-2.7 SB 
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 1553 Normal 9CC3B31 7.6 6.0-8.3 SB 
 1615 High 9CC3B31 21.0 17.3-23.9 SB 
31/7/09 1549 Low 9CC3B31 2.4 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.5 6.0-8.3 JH 
 1615 High 9CC3B31 22.3 17.3-23.9 JH 
1/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 RM 
 1553 Normal 9CC3B31 7.8 6.0-8.3 RM 
 1615 High 9CC3B31 22.3 17.3-23.9 RM 
3/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 SB 
 1553 Normal 9CC3B31 8.1 6.0-8.3 SB 
 1615 High 9CC3B31 21.4 17.3-23.9 SB 
4/8/09 1549 Low 9CC3B31 2.3 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.8 6.0-8.3 SB 
 1615 High 9CC3B31 21.6 17.3-23.9 SB 
5/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.7 6.0-8.3 SB 
 1615 High 9CC3B31 21.7 17.3-23.9 SB 
6/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.4 6.0-8.3 TL 
 1615 High 9CC3B31 22.1 17.3-23.9 TL 
7/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.7 6.0-8.3 JH 
 1615 High 9CC3B31 21.9 17.3-23.9 JH 
8/8/09 1549 Low 9CC3B31 2.6 1.9-2.7 RM 
 1553 Normal 9CC3B31 7.8 6.0-8.3 RM 
 1615 High 9CC3B31 22.3 17.3-23.9 RM 
10/8/09 1549 Low 9CC3B31 2.6 1.9-2.7 TL 
 1553 Normal 9CC3B31 8.1 6.0-8.3 TL 
 1615 High 9CC3B31 23.5 17.3-23.9 TL 
11/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.7 6.0-8.3 SB 
 1615 High 9CC3B31 22.1 17.3-23.9 SB 
12/8/09 1549 Low 9CC3B31 2.3 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.5 6.0-8.3 SB 
 1610 High 9CC3B31 21.3 17.3-23.9 SB 
13/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.9 6.0-8.3 TL 
 1615 High 9CC3B31 21.6 17.3-23.9 TL 
14/8/09 1549 Low 9CC3B31 2.6 1.9-2.7 SB 
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 1553 Normal 9CC3B31 8.1 6.0-8.3 SB 
 1615 High 9CC3B31 21.8 17.3-23.9 SB 
15/8/09 1597 Low 9CC3B31 2.3 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.2 6.0-8.3 JH 
 1615 High 9CC3B31 21.6 17.3-23.9 JH 
 
Practice E 
Meter 3771133 
Date Test Solution Strip lot Result Expected 
range 
Tester 
 
17/8/09 1549 Low 9CC3B31 2.6 1.9-2.7 JH 
 1553 Normal 9CC3B31 8.1 6.0-8.3 JH 
 1615 High 9CC3B31 22.6 17.3-23.9 JH 
18/8/09 1549 Low 9CC3B31 2.6 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.9 6.0-8.3 TL 
 1615 High 9CC3B31 22.7 17.3-23.9 TL 
19/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 JB 
 1553 Normal 9CC3B31 7.7 6.0-8.3 JB 
 1615 High 9CC3B31 22.6 17.3-23.9 JB 
20/8/09 1549 Low 9CC3B31 2.6 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.8 6.0-8.3 SB 
 1615 High 9CC3B31 22.7 17.3-23.9 SB 
21/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.3 6.0-8.3 TL 
 1615 High 9CC3B31 21.1 17.3-23.9 TL 
22/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 RM 
 1553 Normal 9CC3B31 7.8 6.0-8.3 RM 
 1615 High 9CC3B31 22.2 17.3-23.9 RM 
24/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 JB 
 1553 Normal 9CC3B31 8.3 6.0-8.3 JB 
 1615 High 9CC3B31 22.8 17.3-23.9 JB 
25/8/09 1549 Low 9CC3B31 2.7 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.9 6.0-8.3 JH 
 1615 High 9CC3B31 23.0 17.3-23.9 JH 
26/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.2 6.0-8.3 TL 
 1615 High 9CC3B31 21.6 17.3-23.9 TL 
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27/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.4 6.0-8.3 SB 
 1615 High 9CC3B31 21.7 17.3-23.9 SB 
28/8/09 1549 Low 9CC3B31 2.5 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.6 6.0-8.3 SB 
 1615 High 9CC3B31 21.7 17.3-23.9 SB 
29/8/09 1549 Low 9CC3B31 2.4 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.4 6.0-8.3 SB 
 1615 High 9CC3B31 21.8 17.3-23.9 SB 
1/9/09 1549 Low 9CC3B31 2.6 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.9 6.0-8.3 JH 
 1615 High 9CC3B31 23.3 17.3-23.9 JH 
2/9/09 1549 Low 9CC3B31 2.4 1.9-2.7 SB 
 1553 Normal 9CC3B31 7.6 6.0-8.3 SB 
 1615 High 9CC3B31 21.9 17.3-23.9 SB 
3/9/09 1549 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.6 6.0-8.3 TL 
 1615 High 9CC3B31 21.8 17.3-23.9 TL 
4/9/09 1549 Low 9CC3B31 2.6 1.9-2.7 JB 
 1553 Normal 9CC3B31 7.6 6.0-8.3 JB 
 1615 High 9CC3B31 22.5 17.3-23.9 JB 
5/9/09 1549 Low 9CC3B31 2.5 1.9-2.7 RM 
 1553 Normal 9CC3B31 8.1 6.0-8.3 RM 
 1615 High 9CC3B31 23.2 17.3-23.9 RM 
7/9/09 1549 Low 9CC3B31 2.5 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.7 6.0-8.3 TL 
 1615 High 9CC3B31 23.1 17.3-23.9 TL 
8/9/09 1549 Low 9CC3B31 2.7 1.9-2.7 JB 
 1553 Normal 9CC3B31 8.2 6.0-8.3 JB 
 1615 High 9CC3B31 22.7 17.3-23.9 JB 
9/9/09 1549 Low 9CC3B31 2.4 1.9-2.7 JH 
 1553 Normal 9CC3B31 7.4 6.0-8.3 JH 
 1615 High 9CC3B31 21.8 17.3-23.9 JH 
10/9/09 1549 Low 9CC3B31 2.4 1.9-2.7 TL 
 1553 Normal 9CC3B31 7.2 6.0-8.3 TL 
 1615 High 9CC3B31 21.7 17.3-23.9 TL 
11/9/09 1549 Low 9CC3B31 2.5 1.9-2.7 JB 
 1553 Normal 9CC3B31 8.1 6.0-8.3 JB 
 1615 High 9CC3B31 22.0 17.3-23.9 JB 
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Appendix G 
Follow up questionnaire for participants with rCBG 
of 6.1mmol/l or more 
 250
 Feasibility and acceptability of offering finger-prick blood glucose testing in 
optometric practice 
Participant number      xxx 2009 
 
You recently attended your opticians and had your blood sugar levels checked. 
Based on the information you gave us, and the results of the blood test, we 
suggested that you should visit your GP. We also sent the results of your blood 
test to your GP. 
As we explained when you attended your opticians, we are following up on the 
referral. I have enclosed a short questionnaire. I would be very grateful if you 
could complete it as fully as you can and return it in the stamped addressed 
envelope supplied. 
 
Please tick the appropriate statement 
1. Did you visit your GPs practice about the results of the blood test you had at 
the opticians?   ………YES – please go to question 2  
    ………NO – Thank you for your help. Your do not 
     need to answer any further questions 
 
2. Did your GP or Nurse carry out any further tests to see if you had diabetes? 
    ………YES – please go to question 3  
    ………NO – Thank you for your help. Your do not 
     need to answer any further questions 
    ………UNSURE – please go to question 3 
 
3. Did your GP or nurse give you a diagnosis or tell you that you had any of the 
following? 
    ……… Diabetes 
 ……… Pre-diabetes  
 ……… Impaired Fasting Glucose   
 ……… Impaired Glucose tolerance   
   ……… Borderline diabetes 
    ……… No diagnosis/Normal  
    ……… Unsure of diagnosis 
Thank you very much for your help 
 
 
 251
 
 
 
 
 
 
Appendix H 
Acceptability questionnaire 
 252
 Feasibility and acceptability of offering finger-prick blood glucose 
testing in optometric practice 
Participant ID  ……………..     
 
Thank you for taking part in the study today. 
We would be very grateful if you could complete following questions as fully as possible.  
The questionnaires are anonymous. The researcher who will look at the responses will 
not have access to your personal details and we will not report individual responses to 
your optician. 
 
1. How often do you usually visit an optician? Please tick one response 
 ……… Every year 
 ……… Every 2 years 
 ……… Every 3-4 years 
 ……… Less frequently 
 ……… This was my first sight test 
 
2. Have you ever been screened or tested for diabetes before the test that was carried 
out at the opticians? Please tick one response. 
 ……… Yes  
 ……… No 
 
3. Please think about the diabetes test you had done at the opticians (not the sight test) 
and circle the response that you feel most accurately describes your response 
 Strongly 
agree 
Agree Neither 
agree or 
disagree 
Disagree Strongly 
disagree 
The opticians practice was 
convenient for the 
screening test 
1 2 3 4 5 
The screening test was 
uncomfortable 
1 2 3 4 5 
I would recommend 
friends/family to have the 
test 
1 2 3 4 5 
I expect opticians to be 
able to detect health 
problems 
1 2 3 4 5 
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4. If you had not had the diabetes test done at the opticians, would you have gone 
anywhere else and asked for a screening test? 
 ……… NO – please go to question 6 
 ……… YES – please go to question 5 
 
5. Where would you have gone for the diabetes test? 
 ……… GP/practice nurse 
 ……… Pharmacy 
 ……… Other  - Please indicate where…………………………………….. 
 
6. If you have any comments about the diabetes screening test you had at the opticians, 
please write below.  
 
 
 
 
 
 
 
 
Thank you for help. 
 
 
 
Please return the form in the stamped addressed envelope provided. 
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